<SEC-DOCUMENT>0001213900-23-045405.txt : 20230602
<SEC-HEADER>0001213900-23-045405.hdr.sgml : 20230602
<ACCEPTANCE-DATETIME>20230602084312
ACCESSION NUMBER:		0001213900-23-045405
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		22
CONFORMED PERIOD OF REPORT:	20230531
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230602
DATE AS OF CHANGE:		20230602

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Peraso Inc.
		CENTRAL INDEX KEY:			0000890394
		STANDARD INDUSTRIAL CLASSIFICATION:	SEMICONDUCTORS & RELATED DEVICES [3674]
		IRS NUMBER:				770291941
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-32929
		FILM NUMBER:		23986843

	BUSINESS ADDRESS:	
		STREET 1:		2309 BERING DRIVE
		CITY:			SAN JOSE
		STATE:			CA
		ZIP:			95131
		BUSINESS PHONE:		408 418 7500

	MAIL ADDRESS:	
		STREET 1:		2309 BERING DRIVE
		CITY:			SAN JOSE
		STATE:			CA
		ZIP:			95131

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MoSys, Inc.
		DATE OF NAME CHANGE:	20060530

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MONOLITHIC SYSTEM TECHNOLOGY INC
		DATE OF NAME CHANGE:	19960613
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ea179675-8k_peraso.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:us-roles="http://fasb.org/us-roles/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:PRSO="http://perasoinc.com/20230531">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02C_US%2DGAAP%2D2023 -->
<!-- Field: Set; Name: xdx; ID: xdx_036_PRSO_perasoinc.com_20230531 -->
<!-- Field: Set; Name: xdx; ID: xdx_042_20230531_20230531 -->
<!-- Field: Set; Name: xdx; ID: xdx_058_edei%2D%2DEntityCentralIndexKey_0000890394 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2023-05-31to2023-05-31" name="dei:EntityCentralIndexKey">0000890394</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2023-05-31to2023-05-31" name="dei:AmendmentFlag">false</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="prso-20230531.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2023-05-31to2023-05-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000890394</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-05-31</xbrli:startDate>
        <xbrli:endDate>2023-05-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="margin: 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Washington, D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b></b></p>

<!-- Field: Rule-Page --><div style="margin: 0pt auto; width: 25%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM <span id="xdx_909_edei--DocumentType_c20230531__20230531_zia3oFR0Oudk"><ix:nonNumeric contextRef="From2023-05-31to2023-05-31" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b></b></p>

<!-- Field: Rule-Page --><div style="margin: 0pt auto; width: 25%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Date of Report (Date of earliest event Reported):
<span id="xdx_906_edei--DocumentPeriodEndDate_c20230531__20230531_z52SE1JDRF61"><ix:nonNumeric contextRef="From2023-05-31to2023-05-31" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">May 31, 2023</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span id="xdx_903_edei--EntityRegistrantName_c20230531__20230531_z95cakCzsjn9"><ix:nonNumeric contextRef="From2023-05-31to2023-05-31" name="dei:EntityRegistrantName">Peraso Inc.</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Exact Name of Registrant as Specified in Charter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span id="xdx_906_edei--EntityFileNumber_c20230531__20230531_zCDkyiYOGrX5"><ix:nonNumeric contextRef="From2023-05-31to2023-05-31" name="dei:EntityFileNumber">000-32929</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Commission File Number)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: center; width: 49%"><span style="font-size: 10pt"><b><span id="xdx_908_edei--EntityIncorporationStateCountryCode_c20230531__20230531_zMYQFRGFtF1i"><ix:nonNumeric contextRef="From2023-05-31to2023-05-31" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
    <td style="padding-bottom: 1.5pt; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: center; width: 49%"><span style="font-size: 10pt"><b><span id="xdx_901_edei--EntityTaxIdentificationNumber_c20230531__20230531_z1PuQlkzL07i"><ix:nonNumeric contextRef="From2023-05-31to2023-05-31" name="dei:EntityTaxIdentificationNumber">77-0291941</ix:nonNumeric></span></b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="font-size: 10pt; text-align: center"><span style="font-size: 10pt">(State or Other Jurisdiction <br />
of Incorporation)</span></td>
    <td>&#160;</td>
    <td style="font-size: 10pt; text-align: center"><span style="font-size: 10pt">(I.R.S. Employer <br />
Identification Number)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_90C_edei--EntityAddressAddressLine1_c20230531__20230531_zxS8ownGVXP4"><ix:nonNumeric contextRef="From2023-05-31to2023-05-31" name="dei:EntityAddressAddressLine1">2309 Bering Dr.</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_908_edei--EntityAddressCityOrTown_c20230531__20230531_zNLwg4hiVyq2"><ix:nonNumeric contextRef="From2023-05-31to2023-05-31" name="dei:EntityAddressCityOrTown">San Jose</ix:nonNumeric></span>, <span id="xdx_901_edei--EntityAddressStateOrProvince_c20230531__20230531_zqQMLgHCXUa1"><ix:nonNumeric contextRef="From2023-05-31to2023-05-31" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince">California</ix:nonNumeric></span> <span id="xdx_90A_edei--EntityAddressPostalZipCode_c20230531__20230531_zkaiyG9VzlB6"><ix:nonNumeric contextRef="From2023-05-31to2023-05-31" name="dei:EntityAddressPostalZipCode">95131</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Address of principal executive offices, with zip
code)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(<span id="xdx_90D_edei--CityAreaCode_c20230531__20230531_zCKIEmk6rlW7"><ix:nonNumeric contextRef="From2023-05-31to2023-05-31" name="dei:CityAreaCode">408</ix:nonNumeric></span>) <span id="xdx_908_edei--LocalPhoneNumber_c20230531__20230531_zeUtcrijmlSj"><ix:nonNumeric contextRef="From2023-05-31to2023-05-31" name="dei:LocalPhoneNumber">418-7500</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Registrant&#8217;s telephone number, including
area code)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>N/A</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Former name or former address, if changed since
last report)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_edei--WrittenCommunications_c20230531__20230531_zXqtCEipYPTd"><ix:nonNumeric contextRef="From2023-05-31to2023-05-31" format="ixt:booleanfalse" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td><td style="text-align: justify"><span style="font-size: 10pt">Written communications pursuant
to Rule 425 under the Securities Act (17 CFR 230.425)</span></td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_edei--SolicitingMaterial_c20230531__20230531_zHx25ew4G5g8"><ix:nonNumeric contextRef="From2023-05-31to2023-05-31" format="ixt:booleanfalse" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td><td style="text-align: justify"><span style="font-size: 10pt">Soliciting material pursuant to
Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_edei--PreCommencementTenderOffer_c20230531__20230531_ziIIJ01z9O91"><ix:nonNumeric contextRef="From2023-05-31to2023-05-31" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td><td style="text-align: justify"><span style="font-size: 10pt">Pre-commencement communications
pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_edei--PreCommencementIssuerTenderOffer_c20230531__20230531_zQvyn09bnCn5"><ix:nonNumeric contextRef="From2023-05-31to2023-05-31" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td><td style="text-align: justify"><span style="font-size: 10pt">Pre-commencement communications
pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td>
</tr></table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Securities registered pursuant to Section 12(b) of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center; width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title of each class</span></td>
    <td style="padding-bottom: 1.5pt; vertical-align: bottom; text-align: center; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center; width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trading Symbol(s)</span></td>
    <td style="padding-bottom: 1.5pt; vertical-align: bottom; text-align: center; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center; width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name of each exchange on which registered</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_edei--Security12bTitle_c20230531__20230531_z1roFfCgDLZg"><ix:nonNumeric contextRef="From2023-05-31to2023-05-31" name="dei:Security12bTitle">Common Stock, par value $0.001 per share</ix:nonNumeric></span></span></td>
    <td style="text-align: center; vertical-align: top">&#160;</td>
    <td style="text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_edei--TradingSymbol_c20230531__20230531_zku4Mt7Mh2e6"><ix:nonNumeric contextRef="From2023-05-31to2023-05-31" name="dei:TradingSymbol">PRSO</ix:nonNumeric></span></span></td>
    <td style="text-align: center; vertical-align: top">&#160;</td>
    <td style="text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The <span id="xdx_908_edei--SecurityExchangeName_c20230531__20230531_zO9woLMdLggg"><ix:nonNumeric contextRef="From2023-05-31to2023-05-31" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Stock Market LLC</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (17 CFR &#167;230.405) or Rule 12b-2 of the Securities Exchange Act of 1934
(17 CFR &#167;240.12b-2).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Emerging growth company <span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90A_edei--EntityEmergingGrowthCompany_c20230531__20230531_zgafr2vd2ZTk"><ix:nonNumeric contextRef="From2023-05-31to2023-05-31" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section 13(a) of the Exchange Act. <span style="font-family: Times New Roman, Times, Serif">&#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 1.01 Entry into a Material Definitive
Agreement.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On May 31, 2023, Peraso Inc. (the &#8220;Company&#8221;)
entered into a Securities Purchase Agreement (the &#8220;Purchase Agreement&#8221;) with an institutional investor (the &#8220;Purchaser&#8221;),
pursuant to which the Company will offer and sell to the Purchaser, in a registered direct offering, an aggregate of 2,250,000 shares
(the &#8220;Shares&#8221;) of common stock, par value $0.001 per share (the &#8220;Common Stock&#8221;), at a negotiated purchase price
of $0.70 per share. The Company also offered and sold to the Purchaser pre-funded warrants to purchase up to 3,464,286 shares of Common
Stock (the &#8220;Pre-Funded Warrants&#8221;), in lieu of shares of Common Stock at the Purchaser&#8217;s election. Each Pre-Funded Warrant
is exercisable for one share of Common Stock. The purchase price of each Pre-Funded Warrant is $0.69, and the exercise price of each Pre-Funded
Warrant is $0.01 per share. The Pre-Funded Warrants are immediately exercisable and may be exercised at any time until all of the Pre-Funded
Warrants are exercised in full.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Shares, the Pre-Funded Warrants and the shares
of Common Stock issuable upon exercise of the Pre-Funded Warrants (the &#8220;Pre-Funded Warrant Shares&#8221;) are being offered by the
Company pursuant to an effective shelf registration statement on Form S-3 (No. 333-258386), which was declared effective by the United
States Securities and Exchange Commission (the &#8220;SEC&#8221;) on August 9, 2021 (the &#8220;Registration Statement&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In a concurrent private placement, the Company
is also selling to the Purchaser warrants (the &#8220;Purchase Warrants&#8221; and together with the Pre-Funded Warrants, the &#8220;Warrants&#8221;)
to purchase up to 5,714,286 shares of Common Stock (the &#8220;Purchase Warrant Shares&#8221; and, together with the Pre-Funded Warrant
Shares, the &#8220;Warrant Shares&#8221;). The Purchase Warrants will be immediately exercisable upon issuance (the &#8220;Initial Exercise
Date&#8221;) at an exercise price of $0.70 per share and will expire on the five-year anniversary of the Initial Exercise Date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Purchase Warrants will be exercisable on a &#8220;cashless&#8221;
basis, if, at any time they are exercised there is not: i) an effective registration statement for the resale of the Purchase Warrant
Shares in place or ii) a current resale prospectus then available.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The exercise price and number of Warrant Shares
will be subject to adjustment in the event of any stock dividend or split, reverse stock split, recapitalization, reorganization or similar
transaction, as described in the Warrants.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Purchase Agreement contains customary representations
and warranties and agreements of the Company and the Purchaser and customary indemnification rights and obligations of the parties. The
closing of the offering is expected to occur on or about June 2, 2023, subject to customary closing conditions. The Company is expected
to receive gross proceeds of approximately $4 million in connection with the offering, before deducting placement agent fees and related
offering expenses.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">From the date of the Purchase Agreement until
six months after the closing date of the sale of the Shares and the Warrants, the Purchaser will have a right to participate in subsequent
financings by the Company up to an amount equal to 30% of the total amount of such financing by giving notice of the exercise of such
right on the third trading day after which the Purchaser receives notice of the proposed financing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">From the date of the Purchase Agreement until
90 days after the closing date of the sale of the Shares and the Warrants, the provisions of the Purchase Agreement generally prohibit
the Company from issuing or agreeing to issue shares of Common Stock or common stock equivalents other than under equity compensation
plans, outstanding rights to acquire common stock or common stock equivalents, or in connection with certain strategic transactions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 2; Options: NewSection -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the terms of the Purchase Agreement,
the Company is prohibited from (i) entering into an &#8220;ATM&#8221; offering, that is an offering of Common Stock into its existing
trading market for the Common Stock at a price or prices related to the then-market price of the Common Stock, within six months after
the date of the Purchase Agreement and (ii) issuing or agreeing to issue shares of Common Stock or common stock equivalents that are variable
until the earlier of 12 months after the date of the Purchase Agreement or the date the Purchaser no longer holds any Warrants.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Purchase Warrants, the Purchase Warrant Shares,
the Placement Agent Warrants (as defined below) and the shares of Common Stock issuable upon exercise of the Placement Agent Warrants
are not being registered under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), and are instead being offered
pursuant to the exemption provided in Section 4(a)(2) under the Securities Act and Regulation D promulgated thereunder, or in the event
of an issuance of Warrant Shares or shares of Common Stock underlying the Placement Agent Warrants on a cashless basis, pursuant to the
exemption provided in Section 3(a)(9) under the Securities Act.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Purchaser is an &#8220;accredited investor&#8221;
as defined in Rule 501(a)(1), (a)(2), (a)(3), (a)(7), (a)(8), (a)(9), (a)(12) or (a)(13) under the Securities Act. The Purchaser, either
alone or together with its representatives, has enough knowledge and experience to be considered a sophisticated investor, has access
to the type of information normally provided in a prospectus for a registered securities offering, and has agreed not to resell or distribute
the Purchase Warrants or the Purchase Warrant Shares to the public except pursuant to sales registered or exempt from negotiation under
the Securities Act.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Also on or prior to the closing date, in connection
with the Purchase Agreement, the Company will enter into a Registration Rights Agreement (the &#8220;Registration Rights Agreement&#8221;)
with the Purchaser. Under the Registration Rights Agreement, the Company is required to file a registration statement within 15 calendar
days after signing the Registration Rights Agreement to register the Purchase Warrant Shares for resale by the Purchaser. The Company&#8217;s
failure to meet the filing deadlines and other requirements set forth in the Registration Rights Agreement may subject the Company to
monetary penalties.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Benchmark Company, LLC acted as the sole placement
agent (the &#8220;Placement Agent&#8221;) on a &#8220;best efforts&#8221; and exclusive basis, in connection with the offering. The Placement
Agent will be entitled to a cash fee of 7.0% of the gross proceeds paid to the Company for the Shares and the Pre-Funded Warrants, the
reimbursement of certain out-of-pocket expenses and warrants to purchase up to 285,714 shares of Common Stock at an exercise price of
$0.70 per share, which represents 5.0% of the aggregate number of Shares and shares underlying the Pre-Funded Warrants sold in the offering
(the &#8220;Placement Agent Warrants&#8221;). The Placement Agent Warrants will be immediately exercisable for a period of five years.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">An opinion of Mitchell Silberberg &amp; Knupp
LLP regarding the validity of the Shares, the Pre-Funded Warrants and the Pre-Funded Warrant Shares is filed as Exhibit 5.1.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with the execution of the Purchase Agreement, the Company
and the Purchaser entered into an amendment (the &#8220;Amendment&#8221;) to that certain common stock purchase warrant previously issued
by the Company on November 30, 2022 to the Purchaser to purchase up to 3,675,000 shares of Common Stock (the &#8220;Prior Warrant&#8221;).
Pursuant to the terms of the Amendment, the Prior Warrant was amended to reduce the exercise price per share from $1.36 to $1.00, effective
as of the closing date of the offering.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The foregoing summaries of the offering, the
securities to be issued in connection therewith, the Purchase Agreement, the Registration Rights Agreement, the Warrants, the
Placement Agent Warrants and the Amendment do not purport to be complete and are qualified in their entirety by reference to the
definitive transaction documents. Copies of the form of Purchase Agreement, the Registration Rights Agreement, the form of
Pre-Funded Warrant, the form of Purchase Warrant, the form of Placement Agent Warrant and the Amendment are attached hereto as
Exhibits 10.1, 10.2, 4.1, 4.2, 4.3 and 10.3, respectively, and are incorporated by reference in response to this Item 1.01.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b></p>

<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Item 3.02 Unregistered Sales of Equity Securities.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The information set forth in Item 1.01 above is incorporated herein
by reference into this Item 3.02.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Item 8.01 Other Events.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On May 31, 2023, the Company issued a press release announcing the
offering described in Item 1.01 above, a copy of which is attached as Exhibit 99.1 and incorporated by reference into this Item 8.01.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Cautionary Note Regarding Forward-Looking Statements</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The information contained in this Current Report on Form 8-K and the
exhibits attached hereto contain &#8220;forward-looking&#8221; statements within the meaning of the Private Securities Litigation Reform
Act of 1995. The words &#8220;intend,&#8221; &#8220;may,&#8221; &#8220;should,&#8221; &#8220;would,&#8221; &#8220;expect,&#8221; &#8220;plan,&#8221;
&#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;estimate,&#8221; &#8220;predict,&#8221; &#8220;potential&#8221; or &#8220;continue&#8221;
or the negative of these terms or other comparable terminology are intended to identify forward-looking statements, although not all forward-looking
statements contain these identifying words. As noted above, the closing of the offering is subject to the satisfaction of customary closing
conditions and there is no assurance that the Company will satisfy those conditions. While the Company believes its plans, intentions
and expectations reflected in those forward-looking statements are reasonable, these plans, intentions or expectations may not be achieved.
The Company&#8217;s actual results, performance or achievements could differ materially from those contemplated, expressed or implied
by the forward-looking statements. For information about the factors that could cause such differences, please refer to the Company&#8217;s
filings with the SEC. Given these uncertainties, you should not place undue reliance on these forward-looking statements. The Company
assumes no obligation to update any forward-looking statement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Item 9.01 Financial Statements and Exhibits.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(d) Exhibits.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; width: 9%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit&#160;No.</b></span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="border-bottom: Black 1.5pt solid; width: 90%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><a href="ea179675ex4-1_peraso.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Pre-Funded Warrant</span></a></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><a href="ea179675ex4-2_peraso.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Purchase Warrant</span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td>4.3</td>
    <td>&#160;</td>
    <td><a href="ea179675ex4-3_peraso.htm">Form of Placement Agent Warrant</a></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ea179675ex5-1_peraso.htm">Opinion of Mitchell Silberberg &amp; Knupp LLP</a></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1*</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><a href="ea179675ex10-1_peraso.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Securities Purchase Agreement</span></a></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><a href="ea179675ex10-2_peraso.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Registration Rights Agreement</span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><a href="ea179675ex10-3_peraso.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amendment No. 1 to Peraso Inc. Common Stock Purchase Warrant</span></a></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.1</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ea179675ex5-1_peraso.htm">Consent of Mitchell Silberberg &amp; Knupp LLP (included in Exhibit 5.1)</a></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><a href="ea179675ex99-1_peraso.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Press Release by Peraso Inc. dated May 31, 2023</span></a></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The cover page of this
    Current Report on Form 8-K, formatted in Inline XBRL</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left">*</td><td style="text-align: justify">The schedules (and similar attachments) to this exhibit have been omitted
from this filing pursuant to Item 601(b)(10) of Regulation S-K. The Company agrees to furnish a supplemental copy of any omitted schedule
(or similar attachment) to the Securities and Exchange Commission upon request.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 4 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURE</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="background-color: white">
    <td style="padding-left: 9pt">&#160;</td>
    <td colspan="2"><span style="font-size: 10pt"><b>PERASO INC.</b>&#160;</span></td></tr>
  <tr style="background-color: white">
    <td style="padding-left: 9pt; width: 60%">&#160;</td>
    <td style="width: 4%">&#160;</td>
    <td style="width: 36%">&#160;</td></tr>
  <tr style="background-color: white">
    <td style="padding-bottom: 1.5pt"><span style="font-size: 10pt">Date: June 2, 2023</span></td>
    <td style="padding-bottom: 1.5pt"><span style="font-size: 10pt">By:</span></td>
    <td style="border-bottom: Black 1.5pt solid"><span style="font-size: 10pt"><i>/s/ James Sullivan</i></span></td></tr>
  <tr style="background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">James Sullivan</span></td></tr>
  <tr style="background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Chief Financial Officer</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">4</p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjd0KwjAMhZ9g7xB6LW6dKLJLh4o4ZQwRb6uLUtyakdafPZJvabchhkASzvlyhBiJNa10hQynRZHBAeumUg6hwCsymgt6R7rZJuBngTdtHSvj+vMHpuQZ9Mx0LOdnL/TWp7ZYJhDNwkiG8cQviZSQ70TQ6SmZqy7ROK0qUKaEnKlhjU5xO3w4qDcZqts+6ohsNZkE5Dga5A/EkYxhT0/1Ir5byLJUBKO+ArFmejRdzMM6qmFZYe2z7ID+O/gCGPRJSg== -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>2
<FILENAME>ea179675ex4-1_peraso.htm
<DESCRIPTION>FORM OF PRE-FUNDED WARRANT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 4.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PRE-FUNDED COMMON STOCK PURCHASE WARRANT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>peraso
inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; font-size: 10pt">Warrant Shares: 3,464,286</TD>
    <TD STYLE="text-align: right; width: 50%; font-size: 10pt">Initial Exercise Date: June 2, 2023</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">THIS PRE-FUNDED COMMON STOCK
PURCHASE WARRANT (the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, [&#9679;] or its assigns (the &ldquo;<U>Holder</U>&rdquo;)
is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after
the date hereof (the &ldquo;<U>Initial Exercise Date</U>&rdquo;) and until this Warrant is exercised in full (the &ldquo;<U>Termination
Date</U>&rdquo;) but not thereafter, to subscribe for and purchase from Peraso Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;),
up to 3,464,286 shares (as subject to adjustment hereunder, the &ldquo;<U>Warrant Shares</U>&rdquo;) of Common Stock. The purchase price
of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 1</U>. <U>Definitions</U>.
Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain Securities Purchase Agreement
(the &ldquo;<U>Purchase Agreement</U>&rdquo;), dated May 31, 2023, among the Company and the purchasers signatory thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 2</U>. <U>Exercise</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a) <U>Exercise
of Warrant</U>. Subject to Section 2(e) herein, exercise of the purchase rights represented by this Warrant may be made, in whole or in
part, at any time or times on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a
duly executed facsimile copy or PDF copy submitted by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto
(the &ldquo;<U>Notice of Exercise</U>&rdquo;). Within the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days comprising
the Standard Settlement Period (as defined in Section 2(d)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver
the aggregate Exercise Price for the Warrant Shares specified in the applicable Notice of Exercise by wire transfer or cashier&rsquo;s
check drawn on a United States bank unless the cashless exercise procedure specified in Section 2(c) below is specified in the applicable
Notice of Exercise. No ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee
or notarization) of any Notice of Exercise be required. Notwithstanding anything herein to the contrary, the Holder shall not be required
to physically surrender this Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder and the
Warrant has been exercised in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation within three
(3) Trading Days of the date on which the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting
in purchases of a portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding
number of Warrant Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and
the Company shall maintain records showing the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver
any objection to any Notice of Exercise within one (1) Trading Day of receipt of such notice. Notwithstanding the foregoing, with respect
to any Notice(s) of Exercise delivered on or prior to 4:00 p.m. (New York City time) on the Trading Date prior to the Initial Exercise
Date, which may be delivered at any time after the time of execution of the Purchase Agreement, the Company agrees to deliver the Warrant
Shares subject to such notice(s) by 4:00 p.m. (New York City time) on the Initial Exercise Date and the Initial Exercise Date shall be
the Warrant Share Delivery Date for purposes hereunder, provided that payment of the aggregate Exercise Price (other than in the case
of a cashless exercise) is received by such Warrant Share Delivery Date. <B>The Holder and any assignee, by acceptance of this Warrant,
acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder,
the number of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated on the face hereof.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b) <U>Exercise
Price</U>. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.01 per Warrant Share, was pre-funded
to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the nominal exercise
price of $0.01 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The
Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance
or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date. The remaining
unpaid exercise price per share of Common Stock under this Warrant shall be $0.01, subject to adjustment hereunder (such remaining unpaid
exercise price, the &ldquo;<U>Exercise Price</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c) <U>Cashless
Exercise</U>. This Warrant may also be exercised, in whole or in part, at such time by means of a &ldquo;cashless exercise&rdquo; in which
the Holder shall be entitled to receive a number of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 103.5pt; text-align: justify; text-indent: -31.5pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.35in; text-align: left">(A) =</TD><TD STYLE="text-align: justify">as applicable: (i) the VWAP on the Trading Day immediately
preceding the date of the applicable Notice of Exercise if such Notice of Exercise is (1) both executed and delivered pursuant to Section
2(a) hereof on a day that is not a Trading Day or (2) both executed and delivered pursuant to Section 2(a) hereof on a Trading Day prior
to the opening of &ldquo;regular trading hours&rdquo; (as defined in Rule 600(b) of Regulation NMS promulgated under the federal securities
laws) on such Trading Day, or (ii) the VWAP on the date of the applicable Notice of Exercise if the date of such Notice of Exercise is
a Trading Day and such Notice of Exercise is both executed and delivered pursuant to Section 2(a) hereof after the close of &ldquo;regular
trading hours&rdquo; on such Trading Day;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left">(B) =</TD><TD STYLE="text-align: justify">the Exercise Price of this Warrant, as adjusted hereunder;
and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left">(X) =</TD><TD STYLE="text-align: justify">the number of Warrant Shares that would be issuable upon
exercise of this Warrant in accordance with the terms of this Warrant if such exercise were by means of a cash exercise rather than a
cashless exercise.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 103.5pt; text-align: justify; text-indent: -31.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="background-color: white">If
Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the
Securities Act, the Warrant Shares shall take on the registered characteristics of the Warrants being exercised.&nbsp;&nbsp;The Company
agrees not to take any position contrary to this Section 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or
quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m.
(New York City time) to 4:02 p.m. (New York City time)), (b)&nbsp; if OTCQB or OTCQX is not a Trading Market, the volume weighted average
price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not
then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported in The Pink Open Market (or a
similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock
so reported, or (d)&nbsp;in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser
selected in good faith by the Purchasers of a majority in interest of the Securities then outstanding Warrants and reasonably acceptable
to the Company, the fees and expenses of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">d)</TD><TD STYLE="text-align: justify"><U>Mechanics of Exercise</U>.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">i. <U>Delivery
of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by the Transfer
Agent to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository Trust Company
through its Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) if the Company is then a participant in such system
and either (A) there is an effective registration statement registering the issuance of the Warrant Shares to or resale of the Warrant
Shares by the Holder or (B) this Warrant is being exercised via cashless exercise, and otherwise by physical delivery of a certificate,
registered in the Company&rsquo;s share register in the name of the Holder or its designee, for the number of Warrant Shares to which
the Holder is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by the date that is
the earliest of (i) two (2) Trading Days after the delivery to the Company of the Notice of Exercise, (ii) one (1) Trading Day after delivery
of the aggregate Exercise Price to the Company and (iii) the number of Trading Days comprising the Standard Settlement Period after the
delivery to the Company of the Notice of Exercise (such date, the &ldquo;<U>Warrant Share Delivery Date</U>&rdquo;). Upon delivery of
the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder of record of the Warrant Shares
with respect to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant Shares, provided that payment
of the aggregate Exercise Price (other than in the case of a cashless exercise) is received within the earlier of (i) two (2) Trading
Days and (ii) the number of Trading Days comprising the Standard Settlement Period following delivery of the Notice of Exercise. If the
Company fails for any reason to deliver to the Holder the Warrant Shares subject to a Notice of Exercise by the Warrant Share Delivery
Date, the Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant Shares subject
to such exercise (based on the VWAP of the Common Stock on the date of the applicable Notice of Exercise), $10 per Trading Day (increasing
to $20 per Trading Day on the third Trading Day after the Warrant Share Delivery Date) for each Trading Day after such Warrant Share Delivery
Date until such Warrant Shares are delivered or Holder rescinds such exercise. The Company agrees to maintain a transfer agent that is
a participant in the FAST program so long as this Warrant remains outstanding and exercisable. As used herein, &ldquo;<U>Standard Settlement
Period</U>&rdquo; means the standard settlement period, expressed in a number of Trading Days, on the Company&rsquo;s primary Trading
Market with respect to the Common Stock as in effect on the date of delivery of the Notice of Exercise. Notwithstanding the foregoing,
with respect to any Notice(s) of Exercise delivered on or prior to 12:00 p.m. (New York City time) on the Initial Exercise Date, which
may be delivered at any time after the time of execution of the Purchase Agreement, the Company agrees to deliver the Warrant Shares subject
to such notice(s) by 4:00 p.m. (New York City time) on the Initial Exercise Date and the Initial Exercise Date shall be the Warrant Share
Delivery Date for purposes hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">ii. <U>Delivery
of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and
upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing
the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other respects
be identical with this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">iii. <U>Rescission
Rights</U>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section 2(d)(i)
by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">iv. <U>Compensation
for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to the Holder, if
the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions of Section
2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date (other than any such failure that is solely due to
any action or inaction by the Holder with respect to such exercise), and if after such date the Holder is required by its broker to purchase
(in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, shares of Common Stock to deliver
in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise (a &ldquo;<U>Buy-In</U>&rdquo;),
then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x) the Holder&rsquo;s total purchase price (including
brokerage commissions, if any) for the shares of Common Stock so purchased exceeds (y) the amount obtained by multiplying (1) the number
of Warrant Shares that the Company was required to deliver to the Holder in connection with the exercise at issue times (2) the price
at which the sell order giving rise to such purchase obligation was executed, and (B) at the option of the Holder, either reinstate the
portion of the Warrant and equivalent number of Warrant Shares for which such exercise was not honored (in which case such exercise shall
be deemed rescinded) or deliver to the Holder the number of shares of Common Stock that would have been issued had the Company timely
complied with its exercise and delivery obligations hereunder. For example, if the Holder purchases Common Stock having a total purchase
price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares of Common Stock with an aggregate sale price giving
rise to such purchase obligation of $10,000, under clause (A) of the immediately preceding sentence the Company shall be required to pay
the Holder $1,000. The Holder shall provide the Company written notice indicating the amounts payable to the Holder in respect of the
Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing herein shall limit a Holder&rsquo;s right to pursue
any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or
injunctive relief with respect to the Company&rsquo;s failure to timely deliver shares of Common Stock upon exercise of the Warrant as
required pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">v. <U>No
Fractional Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this
Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall,
at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the
Exercise Price or round up to the next whole share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">vi. <U>Charges,
Taxes and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other incidental
expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and such Warrant
Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; <U>provided</U>, <U>however</U>,
that, in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered for
exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may require, as a condition
thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company shall pay all Transfer Agent
fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company (or another established clearing
corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">vii. <U>Closing
of Books</U>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this Warrant,
pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">e)</TD><TD STYLE="text-align: justify"><U>Holder&rsquo;s Exercise Limitations</U>. The Company shall not effect any exercise of this Warrant,
and a Holder shall not have the right to exercise any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that
after giving effect to such issuance after exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s
Affiliates, and any other Persons acting as a group together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;<U>Attribution
Parties</U>&rdquo;)), would beneficially own in excess of the Beneficial Ownership Limitation (as defined below).&nbsp; For purposes of
the foregoing sentence, the number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties
shall include the number of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is
being made, but shall exclude the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, nonexercised
portion of this Warrant beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion
of the unexercised or nonconverted portion of any other securities of the Company (including, without limitation, any other Common Stock
Equivalents) subject to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the
Holder or any of its Affiliates or Attribution Parties.&nbsp; Except as set forth in the preceding sentence, for purposes of this Section
2(e), beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated
thereunder, it being acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance
with Section 13(d) of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith.
To the extent that the limitation contained in this Section 2(e) applies, the determination of whether this Warrant is exercisable (in
relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant
is exercisable shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&rsquo;s
determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates
and Attribution Parties) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation,
and the Company shall have no obligation to verify or confirm the accuracy of such determination. In addition, a determination as to any
group status as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations
promulgated thereunder. For purposes of this Section 2(e), in determining the number of outstanding shares of Common Stock, a Holder may
rely on the number of outstanding shares of Common Stock as reflected in (A) the Company&rsquo;s most recent periodic or annual report
filed with the Commission, as the case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice
by the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding.&nbsp; Upon the written or oral request
of a Holder, the Company shall within one Trading Day confirm orally and in writing to the Holder the number of shares of Common Stock
then outstanding.&nbsp; In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion
or exercise of securities of the Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties since the date
as of which such number of outstanding shares of Common Stock was reported. The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo; shall
be 9.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock
issuable upon exercise of this Warrant. The Holder, upon notice to the Company, may increase or decrease the Beneficial Ownership Limitation
provisions of this Section 2(e), provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of shares of
the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock upon exercise of this Warrant held
by the Holder and the provisions of this Section 2(e) shall continue to apply. Any increase in the Beneficial Ownership Limitation will
not be effective until the 61<SUP>st</SUP> day after such notice is delivered to the Company. The provisions of this paragraph shall be
construed and implemented in a manner otherwise than in strict conformity with the terms of this Section 2(e) to correct this paragraph
(or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein contained or to
make changes or supplements necessary or desirable to properly give effect to such limitation. The limitations contained in this paragraph
shall apply to a successor holder of this Warrant.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 3</U>. <U>Certain
Adjustments</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a) <U>Stock
Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise makes
a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares of
Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse
stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the Common
Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the
numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event
and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of
shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant
shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for
the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the effective
date in the case of a subdivision, combination or re-classification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b) <U>Intentionally
Omitted</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c) <U>Subsequent
Rights Offerings</U>. In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants, issues or sells
any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record holders of any
class of shares of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder will be entitled to acquire, upon the terms
applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number
of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including
without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for the grant, issuance
or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are
to be determined for the grant, issue or sale of such Purchase Rights (provided, however, to the extent that the Holder&rsquo;s right
to participate in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall
not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such shares of Common Stock as a result
of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance for the Holder until such time,
if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">d) <U>Pro
Rata Distributions</U>. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or other distribution
of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital or otherwise (including,
without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend, spin off, reclassification,
corporate rearrangement, scheme of arrangement or other similar transaction) (a &ldquo;<U>Distribution</U>&rdquo;), at any time after
the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution to the same extent
that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable upon complete exercise
of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation)
immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the date as of which the
record holders of shares of Common Stock are to be determined for the participation in such Distribution (<U>provided</U>,&nbsp;<U>however</U>,
to the extent that the Holder&rsquo;s right to participate in any such Distribution would result in the Holder exceeding the Beneficial
Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in the beneficial ownership
of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution shall be held in abeyance
for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership
Limitation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">e) <U>Fundamental
Transaction</U>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more related transactions
effects any merger or consolidation of the Company with or into another Person other than any Subsidiary or any Affiliate of the Company,
whereby the stockholders of the Company immediately prior to such merger or consolidation do not own, directly or indirectly, at least
50% of the voting power of the surviving entity immediately after such merger or consolidation, (ii) the Company, directly or indirectly,
effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of its assets in one
or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the Company
or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange their shares for other
securities, cash or property and has been accepted by the holders of 50% or more of the outstanding Common Stock, (iv) the Company, directly
or indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization of the Common Stock
or any compulsory share exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash
or property, or (v) the Company, directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement
or other business combination (including, without limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement)
with another Person or group of Persons whereby such other Person or group acquires more than 50% of the outstanding shares of Common
Stock (not including any shares of Common Stock held by the other Person or other Persons making or party to, or associated or affiliated
with the other Persons making or party to, such stock or share purchase agreement or other business combination) (each a &ldquo;<U>Fundamental
Transaction</U>&rdquo;), then, upon any subsequent exercise of this Warrant, the Holder shall have the right to receive, for each Warrant
Share that would have been issuable upon such exercise immediately prior to the occurrence of such Fundamental Transaction, at the option
of the Holder (without regard to any limitation in Section 2(e) on the exercise of this Warrant), the number of shares of Common Stock
of the successor or acquiring corporation or of the Company, if it is the surviving corporation, and any additional consideration (the
&ldquo;<U>Alternate Consideration</U>&rdquo;) receivable as a result of such Fundamental Transaction by a holder of the number of shares
of Common Stock for which this Warrant is exercisable immediately prior to such Fundamental Transaction (without regard to any limitation
in Section 2(e) on the exercise of this Warrant). For purposes of any such exercise, the determination of the Exercise Price shall be
appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of
one share of Common Stock in such Fundamental Transaction, and the Company shall apportion the Exercise Price among the Alternate Consideration
in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration. If holders of Common
Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder shall be
given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction.
The Company shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor (the &ldquo;Successor
Entity&rdquo;) to assume in writing all of the obligations of the Company under this Warrant and the other Transaction Documents in accordance
with the provisions of this Section 3(e) pursuant to written agreements in form and substance reasonably satisfactory to the Holder and
approved by the Holder (without unreasonable delay) prior to such Fundamental Transaction and shall, at the option of the Holder, deliver
to the Holder in exchange for this Warrant a security of the Successor Entity evidenced by a written instrument substantially similar
in form and substance to this Warrant which is exercisable for a corresponding number of shares of capital stock of such Successor Entity
(or its parent entity) equivalent to the shares of Common Stock acquirable and receivable upon exercise of this Warrant (without regard
to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies the
exercise price hereunder to such shares of capital stock (but taking into account the relative value of the shares of Common Stock pursuant
to such Fundamental Transaction and the value of such shares of capital stock, such number of shares of capital stock and such exercise
price being for the purpose of protecting the economic value of this Warrant immediately prior to the consummation of such Fundamental
Transaction), and which is reasonably satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction,
the Successor Entity shall succeed to, and be substituted for (so that from and after the date of such Fundamental Transaction, the provisions
of this Warrant and the other Transaction Documents referring to the &ldquo;Company&rdquo; shall refer instead to the Successor Entity),
and may exercise every right and power of the Company and shall assume all of the obligations of the Company under this Warrant and the
other Transaction Documents with the same effect as if such Successor Entity had been named as the Company herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">f) <U>Calculations</U>.
All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For purposes
of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the
number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">g) <U>Notice
to Holder</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">i. <U>Adjustment
to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly
deliver to the Holder by facsimile or email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment
to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">ii. <U>Notice
to Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the Common
Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the Company shall
authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of capital stock
of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with any reclassification
of the Common Stock, any consolidation or merger to which the Company (or any of its Subsidiaries) is a party, any sale or transfer of
all or substantially all of its assets, or any compulsory share exchange whereby the Common Stock is converted into other securities,
cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs
of the Company, then, in each case, the Company shall cause to be delivered by facsimile or email to the Holder at its last facsimile
number or email address as it shall appear upon the Warrant Register of the Company, at least 10 calendar days prior to the applicable
record or effective date hereinafter specified, a notice (unless such information is filed with the Commission, in which case a notice
shall not be required) stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption,
rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock of record to be entitled to
such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification, consolidation,
merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected that holders
of the Common Stock of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other property deliverable
upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure to deliver such notice
or any defect therein or in the delivery thereof shall not affect the validity of the corporate action required to be specified in such
notice. To the extent that any notice provided in this Warrant constitutes, or contains, material, non-public information regarding the
Company or any of the Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Current Report
on Form 8-K. The Holder shall remain entitled to exercise this Warrant during the period commencing on the date of such notice to the
effective date of the event triggering such notice except as may otherwise be expressly set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 4</U>. <U>Transfer
of Warrant</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a) <U>Transferability</U>.
Subject to compliance with any applicable securities laws, this Warrant and all rights hereunder (including, without limitation, any registration
rights) are transferable, in whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated
agent, together with a written assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its
agent or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer. Upon such surrender and, if
required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable,
and in the denomination or denominations specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing
the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary,
the Holder shall not be required to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full,
in which case, the Holder shall surrender this Warrant to the Company within three (3) Trading Days of the date on which the Holder delivers
an assignment form to the Company assigning this Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised
by a new holder for the purchase of Warrant Shares without having a new Warrant issued.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b) <U>New
Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company,
together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or
its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division or combination,
the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance
with such notice. All Warrants issued on transfers or exchanges shall be dated the initial issuance date of this Warrant and shall be
identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c) <U>Warrant
Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the &ldquo;<U>Warrant
Register</U>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder
of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other
purposes, absent actual notice to the contrary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 5</U>. <U>Miscellaneous</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a) <U>No
Rights as Stockholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights, dividends
or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly set
forth in Section 3. Without limiting any rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise&rdquo; pursuant to
Section 2(c) or to receive cash payments pursuant to Section 2(d)(i), Section 2(d)(iv) and Section 3(e) herein, in no event shall the
Company be required to net cash settle an exercise of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b) <U>Loss,
Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory
to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case
of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include
the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make
and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c) <U>Saturdays,
Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required or granted
herein shall not be a Trading Day, then such action may be taken or such right may be exercised on the next succeeding Trading Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">d) <U>Authorized
Shares</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">The Company covenants
that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a sufficient number
of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant. The Company further
covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with the duty of issuing the
necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all such reasonable action
as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any applicable law or regulation,
or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company covenants that all Warrant Shares
which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise of the purchase rights represented
by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable
and free from all taxes, liens and charges created by the Company in respect of the issue thereof (other than taxes in respect of any
transfer occurring contemporaneously with such issue).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">Except and to the
extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its certificate
of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or
any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all
times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate
to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the foregoing, the
Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise immediately prior
to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company may validly and
legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially reasonable efforts
to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof, as may be, necessary
to enable the Company to perform its obligations under this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">Before taking any
action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise Price,
the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory
body or bodies having jurisdiction thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">e) <U>Jurisdiction</U>.
All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined in accordance
with the provisions of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">f) <U>Restrictions</U>.
The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and the Holder does not
utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">g) <U>Nonwaiver
and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as
a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies. Without limiting any other provision of this
Warrant or the Purchase Agreement, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results
in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and
expenses including, but not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings, incurred by the Holder
in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">h) <U>Notices</U>.
Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall be delivered in
accordance with the notice provisions of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">i) <U>Limitation
of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant
Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase
price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the
Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">j) <U>Remedies</U>.
The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific
performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss
incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any
action for specific performance that a remedy at law would be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">k) <U>Successors
and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the
benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder.
The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable
by the Holder or holder of Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">l) <U>Amendment</U>.
This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company and the holders of a majority
of the then outstanding Warrants (based on the number of Warrant Shares then underlying such Warrants), provided that if any amendment,
modification or waiver disproportionately and adversely impacts a Holder (or group of Holders), the consent of such disproportionately
impacted Holder (or group of Holders) shall also be required.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">m) <U>Severability</U>.
Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law,
but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the
extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">n) <U>Headings</U>.
The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">********************</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>(Signature Page Follows)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>


<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">IN WITNESS WHEREOF, the Company
has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-transform: uppercase"><B>PERASO INC.</B></FONT></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; width: 4%">By:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; width: 36%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">Name:</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">Title:</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B></B></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>NOTICE OF EXERCISE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="text-transform: uppercase">To: </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(1) The
undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised
in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(2) Payment
shall take the form of (check applicable box):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&#9744; in
lawful money of the United States; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&#9744; [if
permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection
2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise
procedure set forth in subsection 2(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(3) Please
issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Warrant Shares shall be delivered to the following
DWAC Account Number:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="text-transform: uppercase">[SIGNATURE
OF HOLDER]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Investing Entity: ________________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Signature of Authorized Signatory of Investing
Entity</I>: _________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Authorized Signatory: ___________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Title of Authorized Signatory: ____________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Date: ________________________________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-weight: normal">ASSIGNMENT FORM</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt"><I>(To assign the foregoing
Warrant, execute this form and supply required information. Do not use this form to purchase shares.)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt">FOR VALUE RECEIVED, the foregoing
Warrant and all rights evidenced thereby are hereby assigned to</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify">Name:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">(Please Print)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify">Address:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">(Please Print)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify">Phone Number:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify"></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify">Email Address: </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify"></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify">Dated: _______________ __, ______</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 10%">Holder&rsquo;s Signature:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify; width: 40%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 50%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Holder&rsquo;s Address:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.2
<SEQUENCE>3
<FILENAME>ea179675ex4-2_peraso.htm
<DESCRIPTION>FORM OF PURCHASE WARRANT
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>


<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Exhibit 4.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH
THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE
IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &ldquo;SECURITIES ACT&rdquo;), AND,
ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO
AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE
WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED
IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PERASO INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>COMMON STOCK PURCHASE WARRANT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B></B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 50%">Warrant Shares: <B>5,714,286</B><TD STYLE="text-align: right; width: 50%">Initial Exercise Date: June 2, 2023</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>Issue Date: June 2, 2023</TD>
  <TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">THIS COMMON STOCK PURCHASE WARRANT (the &ldquo;<U>Warrant</U>&rdquo;)
certifies that, for value received, [&#9679;] or its assigns (the &ldquo;<U>Holder</U> &rdquo;) is entitled, upon the terms and subject
to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the &ldquo;<U>Initial
Exercise Date</U>&rdquo;) and on or prior to 5:00 p.m. (New York City time) on June 2, 2028 (the &ldquo;<U>Termination Date</U> &rdquo;)
but not thereafter, to subscribe for and purchase from Peraso Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), up to 5,714,286
shares (as subject to adjustment hereunder, the &ldquo;<U>Warrant Shares</U> &rdquo;) of Common Stock. The purchase price of
one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Section 1</U> .<U>Definitions</U> . Capitalized
terms used and not otherwise defined herein shall have the meanings set forth in that certain Securities Purchase Agreement (the &ldquo;<U>Purchase
Agreement</U>&rdquo;), dated May 31, 2023, among the Company and the purchasers signatory thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Section 2</U>. <U>Exercise</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">a) <U>Exercise of
Warrant</U>. Subject to Section 2(e) herein, exercise of the purchase rights represented by this Warrant may be made, in
whole or in part, at any time or times on or after the Initial Exercise Date and on or before the Termination Date by delivery to
the Company of a duly executed facsimile copy or PDF copy submitted by e-mail (or e-mail attachment) of the Notice of Exercise in
the form annexed hereto (the &ldquo; <U>Notice of Exercise</U>&rdquo;). Within the earlier of (i) two (2) Trading Days
and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined in Section 2(d)(i) herein) following the
date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price for the Warrant Shares specified in the
applicable Notice of Exercise by wire transfer or cashier&rsquo;s check drawn on a United States bank unless the cashless exercise
procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise. No&nbsp;ink-original Notice of Exercise
shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization ) of any Notice of Exercise be
required. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to
the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised in full,
in which case, the Holder shall surrender this Warrant to the Company for cancellation within three (3) Trading Days of the date on
which the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a
portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of
Warrant Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder
and the Company shall maintain records showing the number of Warrant Shares purchased and the date of such purchases. The Company
shall deliver any objection to any Notice of Exercise within one (1 ) Trading Day of receipt of such notice.  <B>The
Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of the provisions of this paragraph,
following the purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares available for purchase hereunder
at any given time may be less than the amount stated on the face hereof.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">b) <U>Exercise Price</U>. The exercise
price per share of Common Stock under this Warrant shall be <B>$0.70</B>, subject to adjustment hereunder (the &ldquo; <U>Exercise Price</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">c) <U>Cashless Exercise</U> . If at
the time of exercise hereof there is No&nbsp;effective registration statement registering, or the prospectus contained therein is not
available for the resale of the Warrant Shares by the Holder, then this Warrant may also be exercised, in whole or in part, at such time
by means of a &ldquo;cashless exercise&rdquo; in which the Holder shall be entitled to receive a number of Warrant Shares equal to the
quotient obtained by dividing [(A-B) (X)] by (A), where:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(A) = as applicable: (i) the VWAP on the Trading
Day immediately preceding the date of the applicable Notice of Exercise if such Notice of Exercise is (1) both executed and delivered
pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2) both executed and delivered pursuant to Section 2(a) hereof
on a Trading Day prior to the opening of &ldquo;regular trading hours&rdquo; (as defined in Rule 600(b) of Regulation NMS promulgated
under the federal securities laws) on such Trading Day, or (ii) the VWAP on the date of the applicable Notice of Exercise if the date
of such Notice of Exercise is a Trading Day and such Notice of Exercise is both executed and delivered pursuant to Section 2(a) hereof
after the close of &ldquo;regular trading hours&rdquo; on such Trading Day;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(B) = the Exercise Price of this Warrant, as adjusted
hereunder; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(X) = the number of Warrant Shares that would
be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such exercise were by means of a cash exercise
rather than a cashless exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white">If Warrant
Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the Securities
Act, the Warrant Shares shall take on the characteristics of the Warrants being exercised, and the holding period of the Warrant Shares
being issued may be tacked on to the holding period of this Warrant. The Company agrees not to take any position contrary to
this Section 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo; <U>VWAP</U>&rdquo; means, for any date,
the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or quoted on a Trading
Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date) on the Trading Market
on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m. (New York City time)
to 4:02 p.m. (New York City time)), (b)&nbsp; if OTCQB or OTCQX is not a Trading Market, the volume weighted average price of the Common
Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then listed or quoted
for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported in The Pink Open Market (or a similar organization
or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported, or (d)&nbsp;in
all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good faith by
the Purchasers of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees and expenses
of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Mechanics
of Exercise</U> .</FONT></TD>
</TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">i. <U>Delivery of Warrant Shares Upon
Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by the Transfer Agent to
the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository Trust Company
through its Deposit or Withdrawal at Custodian system (&ldquo; <U>DWAC</U>&rdquo;) if the Company is then a participant in such
system and either (A) there is an effective registration statement registering the issuance of the Warrant Shares to or resale of
the Warrant Shares by the Holder or (B) the Warrant Shares are eligible for resale by the Holder without volume or manner-of-sale
limitations pursuant to Rule 144 (assuming cashless exercise of the Warrants), and otherwise by physical delivery of a certificate,
registered in the Company&rsquo;s share register in the name of the Holder or its designee, for the number of Warrant Shares to
which the Holder is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by the date
that is the earliest of (i) two (2) Trading Days after the delivery to the Company of the Notice of Exercise, (ii) one (1) Trading
Day after delivery of the aggregate Exercise Price to the Company and (iii) the number of Trading Days comprising the Standard
Settlement Period after the delivery to the Company of the Notice of Exercise ( such date, the &ldquo; <U>Warrant Share Delivery
Date</U>&rdquo; ).   Upon delivery of the Notice of Exercise , the Holder shall be deemed for all corporate purposes to
have become the holder of record of the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the
date of delivery of the Warrant Shares, provided that payment of the aggregate Exercise Pric e (other than in the case of
a cashless exercise ) is received within the earlier of ( i) two (2) Trading Days and (ii) the number of Trading Days comprising the
Standard Settlement Period following delivery of the Notice of Exercise. If the Company fails for any reason to deliver
to the Holder the Warrant Shares subject to a Notice of Exercise by the Warrant Share Delivery Date, the Company shall pay to the
Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant Shares subject to such exercise (based on
the VWAP of the Common Stock on the date of the applicable Notice of Exercise), $10 per Trading Day (increasing to $20 per Trading
Day on the third Trading Day after the Warrant Share Delivery Date) for each Trading Day after such Warrant Share Delivery Date
until such Warrant Shares are delivered or Holder rescinds such exercise. The Company agrees to maintain a transfer agent that is a
participant in the FAST program so long as this Warrant remains outstanding and exercisable . As used herein, &ldquo; <U>Standard
Settlement Period</U>&rdquo; means the standard settlement period, expressed in a number of Trading Days, on the Company&rsquo;s
primary Trading Market with respect to the Common Stock as in effect on the date of delivery of the Notice of Exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">ii. <U>Delivery of New Warrants Upon Exercise</U>
.. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and upon surrender of this
Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing the rights of the Holder
to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other respects be identical with
this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">iii. <U>Rescission Rights</U> . If
the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section 2(d)(i) by the Warrant
Share Delivery Date, then the Holder will have the right to rescind such exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">iv. <U>Compensation for Buy-In on Failure to
Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to the Holder, if the Company
fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions of Section 2(d)(i)
above pursuant to an exercise on or before the Warrant Share Delivery Date (other than any such failure that is solely due to any
action or inaction by the Holder with respect to such exercise), and if after such date the Holder is required by its broker to
purchase (in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, shares of Common
Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such
exercise (a &ldquo; <U>Buy-In</U>&rdquo; ), then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x)
the Holder&rsquo;s total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased
exceeds (y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company was required to deliver to the
Holder in connection with the exercise at issue times (2) the price at which the sell order giving rise to such purchase obligation
was executed, and (B) at the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant
Shares for which such exercise was not honored (in which case such exercise shall be deemed rescinded) or deliver to the Holder the
number of shares of Common Stock that would have been issued had the Company timely complied with its exercise and delivery
obligations hereunder. For example, if the Holder purchases Common Stock having a total purchase price of $11,000 to
cover a Buy-In with respect to an attempted exercise of shares of Common Stock with an aggregate sale price giving rise to such
purchase obligation of $10,000, under clause ( A) of the immediately preceding sentence the Company shall be required to pay the
Holder $1,000. The Holder shall provide the Company written notice indicating the amounts payable to the Holder in respect of the
Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing herein shall limit a Holder&rsquo;s
right to pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of
specific performance and/or injunctive relief with respect to the Company&rsquo;s failure to timely deliver shares of Common Stock
upon exercise of the Warrant as required pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">v. <U>No&nbsp;Fractional Shares or Scrip</U> . No&nbsp;fractional
shares or scrip representing fractional shares shall be issued upon the exercise of this Warrant. As to any fraction of a share
which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall, at its election, either pay a cash adjustment
in respect of such final fraction in an amount equal to such fraction multiplied by the Exercise Price or round up to the next whole share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">vi. <U>Charges, Taxes and
Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or
other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the
Company, and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the
Holder; <U>provided</U> , <U>however</U> , that, in the event that Warrant Shares are to be issued in a name other than the name of
the Holder, this Warrant when surrendered for exercise shall be accompanied by the Assignment Form attached hereto duly executed by
the Holder and the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax
incidental thereto.  The Company shall pay all Transfer Agent fees required for same-day processing of any Notice of
Exercise and all fees to the Depository Trust Company (or another established clearing corporation performing similar functions)
required for same-day electronic delivery of the Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">vii. <U>Closing of Books</U> . The
Company will not close its stockholder books or records in any manner which prevents the timely exercise of this Warrant, pursuant to
the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">e) <U>Holder&rsquo;s Exercise
Limitations</U> . The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to exercise any
portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance after exercise
as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates, and any other Persons
acting as a group together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;<U>Attribution
Parties</U>&rdquo;)), would beneficially own in excess of the Beneficial Ownership Limitation (as defined below).&nbsp; For purposes
of the foregoing sentence, the number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution
Parties shall include the number of shares of Common Stock issuable upon exercise of this Warrant with respect to which such
determination is being made, but shall exclude the number of shares of Common Stock which would be issuable upon (i) exercise of the
remaining, nonexercised portion of this Warrant beneficially owned by the Holder or any of its Affiliates or Attribution Parties and
(ii) exercise or conversion of the unexercised or nonconverted portion of any other securities of the Company (including, without
limitation, any other Common Stock Equivalents) subject to a limitation on conversion or exercise analogous to the limitation
contained herein beneficially owned by the Holder or any of its Affiliates or Attribution Parties.&nbsp; Except as set forth in the
preceding sentence, for purposes of this Section 2(e), beneficial ownership shall be calculated in accordance with Section 13(d) of
the Exchange Act and the rules and regulations promulgated thereunder, it being acknowledged by the Holder that the Company is not
representing to the Holder that such calculation is in compliance with Section 13(d) of the Exchange Act and the Holder is solely
responsible for any schedules required to be filed in accordance therewith. To the extent that the limitation contained in this
Section 2(e) applies, the determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder
together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable shall be in the sole
discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&rsquo;s determination of
whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and
Attribution Parties) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership L
imitation, and the Company shall have No&nbsp;obligation to verify or confirm the accuracy of such determination. In addition, a
determination as to any group status as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act
and the rules and regulations promulgated thereunder. For purposes of this Section 2(e) , in determining the number of outstanding
shares of Common Stock, a Holder may rely on the number of outstanding shares of Common Stock as reflected in (A ) the
Company&rsquo;s most recent periodic or annual report filed with the Commission, as the case may be , (B ) a more recent public
announcement by the Company or (C ) a more recent written notice by the Company or the Transfer Agent setting forth the number of
shares of Common Stock outstanding.&nbsp; Upon the written or oral request of a Holder, the Company shall within one Trading Day
confirm orally and in writing to the Hold er the number of shares of Common Stock then outstanding.&nbsp; In any case, the number of
outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities of the
Company, including this Warrant, by the Holder or its A ffiliates or Attribution Parties since the date as of which such number of
outstanding shares of Common Stock was reported. The &ldquo;<U>Beneficial Ownership Limitation</U> &rdquo; shall be 4.99% of the
number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable
upon exercise of this Warrant. The Holder , upon notice to the Company, may increase or decrease the Beneficial Ownership Limitation
provisions of this Section 2(e), provided that the Beneficial Ownership Limitation in No&nbsp;event exceeds 9.99% of the number of
shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock upon exercise of
this Warrant held by the Holder and the provisions of this Section 2(e) shall continue to apply. Any increase in the Beneficial
Ownership Limitation will not be effective until the 61 <SUP>st</SUP> day after such notice is delivered to the Company. The
provisions of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity with the terms of
this Section 2(e) to correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended
Beneficial Ownership Limitation herein contained or to make changes or supplements necessary or desirable to properly give effect to
such limitation. The limitations contained in this paragraph shall apply to a successor holder of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Section 3</U>. <U>Certain Adjustments</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">a) <U>Stock Dividends and Splits</U>. If the
Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise makes a distribution or distributions
on shares of its Common Stock or any other equity or equity equivalent securities payable in shares of Common Stock (which, for
avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this Warrant), (ii)
subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse stock
split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the
Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of
which the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before
such event and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and
the number of shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price
of this Warrant shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective
immediately after the record date for the determination of stockholders entitled to receive such dividend or distribution and shall
become effective immediately after the effective date in the case of a subdivision, combination or re &#45;classification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">b) <U>Intentionally Omitted</U> .</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">c) <U>Subsequent Rights Offerings</U>. In
addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants, issues or sells any Common Stock Equivalents
or rights to purchase stock, warrants, securities or other property pro rata to the record holders of any class of shares of Common Stock
(the &ldquo; <U>Purchase Rights</U>&rdquo;), then the Holder will be entitled to acquire, upon the terms applicable to such Purchase Rights,
the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number of shares of Common Stock acquirable
upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial
Ownership Limitation) immediately before the date on which a record is taken for the grant, issuance or sale of such Purchase Rights,
or, if No&nbsp;such record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the grant,
issue or sale of such Purchase Rights (provided, however, to the extent that the Holder&rsquo;s right to participate in any such Purchase
Right would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in
such Purchase Right to such extent (or beneficial ownership of such shares of Common Stock as a result of such Purchase Right to such
extent) and such Purchase Right to such extent shall be held in abeyance for the Holder until such time, if ever, as its right thereto
would not result in the Holder exceeding the Beneficial Ownership Limitation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">d) <U>Pro Rata Distributions</U>
.. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or other
distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital or
otherwise (including, without limitation, any distribution of cash, stock or other securities, property or options by way of a
dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a &ldquo; <U>Distribution</U>&rdquo;),
at any time after the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such
Distribution to the same extent that the Holder would have participated therein if the Holder had held the number of shares of
Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including
without limitation, the Beneficial Ownership Limitation) immediately before the date of which a record is taken for such
Distribution, or, if No&nbsp;such record is taken, the date as of which the record holders of shares of Common Stock are to be
determined for the participation in such Distribution ( <U>provided</U>,&nbsp; <U>however</U>, to the extent that the Holder&rsquo;s
right to participate in any such Distribution would result in the Holder exceeding the Beneficial Ownership Limitation, then the
Holder shall not be entitled to participate in such Distribution to such extent (or in the beneficial ownership of any shares of
Common Stock as a result of such Distribution to such extent) and the portion of such Distribution shall be held in abeyance for the
benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial
Ownership Limitation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">e) <U>Fundamental Transaction.</U> If, at
any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more related transactions effects any
merger or consolidation of the Company with or into another Person other than any Subsidiary or any Affiliate of the Company,
whereby the stockholders of the Company immediately prior to such merger or consolidation do not own, directly or indirectly, at
least 50% of the voting power of the surviving entity immediately after such merger or consolidation, (ii) the Company, directly or
indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of
its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer
(whether by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or
exchange their shares for other securities, cash or property and has been accepted by the holders of 50% or more of the outstanding
Common Stock, (iv) the Company, directly or indirectly, in one or more related transactions effects any reclassification,
reorganization or recapitalization of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is
effectively converted into or exchanged for other securities, cash or property, or (v) the Company, directly or indirectly, in one
or more related transactions consummates a stock or share purchase agreement or other business combination (including, without
limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with another Person or group of Persons
whereby such other Person or group acquires more than 50% of the outstanding shares of Common Stock (not including any shares of
Common Stock held by the other Person or other Persons making or party to, or associated or affiliated with the other Persons making
or party to, such stock or share purchase agreement or other business combination) (each a &ldquo;<U>Fundamental Transaction</U>
&rdquo;), then, upon any subsequent exercise of this Warrant, the Holder shall have the right to receive, for each Warrant Share
that would have been issuable upon such exercise immediately prior to the occurrence of such Fundamental Transaction, at the option
of the Holder (without regard to any limitation in Section 2(e) on the exercise of this Warrant), the number of shares of Common
Stock of the successor or acquiring corporation or of the Company, if it is the surviving corporation, and any additional
consideration (the &ldquo;<U>Alternate Consideration</U> &rdquo;) receivable as a result of such Fundamental Transaction by a holder
of the number of shares of Common Stock for which this Warrant is exercisable immediately prior to such Fundamental Transaction
(without regard to any limitation in Section 2(e) on the exercise of this Warrant). For purposes of any such exercise,
the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration based on the amount
of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental Transaction, and the Company shall
apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative value of any different
components of the Alternate Consideration. If holders of Common Stock are given any choice as to the securities, cash or property to
be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration it
receives upon any exercise of this Warrant following such Fundamental Transaction. Notwithstanding anything to the
contrary, in the event of a Fundamental Transaction, the Company or any Successor Entity (as defined below) shall, at the
Holder&rsquo;s option, exercisable at any time concurrently with, or within 30 days after, the consummation of the Fundamental
Transaction (or, if later, the date of the public announcement of the applicable Fundamental Transaction), purchase this Warrant
from the Holder by paying to the Holder an amount of cash equal to the Black Scholes Value (as defined below) of the remaining
unexercised portion of this Warrant on the date of the consummation of such Fundamental Transaction ; provided, however, that, if
the Fundamental Transaction is not within the Company&rsquo;s control, including not approved by the Company&rsquo;s Board of Directors, Holder
shall only be entitled to receive from the Company or any Successor Entity the same type or form of consideration (and in the same
proportion), at the Black Scholes Value of the unexercised portion of this Warrant, that is being offered and paid to the holders of
Common Stock of the Company in connection with the Fundamental Transaction, whether that consideration be in the form of cash, stock
or any combination thereof, or whether the holders of Common Stock are given the choice to receive from among alternative forms of
consideration in connection with the Fundamental Transaction; provided, further, that if holders of Common Stock of the Company are
not offered or paid any consideration in such Fundamental Transaction, such holders of Common Stock will be deemed to have received
common stock of the Successor Entity (which Entity may be the Company following such Fundamental Transaction) in such Fundamental
Transaction. &ldquo;Black Scholes Value &rdquo; means the value of this Warrant based on the Black-Scholes Option Pricing
Model obtained from the &ldquo;OV&rdquo; function on Bloomberg determined as of the day of consummation of the applicable
Fundamental Transaction for pricing purposes and reflecting (A) a risk-free interest rate corresponding to the U.S. Treasury rate
for a period equal to the time between the date of the public announcement of the applicable Fundamental Transaction and the
Termination Date, (B) an expected volatility equal to the greater of 100% and the 100 day volatility obtained from the HVT function
on Bloomberg (determined utilizing a 365 day annualization factor) as of the Trading Day immediately following the public
announcement of the applicable Fundamental Transaction, (C) the underlying price per share used in such calculation shall be the
greater of (i ) the sum of the price per share being offered in cash, if any, plus the value of any non-cash consideration, if any,
being offered in such Fundamental Transaction and (ii) the highest VWAP during the period beginning on the Trading Day immediately
preceding the announcement of the applicable Fundamental Transaction (or the consummation of the applicable Fundamental Transaction,
if earlier) and ending on the Trading Day of the Holder&rsquo;s request pursuant to this Section 3(e) and (D) a remaining option
time equal to the time between the date of the public announcement of the applicable Fundamental Transa ction and the Termination
Date and (E) a zero cost of borrow. The payment of the Black Scholes Value will be made by wire transfer of immediately available
funds (or such other consideration) within the later of ( i) five Business Days of the Holder&rsquo;s election and (ii) the date of
consummation of the Fundamental Transaction. The Company shall cause any successor entity in a Fundamental Transaction in
which the Company is not the survivor (the &ldquo;Successor Entity&rdquo;) to assume in writing all of the obligations of the
Company under this Warrant and the other Transaction Documents in accordance with the provisions of this Section 3(e) pursuant to
written agreements in form and substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable
delay) prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange for this
Warrant a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance to this
Warrant which is exercisable for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity)
equivalent to the shares of Common Stock acquirable and receivable upon exercise of this Warrant (without regard to any limitations
on the exercise of this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies the exercise price
hereunder to such shares of capital stock (but taking into account the relative value of the shares of Common Stock pursuant to such
Fundamental Transaction and the value of such shares of capital stock, such number of shares of capital stock and such exercise
price being for the purpose of protecting the economic value of this Warrant immediately prior to the consummation of such
Fundamental Transaction), and which is reasonably satisfactory in form and substance to the Holder. Upon the occurrence of any such
Fundamental Transaction, the Successor Entity shall succeed to, and be substituted for (so that from and after the date of such
Fundamental Transaction, the provisions of this Warrant and the other Transaction Documents referring to the &ldquo;Company&rdquo;
shall refer instead to the Successor Entity), and may exercise every right and power of the Company and shall assume all of the
obligations of the Company under this Warrant and the other Transaction Documents with the same effect as if such Successor Entity
had been named as the Company herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">f) <U>Calculations</U>. All calculations under
this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For purposes of this Section 3,
the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the number of shares of
Common Stock (excluding treasury shares, if any) issued and outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">g) <U>Notice to Holder</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">i. <U>Adjustment to Exercise Price</U>. Whenever
the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly deliver to the Holder by facsimile
or email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number of Warrant Shares
and setting forth a brief statement of the facts requiring such adjustment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">ii. <U>Notice to Allow Exercise by
Holder</U> . If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the Common Stock, (B) the
Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the Company shall authorize
the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of capital stock of any
class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with any
reclassification of the Common Stock, any consolidation or merger to which the Company (or any of its Subsidiaries) is a party, any
sale or transfer of all or substantially all of its assets, or any compulsory share exchange whereby the Common Stock is converted
into other securities, cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or
winding up of the affairs of the Company, then, in each case, the Company shall cause to be delivered by facsimile or email to the
Holder at its last facsimile number or email address as it shall appear upon the Warrant Reg ister of the Company, at least 10
calendar days prior to the applicable record or effective date hereinafter specified, a notice (unless such information is filed
with the Commission, in which case a notice shall not be required) stating (x) the date on which a record is to be taken for the
purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the
holders of the Common Stock of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be
determined or (y) the date on which such reclassification, consolidation, merger, sale, transfer or share exchange is expected to
become effective or close, and the date as of which it is expected that holders of the Common Stock of record shall be entitled to
exchange their shares of the Common Stock for securities, cash or other property deliverable upon such reclassification,
consolidation, merger, sale, transfer or share exchange; provided that the failure to deliver such notice or any defect therein or
in the delivery thereof shall not affect the validity of the corporate action required to be specified in such notice. To
the extent that any notice provided in this Warrant constitutes, or contains, material, non-public information regarding the Company
or any of the Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Current Report on
Form 8-K. The Holder shall remain entitled to exercise this Warrant during the period commencing on the date of such notice to the
effective date of the event triggering such notice except as may otherwise be expressly set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">h) <U>Voluntary Adjustment By Company</U> . Subject
to the rules and regulations of the Trading Market, the Company may at any time during the term of this Warrant, subject to the prior
written consent of the holders of a majority of the then outstanding Warrants (based on the number of Warrant Shares then underlying such
Warrants) , reduce the then current Exercise Price to any amount and for any period of time deemed appropriate by the board of directors
of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Section 4</U>. <U>Transfer of Warrant</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">a) <U>Transferability</U>. Subject
to compliance with any applicable securities laws and the conditions set forth in Section 4(d) hereof and to the provisions of
Section 4.1 of the Purchase Agreement, this Warrant and all rights hereunder (including, without limitation, any registration
rights) are transferable, in whole or in part, upon surrender of this Warrant at the principal office of the Company or its
designated agent , together with a written assignment of this Warrant substantially in the form attached hereto duly executed by the
Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon the making of such
transfer. Upon such surrender and, if required, such payment, the Company shall execute and deliver a new Warrant or
Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations specified in such
instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and
this Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be
required to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the
Holder shall surrender this Warrant to the Company within three (3) Trading Days of the date on which the Holder delivers an
assignment form to the Company assigning this Warrant in full. The Warrant, if properly assigned in accordance herewith , may be
exercised by a new holder for the purchase of Warrant Shares without having a new Warrant issued. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">b) <U>New Warrants</U>. This Warrant may be divided
or combined with other Warrants upon presentation hereof at the aforesaid office of the Company, together with a written notice specifying
the names and denominations in which new Warrants are to be issued, signed by the Holder or its agent or attorney. Subject
to compliance with Section 4(a), as to any transfer which may be involved in such division or combination, the Company shall execute and
deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance with such notice. All
Warrants issued on transfers or exchanges shall be dated the original Issue Date and shall be identical with this Warrant except as to
the number of Warrant Shares issuable pursuant thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">c) <U>Warrant Register</U>. The Company shall
register this Warrant, upon records to be maintained by the Company for that purpose (the &ldquo;<U>Warrant Register</U> &rdquo;), in
the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder of this Warrant
as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other purposes, absent
actual notice to the contrary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">d) <U>Transfer Restrictions</U>. If, at the
time of the surrender of this Warrant in connection with any transfer of this Warrant, the transfer of this Warrant shall not be either
(i) registered pursuant to an effective registration statement under the Securities Act and under applicable state securities or blue
sky laws or (ii) eligible for resale without volume or manner-of-sale restrictions or current public information requirements pursuant
to Rule 144, the Company may require, as a condition of allowing such transfer, that the Holder or transferee of this Warrant, as the
case may be, comply with the provisions of Section 5.7 of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">e) <U>Representation by the Holder</U>. The
Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant and, upon any exercise hereof, will
acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to or for distributing or reselling
such Warrant Shares or any part thereof in violation of the Securities Act or any applicable state securities law, except pursuant
to sales registered or exempted under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Section 5</U>. <U>Miscellaneous</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">a) <U>No&nbsp;Rights as Stockholder Until Exercise;
No&nbsp;Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights, dividends or other rights as a stockholder
of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly set forth in Section 3. Without limiting
any rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise&rdquo; pursuant to Section 2(c) or to receive cash payments
pursuant to Section 2(d)(i), Section 2(d)(iv) and Section 3(e) herein, in No&nbsp;event shall the Company be required to net cash settle
an exercise of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">b) <U>Loss, Theft, Destruction or Mutilation of
Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory to it of the loss, theft, destruction
or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case of loss, theft or destruction, of indemnity
or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include the posting of any bond), and upon surrender
and cancellation of such Warrant or stock certificate, if mutilated, the Company will make and deliver a new Warrant or stock certificate
of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">c) <U>Saturdays, Sundays, Holidays, etc</U>.
If the last or appointed day for the taking of any action or the expiration of any right required or granted herein shall not be a Trading
Day, then such action may be taken or such right may be exercised on the next succeeding Trading Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">d) <U>Authorized Shares</U>. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company covenants that, during the
period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a sufficient number of shares to
provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant. The Company
further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with the duty of
issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take
all such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation
of any applicable law or regulation, or of any requirements of the Trading Market upon which the Common Stock may be
listed. The Company covenants that all Warrant Shares which may be issued upon the exercise of the purchase rights
represented by this Warrant will, upon exercise of the purchase rights represented by this Warrant and payment for such Warrant
Shares in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable and free from all taxes, liens and
charges created by the Company in respect of the issue thereof (other than taxes in respect of any transfer occurring
contemporaneously with such issue). </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Except and to the extent as waived or consented
to by the Holder, the Company shall not by any action, including, without limitation, amending its certificate of incorporation or through
any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or any other voluntary action,
avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all times in good faith assist in
the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate to protect the rights of Holder
as set forth in this Warrant against impairment. Without limiting the generality of the foregoing, the Company will (i) not
increase the par value of any Warrant Shares above the amount payable therefor upon such exercise immediately prior to such increase in
par value, (ii) take all such action as may be necessary or appropriate in order that the Company may validly and legally issue fully
paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially reasonable efforts to obtain all such
authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof, as may be, necessary to enable the
Company to perform its obligations under this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Before taking any action which would result in
an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise Price, the Company shall obtain
all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory body or bodies having
jurisdiction thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">e) <U>Jurisdiction</U>. All questions concerning
the construction, validity, enforcement and interpretation of this Warrant shall be determined in accordance with the provisions of the
Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">f) <U>Restrictions</U>. The Holder acknowledges
that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and the Holder does not utilize cashless exercise,
will have restrictions upon resale imposed by state and federal securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">g) <U>Nonwaiver and Expenses</U>. No&nbsp;course
of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as a waiver of such right or otherwise
prejudice the Holder&rsquo;s rights, powers or remedies. Without limiting any other provision of this Warrant or the Purchase
Agreement, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results in any material damages
to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including, but
not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings, incurred by the Holder in collecting any amounts
due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">h) <U>Notices</U>. Any notice, request or other
document required or permitted to be given or delivered to the Holder by the Company shall be delivered in accordance with the notice
provisions of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">i) <U>Limitation of Liability</U>. No&nbsp;provision
hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant Shares, and No&nbsp;enumeration
herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase price of any Common
Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">j) <U>Remedies</U>. The Holder, in addition to
being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific performance of its
rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss incurred by reason
of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any action for specific
performance that a remedy at law would be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">k) <U>Successors and Assigns</U>. Subject
to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the benefit of and be binding
upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder. The provisions
of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable by the Holder
or holder of Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">l) <U>Amendment</U>. This Warrant may be modified
or amended or the provisions hereof waived with the written consent of the Company and holders of a majority of the then outstanding
Warrants (based on the number of Warrant Shares then underlying such Warrants), provided that if any amendment, modification or waiver
disproportionately and adversely impacts a Holder (or group of Holders), the consent of such disproportionately impacted Holder (or group
of Holders) shall also be required.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">m) <U>Severability</U>. Wherever possible,
each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law, but if any provision
of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the extent of such prohibition
or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">n) <U>Headings</U>. The headings used
in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">********************</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>(Signature Page Follows)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">IN WITNESS WHEREOF, the Company has caused this
Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PERASO INC. </B></FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&nbsp; </FONT></TD>
    <TD STYLE="width: 31%">&nbsp;</TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: </FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTICE OF EXERCISE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To:[_______________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(1) The undersigned hereby elects to purchase
________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised in full), and tenders herewith
payment of the exercise price in full, together with all applicable transfer taxes, if any.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(2) Payment shall take the form of (check applicable
box):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#9744; in lawful money of the United States;
or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#9744; if permitted the cancellation of such number
of Warrant Shares as is necessary, in accordance with the formula set forth in subsection 2(c), to exercise this Warrant with respect
to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure set forth in subsection 2(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(3) Please issue said Warrant Shares in the name
of the undersigned or in such other name as is specified below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Warrant Shares shall be delivered to the following
DWAC Account Number:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(4) <U>Accredited Investor</U>. The
undersigned is an &ldquo;accredited investor&rdquo; as defined in Regulation D promulgated under the Securities Act of 1933, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">[SIGNATURE OF HOLDER]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Investing Entity: ________________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Signature of Authorized Signatory of Investing
Entity</I>: _________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Authorized Signatory: ___________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Title of Authorized Signatory: ____________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Date: ________________________________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">ASSIGNMENT FORM</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>(To assign the foregoing Warrant, execute this form and supply required
information. Do not use this form to purchase shares.)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">FOR VALUE RECEIVED, the foregoing Warrant and all rights evidenced
thereby are hereby assigned to</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 1.8pt; padding-right: 1.8pt; text-align: justify; width: 49%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="padding-top: 1.8pt; padding-right: 1.8pt; width: 49%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 1.8pt; padding-right: 1.8pt">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-top: 1.8pt; padding-right: 1.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please Print)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 1.8pt; padding-right: 1.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-top: 1.8pt; padding-right: 1.8pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 1.8pt; padding-right: 1.8pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-top: 1.8pt; padding-right: 1.8pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(Please Print)</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 1.8pt; padding-right: 1.8pt">Phone Number:</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; padding-top: 1.8pt; padding-right: 1.8pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 1.8pt; padding-right: 1.8pt">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-top: 1.8pt; padding-right: 1.8pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 1.8pt; padding-right: 1.8pt">Email Address:</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; padding-top: 1.8pt; padding-right: 1.8pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 1.8pt; padding-right: 1.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated: _______________ __, ______</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-top: 1.8pt; padding-right: 1.8pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 1.8pt; padding-right: 1.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s Signature:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-top: 1.8pt; padding-right: 1.8pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 1.8pt; padding-right: 1.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s Address:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-top: 1.8pt; padding-right: 1.8pt">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.3
<SEQUENCE>4
<FILENAME>ea179675ex4-3_peraso.htm
<DESCRIPTION>FORM OF PLACEMENT AGENT WARRANT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0pt"><B>Exhibit 4.3</B></P>

<P STYLE="margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH
THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE
IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &ldquo;SECURITIES ACT&rdquo;), AND,
ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO
AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE
WITH APPLICABLE STATE SECURITIES LAWS.&nbsp;&nbsp;THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED
IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>PERASO INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>COMMON STOCK PURCHASE WARRANT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 50%">Warrant Shares: [&#9679;]</TD>
  <TD STYLE="text-align: right; width: 50%">Initial Exercise Date: June 2, 2023</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Issue Date: June 2, 2023</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">THIS COMMON STOCK PURCHASE WARRANT (the &ldquo;<U>Warrant</U>&rdquo;)
certifies that, for value received, The Benchmark Company, LLC or its assigns (the &ldquo;<U>Holder</U> &rdquo;) is entitled, upon the
terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the
&ldquo;<U>Initial Exercise Date</U>&rdquo;) and on or prior to 5:00 p.m. (New York City time) on June 2, 2028 (the &ldquo;<U>Termination
Date</U> &rdquo;) but not thereafter, to subscribe for and purchase from Peraso Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;),
up to [&#9679;] shares (as subject to adjustment hereunder, the &ldquo;<U>Warrant Shares</U> &rdquo;) of Common Stock.&nbsp;&nbsp;The
purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Section 1</U> .<U>Definitions</U> .&nbsp;&nbsp;Capitalized
terms used and not otherwise defined herein shall have the meanings set forth in that certain Securities Purchase Agreement (the &ldquo;<U>Purchase
Agreement</U>&rdquo;), dated May 31, 2023, among the Company and the purchasers signatory thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Section 2</U>. <U>Exercise</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">a) <U>Exercise of Warrant</U>.&nbsp;&nbsp;Subject
to Section 2(e) herein, exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times
on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed facsimile copy
or PDF copy submitted by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto (the &ldquo; <U>Notice of
Exercise</U>&rdquo;).&nbsp;&nbsp;Within the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard
Settlement Period (as defined in Section 2(d)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver the aggregate
Exercise Price for the Warrant Shares specified in the applicable Notice of Exercise by wire transfer or cashier&rsquo;s check drawn on
a United States bank unless the cashless exercise procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise.
No&nbsp;ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization
) of any Notice of Exercise be required. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically
surrender this Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has
been exercised in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation within three (3) Trading
Days of the date on which the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases
of a portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant
Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased.&nbsp;&nbsp;The Holder and the Company
shall maintain records showing the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection
to any Notice of Exercise within one (1 ) Trading Day of receipt of such notice.&nbsp;&nbsp; <B>The Holder and any assignee, by acceptance
of this Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the
Warrant Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given time may be less than the amount
stated on the face hereof.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">b) <U>Exercise Price</U>.&nbsp;&nbsp;The exercise
price per share of Common Stock under this Warrant shall be <B>$0.70</B>, subject to adjustment hereunder (the &ldquo; <U>Exercise Price</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">c) <U>Cashless Exercise</U> .&nbsp;&nbsp;This
Warrant may be exercised, in whole or in part, by means of a &ldquo;cashless exercise&rdquo; in which the Holder shall be entitled to
receive a number of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(A) = as applicable: (i) the VWAP on the Trading
Day immediately preceding the date of the applicable Notice of Exercise if such Notice of Exercise is (1) both executed and delivered
pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2) both executed and delivered pursuant to Section 2(a) hereof
on a Trading Day prior to the opening of &ldquo;regular trading hours&rdquo; (as defined in Rule 600(b) of Regulation NMS promulgated
under the federal securities laws) on such Trading Day, or (ii) the VWAP on the date of the applicable Notice of Exercise if the date
of such Notice of Exercise is a Trading Day and such Notice of Exercise is both executed and delivered pursuant to Section 2(a) hereof
after the close of &ldquo;regular trading hours&rdquo; on such Trading Day;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(B) = the Exercise Price of this Warrant, as adjusted
hereunder; and &nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(X) = the number of Warrant Shares that would
be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such exercise were by means of a cash exercise
rather than a cashless exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white">If Warrant
Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the Securities
Act, the Warrant Shares shall take on the characteristics of the Warrants being exercised, and the holding period of the Warrant Shares
being issued may be tacked on to the holding period of this Warrant.&nbsp;&nbsp;The Company agrees not to take any position contrary to
this Section 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo; <U>VWAP</U>&rdquo; means, for any date,
the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or quoted on a Trading
Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date) on the Trading Market
on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m. (New York City time)
to 4:02 p.m. (New York City time)), (b)&nbsp; if OTCQB or OTCQX is not a Trading Market, the volume weighted average price of the Common
Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then listed or quoted
for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported in The Pink Open Market (or a similar organization
or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported, or (d)&nbsp;in
all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good faith by
the Purchasers of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees and expenses
of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d) <U>Mechanics
of Exercise</U> .</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">i. <U>Delivery of Warrant Shares Upon Exercise</U>.&nbsp;&nbsp;The
Company shall cause the Warrant Shares purchased hereunder to be transmitted by the Transfer Agent to the Holder by crediting the account
of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository Trust Company through its Deposit or Withdrawal at Custodian
system (&ldquo; <U>DWAC</U>&rdquo;) if the Company is then a participant in such system and either (A) there is an effective registration
statement registering the issuance of the Warrant Shares to or resale of the Warrant Shares by the Holder or (B) the Warrant Shares are
eligible for resale by the Holder without volume or manner-of-sale limitations pursuant to Rule 144 (assuming cashless exercise of the
Warrants), and otherwise by physical delivery of a certificate, registered in the Company&rsquo;s share register in the name of the Holder
or its designee, for the number of Warrant Shares to which the Holder is entitled pursuant to such exercise to the address specified by
the Holder in the Notice of Exercise by the date that is the earliest of (i) two (2) Trading Days after the delivery to the Company of
the Notice of Exercise, (ii) one (1) Trading Day after delivery of the aggregate Exercise Price to the Company and (iii) the number of
Trading Days comprising the Standard Settlement Period after the delivery to the Company of the Notice of Exercise ( such date, the &ldquo;
<U>Warrant Share Delivery Date</U>&rdquo; ). &nbsp;&nbsp; Upon delivery of the Notice of Exercise , the Holder shall be deemed for all
corporate purposes to have become the holder of record of the Warrant Shares with respect to which this Warrant has been exercised, irrespective
of the date of delivery of the Warrant Shares, provided&nbsp;&nbsp;that payment of the aggregate Exercise Pric e (other than in the case
of a cashless exercise ) is received within the earlier of ( i) two (2) Trading Days and (ii) the number of Trading Days comprising the
Standard Settlement Period following delivery of the Notice of Exercise.&nbsp;&nbsp;If the Company fails for any reason to deliver to
the Holder the Warrant Shares subject to a Notice of Exercise by the Warrant Share Delivery Date, the Company shall pay to the Holder,
in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant Shares subject to such exercise (based on the VWAP of
the Common Stock on the date of the applicable Notice of Exercise), $10 per Trading Day (increasing to $20 per Trading Day on the third
Trading Day after the Warrant Share Delivery Date) for each Trading Day after such Warrant Share Delivery Date until such Warrant Shares
are delivered or Holder rescinds such exercise. The Company agrees to maintain a transfer agent that is a participant in the FAST program
so long as this Warrant remains outstanding and exercisable . As used herein, &ldquo; <U>Standard Settlement Period</U>&rdquo; means the
standard settlement period, expressed in a number of Trading Days, on the Company&rsquo;s primary Trading Market with respect to the Common
Stock as in effect on the date of delivery of the Notice of Exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">ii. <U>Delivery of New Warrants Upon Exercise</U>
..&nbsp;&nbsp;If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and upon surrender of this
Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing the rights of the Holder
to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other respects be identical with
this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">iii. <U>Rescission Rights</U> .&nbsp;&nbsp;If
the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section 2(d)(i) by the Warrant
Share Delivery Date, then the Holder will have the right to rescind such exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">iv. <U>Compensation for Buy-In on Failure to Timely
Deliver Warrant Shares Upon Exercise</U>.&nbsp;&nbsp;In addition to any other rights available to the Holder, if the Company fails to
cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions of Section 2(d)(i) above pursuant
to an exercise on or before the Warrant Share Delivery Date (other than any such failure that is solely due to any action or inaction
by the Holder with respect to such exercise), and if after such date the Holder is required by its broker to purchase (in an open market
transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, shares of Common Stock to deliver in satisfaction
of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise (a &ldquo; <U>Buy-In</U>&rdquo;
), then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x) the Holder&rsquo;s total purchase price (including
brokerage commissions, if any) for the shares of Common Stock so purchased exceeds (y) the amount obtained by multiplying (1) the number
of Warrant Shares that the Company was required to deliver to the Holder in connection with the exercise at issue times (2) the price
at which the sell order giving rise to such purchase obligation was executed, and (B) at the option of the Holder, either reinstate the
portion of the Warrant and equivalent number of Warrant Shares for which such exercise was not honored (in which case such exercise shall
be deemed rescinded) or deliver to the Holder the number of shares of Common Stock that would have been issued had the Company timely
complied with its exercise and delivery obligations hereunder.&nbsp;&nbsp;For example, if the Holder purchases Common Stock having a total
purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares of Common Stock with an aggregate sale price
giving rise to such purchase obligation of $10,000, under clause ( A) of the immediately preceding sentence the Company shall be required
to pay the Holder $1,000. The Holder shall provide the Company written notice indicating the amounts payable to the Holder in respect
of the Buy-In and, upon request of the Company, evidence of the amount of such loss.&nbsp;&nbsp;Nothing herein shall limit a Holder&rsquo;s
right to pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific
performance and/or injunctive relief with respect to the Company&rsquo;s failure to timely deliver shares of Common Stock upon exercise
of the Warrant as required pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">v. <U>No&nbsp;Fractional Shares or
Scrip</U>. No&nbsp;fractional shares or scrip representing fractional shares shall be issued upon the exercise of this
Warrant.&nbsp;&nbsp;As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the
Company shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction
multiplied by the Exercise Price or round up to the next whole share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">vi. <U>Charges, Taxes and Expenses</U>.
Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other incidental expense in
respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and such Warrant
Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; <U>provided</U> , <U>however</U>
, that, in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered
for exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may require, as
a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. &nbsp;&nbsp;The
Company shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise and all fees to the Depository
Trust Company (or another established clearing corporation performing similar functions) required for same-day electronic delivery
of the Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">vii. <U>Closing of Books</U> .&nbsp;&nbsp;The
Company will not close its stockholder books or records in any manner which prevents the timely exercise of this Warrant, pursuant to
the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">e) <U>Holder&rsquo;s Exercise
Limitations</U>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to exercise any
portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance after exercise
as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates, and any other Persons
acting as a group together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;<U>Attribution
Parties</U>&rdquo;)), would beneficially own in excess of the Beneficial Ownership Limitation (as defined below).&nbsp; For purposes
of the foregoing sentence, the number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution
Parties shall include the number of shares of Common Stock issuable upon exercise of this Warrant with respect to which such
determination is being made, but shall exclude the number of shares of Common Stock which would be issuable upon (i) exercise of the
remaining, nonexercised portion of this Warrant beneficially owned by the Holder or any of its Affiliates or Attribution Parties and
(ii) exercise or conversion of the unexercised or nonconverted portion of any other securities of the Company (including, without
limitation, any other&nbsp;&nbsp;Common Stock Equivalents) subject to a limitation on conversion or exercise analogous to the
limitation contained herein beneficially owned by the Holder or any of its Affiliates or Attribution Parties.&nbsp; Except as set
forth in the preceding sentence, for purposes of this Section 2(e), beneficial ownership shall be calculated in accordance with
Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being acknowledged by the Holder that the
Company is not representing to the Holder that such calculation is in compliance with Section 13(d) of the Exchange Act and the
Holder is solely responsible for any schedules required to be filed in accordance therewith.&nbsp;&nbsp; To the extent that the
limitation contained in this Section 2(e) applies, the determination of whether this Warrant is exercisable (in relation to other
securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is
exercisable shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the
Holder&rsquo;s determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together
with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable, in each case subject to the
Beneficial Ownership Limitation, and the Company shall have No&nbsp;obligation to verify or confirm the accuracy of such
determination.&nbsp;&nbsp; In addition, a determination as to any group status as contemplated above shall be determined in
accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder.&nbsp;&nbsp;For purposes of
this Section 2(e) , in determining the number of outstanding shares of Common Stock, a Holder may rely on the number of outstanding
shares of Common Stock as reflected in (A ) the Company&rsquo;s most recent periodic or annual report filed with the Commission, as
the case may be , (B ) a more recent public announcement by the Company or (C ) a more recent written notice by the Company or the
Transfer Agent setting forth the number of shares of Common Stock outstanding.&nbsp; Upon the written or oral request of a Holder,
the Company shall within one Trading Day confirm orally and in writing to the Hold er the number of shares of Common Stock then
outstanding.&nbsp; In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the
conversion or exercise of securities of the Company, including this Warrant, by the Holder or its A ffiliates or Attribution Parties
since the date as of which such number of outstanding shares of Common Stock was reported.&nbsp;&nbsp;The &ldquo;<U>Beneficial
Ownership Limitation</U> &rdquo; shall be 4.99% of the number of shares of the Common Stock outstanding immediately after giving
effect to the issuance of shares of Common Stock issuable upon exercise of this Warrant.&nbsp;&nbsp;The Holder , upon notice to the
Company, may increase or decrease the Beneficial Ownership Limitation provisions of this Section 2(e), provided that the Beneficial
Ownership Limitation in No&nbsp;event exceeds 9.99% of the number of shares of the Common Stock outstanding immediately after giving
effect to the issuance of shares of Common Stock upon exercise of this Warrant held by the Holder and the provisions of this Section
2(e) shall continue to apply.&nbsp;&nbsp; Any increase in the Beneficial Ownership Limitation will not be effective until the 61 <SUP>st</SUP>
day after such notice is delivered to the Company. &nbsp;&nbsp;The provisions of this paragraph shall be construed and implemented
in a manner otherwise than in strict conformity with the terms of this Section 2(e) to correct this paragraph (or any portion
hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein contained or to make changes
or supplements necessary or desirable to properly give effect to such limitation. The limitations contained in this paragraph shall
apply to a successor holder of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Section 3</U>. <U>Certain Adjustments</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">a) <U>Stock Dividends and Splits</U>. If the Company,
at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise makes a distribution or distributions on shares
of its Common Stock or any other equity or equity equivalent securities payable in shares of Common Stock (which, for avoidance of doubt,
shall not include any shares of Common Stock issued by the Company upon exercise of this Warrant), (ii) subdivides outstanding shares
of Common Stock into a larger number of shares, (iii) combines (including by way of reverse stock split) outstanding shares of Common
Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the Common Stock any shares of capital stock of
the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the numerator shall be the number of shares
of Common Stock (excluding treasury shares, if any) outstanding immediately before such event and of which the denominator shall be the
number of shares of Common Stock outstanding immediately after such event , and the number of shares issuable upon exercise of this Warrant
shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant shall remain unchanged.&nbsp;&nbsp;Any adjustment
made pursuant to this Section 3(a) shall become effective immediately after the record date for the determination of stockholders entitled
to receive such dividend or distribution and shall become effective immediately after the effective date in the case of a subdivision,
combination or re-classification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">b) <U>Intentionally Omitted</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">c) <U>Intentionally Omitted.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: justify">d) <U>Intentionally Omitted.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">e) <U>Fundamental Transaction.</U> If, at any
time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more related transactions effects any merger
or consolidation of the Company with or into another Person other than any Subsidiary or any Affiliate of the Company, whereby the stockholders
of the Company immediately prior to such merger or consolidation do not own, directly or indirectly, at least 50% of the voting power
of the surviving entity immediately after such merger or consolidation, (ii) the Company, directly or indirectly, effects any sale, lease,
license, assignment, transfer, conveyance or other disposition of all or substantially all of its assets in one or a series of related
transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the Company or another Person)
is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange their shares for other securities, cash
or property and has been accepted by the holders of 50% or more of the outstanding Common Stock, (iv) the Company, directly or indirectly,
in one or more related transactions effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory
share exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash or property,
or (v) the Company, directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other
business combination (including, without limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with
another Person or group of Persons whereby such other Person or group acquires more than 50% of the outstanding shares of Common Stock
(not including any shares of Common Stock held by the other Person or other Persons making or party to, or associated or affiliated with
the other Persons making or party to, such stock or share purchase agreement or other business combination) (each a &ldquo;<U>Fundamental
Transaction</U> &rdquo;), then, upon any subsequent exercise of this Warrant, the Holder shall have the right to receive, for each Warrant
Share that would have been issuable upon such exercise immediately prior to the occurrence of such Fundamental Transaction, at the option
of the Holder (without regard to any limitation in Section 2(e) on the exercise of this Warrant), the number of shares of Common Stock
of the successor or acquiring corporation or of the Company, if it is the surviving corporation, and any additional consideration (the
&ldquo;<U>Alternate Consideration</U> &rdquo;) receivable as a result of such Fundamental Transaction by a holder of the number of shares
of Common Stock for which this Warrant is exercisable immediately prior to such Fundamental Transaction (without regard to any limitation
in Section 2(e) on the exercise of this Warrant).&nbsp;&nbsp;For purposes of any such exercise, the determination of the Exercise Price
shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect
of one share of Common Stock in such Fundamental Transaction, and the Company shall apportion the Exercise Price among the Alternate
Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration. If holders
of Common Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder
shall be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such Fundamental
Transaction. The Company shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor
(the &ldquo;Successor Entity&rdquo;) to assume in writing all of the obligations of the Company under this Warrant and the other Transaction
Documents in accordance with the provisions of this Section 3(e) pursuant to written agreements in form and substance reasonably satisfactory
to the Holder and approved by the Holder (without unreasonable delay) prior to such Fundamental Transaction and shall, at the option
of the Holder, deliver to the Holder in exchange for this Warrant a security of the Successor Entity evidenced by a written instrument
substantially similar in form and substance to this Warrant which is exercisable for a corresponding number of shares of capital stock
of such Successor Entity (or its parent entity) equivalent to the shares of Common Stock acquirable and receivable upon exercise of this
Warrant (without regard to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and with an exercise
price which applies the exercise price hereunder to such shares of capital stock (but taking into account the relative value of the shares
of Common Stock pursuant to such Fundamental Transaction and the value of such shares of capital stock, such number of shares of capital
stock and such exercise price being for the purpose of protecting the economic value of this Warrant immediately prior to the consummation
of such Fundamental Transaction), and which is reasonably satisfactory in form and substance to the Holder. Upon the occurrence of any
such Fundamental Transaction, the Successor Entity shall succeed to, and be substituted for (so that from and after the date of such
Fundamental Transaction, the provisions of this Warrant and the other Transaction Documents referring to the &ldquo;Company&rdquo; shall
refer instead to the Successor Entity), and may exercise every right and power of the Company and shall assume all of the obligations
of the Company under this Warrant and the other Transaction Documents with the same effect as if such Successor Entity had been named
as the Company herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">f) <U>Calculations</U>. All calculations under
this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For purposes of this Section 3,
the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the number of shares of
Common Stock (excluding treasury shares, if any) issued and outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">g) <U>Notice to Holder</U> .&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">i. <U>Adjustment to Exercise Price</U>. Whenever
the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly deliver to the Holder by facsimile
or email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number of Warrant Shares
and setting forth a brief statement of the facts requiring such adjustment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">ii. <U>Notice to Allow Exercise by Holder</U>
.. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the Common Stock, (B) the Company shall
declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the Company shall authorize the granting to all
holders of the Common Stock rights or warrants to subscribe for or purchase any shares of capital stock of any class or of any rights,
(D) the approval of any stockholders of the Company shall be required in connection with any reclassification of the Common Stock, any
consolidation or merger to which the Company (or any of its Subsidiaries) is a party, any sale or transfer of all or substantially all
of its assets, or any compulsory share exchange whereby the Common Stock is converted into other securities, cash or property, or (E)
the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs of the Company, then, in
each case, the Company shall cause to be delivered by facsimile or email to the Holder at its last facsimile number or email address as
it shall appear upon the Warrant Reg ister of the Company, at least 10 calendar days prior to the applicable record or effective date
hereinafter specified, a notice (unless such information is filed with the Commission, in which case a notice shall not be required) stating
(x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants, or if a
record is not to be taken, the date as of which the holders of the Common Stock of record to be entitled to such dividend, distributions,
redemption, rights or warrants are to be determined or (y) the date on which such reclassification, consolidation, merger, sale, transfer
or share exchange is expected to become effective or close, and the date as of which it is expected that holders of the Common Stock of
record shall be entitled to exchange their shares of the Common Stock for securities, cash or other property deliverable upon such reclassification,
consolidation, merger, sale, transfer or share exchange; provided that the failure to deliver such notice or any defect therein or in
the delivery thereof shall not affect the validity of the corporate action required to be specified in such notice.&nbsp;&nbsp;To the
extent that any notice provided in this Warrant constitutes, or contains, material, non-public information regarding the Company or any
of the Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K. The
Holder shall remain entitled to exercise this Warrant during the period commencing on the date of such notice to the effective date of
the event triggering such notice except as may otherwise be expressly set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">h) <U>Voluntary Adjustment By Company</U> .&nbsp;&nbsp;Subject
to the rules and regulations of the Trading Market, the Company may at any time during the term of this Warrant, subject to the prior
written consent of the holders of a majority of the then outstanding Warrants (based on the number of Warrant Shares then underlying such
Warrants) , reduce the then current Exercise Price to any amount and for any period of time deemed appropriate by the board of directors
of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Section 4</U>. <U>Transfer of Warrant</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">a) <U>Transferability</U>.&nbsp;&nbsp;Subject
to compliance with any applicable securities laws and the conditions set forth in Section 4(d) hereof and to the provisions of Section
4.1 of the Purchase Agreement, this Warrant and all rights hereunder (including, without limitation, any registration rights) are transferable,
in whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated agent , together with a written
assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient
to pay any transfer taxes payable upon the making of such transfer.&nbsp;&nbsp;Upon such surrender and, if required, such payment, the
Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination
or denominations specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this
Warrant not so assigned, and this Warrant shall promptly be cancelled.&nbsp;&nbsp;Notwithstanding anything herein to the contrary, the
Holder shall not be required to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full,
in which case, the Holder shall surrender this Warrant to the Company within three (3) Trading Days of the date on which the Holder delivers
an assignment form to the Company assigning this Warrant in full. The Warrant, if properly assigned in accordance herewith , may be exercised
by a new holder for the purchase of Warrant Shares without having a new Warrant issued.&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">b) <U>New Warrants</U>. This Warrant may be divided
or combined with other Warrants upon presentation hereof at the aforesaid office of the Company, together with a written notice specifying
the names and denominations in which new Warrants are to be issued, signed by the Holder or its agent or attorney.&nbsp;&nbsp;Subject
to compliance with Section 4(a), as to any transfer which may be involved in such division or combination, the Company shall execute and
deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance with such notice. All
Warrants issued on transfers or exchanges shall be dated the original Issue Date and shall be identical with this Warrant except as to
the number of Warrant Shares issuable pursuant thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">c) <U>Warrant Register</U> . The Company shall
register this Warrant, upon records to be maintained by the Company for that purpose (the &ldquo;<U>Warrant Register</U> &rdquo;), in
the name of the record Holder hereof from time to time.&nbsp;&nbsp;The Company may deem and treat the registered Holder of this Warrant
as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other purposes, absent
actual notice to the contrary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">d) <U>Transfer Restrictions</U> . If , at the
time of the surrender of this Warrant in connection with any transfer of this Warrant, the transfer of this Warrant shall not be either
(i) registered pursuant to an effective registration statement under the Securities Act and under applicable state securities or blue
sky laws or (ii) eligible for resale without volume or manner-of-sale restrictions or current public information requirements pursuant
to Rule 144, the Company may require, as a condition of allowing such transfer, that the Holder or transferee of this Warrant, as the
case may be, comply with the provisions of Section 5.7 of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">e) <U>Representation by the Holder</U>.&nbsp;&nbsp;The
Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant and, upon any exercise hereof, will acquire
the Warrant Shares issuable upon such exercise, for its own account and not with a view to or for distributing or reselling such Warrant
Shares or any part thereof in violation of the Securities Act or any applicable state securities law, except pursuant to sales registered
or exempted under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Section 5</U>. <U>Miscellaneous</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">a) <U>No&nbsp;Rights as Stockholder Until Exercise;
No&nbsp;Settlement in Cash</U> .&nbsp;&nbsp;This Warrant does not entitle the Holder to any voting rights, dividends or other rights as
a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly set forth in Section 3.&nbsp;&nbsp;Without
limiting any rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise&rdquo; pursuant to Section 2(c) or to receive
cash payments pursuant to Section 2(d)(i), Section 2(d)(iv) and Section 3(e) herein, in No&nbsp;event shall the Company be required to
net cash settle an exercise of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">b) <U>Loss, Theft, Destruction or Mutilation of
Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory to it of the loss, theft, destruction
or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case of loss, theft or destruction, of indemnity
or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include the posting of any bond), and upon surrender
and cancellation of such Warrant or stock certificate, if mutilated, the Company will make and deliver a new Warrant or stock certificate
of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">c) <U>Saturdays, Sundays, Holidays, etc</U> .&nbsp;&nbsp;If
the last or appointed day for the taking of any action or the expiration of any right required or granted herein shall not be a Trading
Day, then such action may be taken or such right may be exercised on the next succeeding Trading Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">d) <U>Authorized Shares</U>.&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company covenants that, during the period
the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a sufficient number of shares to provide for
the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant.&nbsp;&nbsp;The Company further covenants
that its issuance of this Warrant shall constitute full authority to its officers who are charged with the duty of issuing the necessary
Warrant Shares upon the exercise of the purchase rights under this Warrant.&nbsp;&nbsp;The Company will take all such reasonable action
as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any applicable law or regulation,
or of any requirements of the Trading Market upon which the Common Stock may be listed.&nbsp;&nbsp;The Company covenants that all Warrant
Shares which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise of the purchase rights
represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued, fully paid
and nonassessable and free from all taxes, liens and charges created by the Company in respect of the issue thereof (other than taxes
in respect of any transfer occurring contemporaneously with such issue).&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Except and to the extent as waived or consented
to by the Holder, the Company shall not by any action, including, without limitation, amending its certificate of incorporation or through
any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or any other voluntary action,
avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all times in good faith assist in
the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate to protect the rights of Holder
as set forth in this Warrant against impairment.&nbsp;&nbsp;Without limiting the generality of the foregoing, the Company will (i) not
increase the par value of any Warrant Shares above the amount payable therefor upon such exercise immediately prior to such increase in
par value, (ii) take all such action as may be necessary or appropriate in order that the Company may validly and legally issue fully
paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially reasonable efforts to obtain all such
authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof, as may be, necessary to enable the
Company to perform its obligations under this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Before taking any action which would result in
an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise Price, the Company shall obtain
all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory body or bodies having
jurisdiction thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">e) <U>Jurisdiction</U>. All questions concerning
the construction, validity, enforcement and interpretation of this Warrant shall be determined in accordance with the provisions of the
Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">f) <U>Restrictions</U> .&nbsp;&nbsp;The Holder
acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and the Holder does not utilize cashless
exercise, will have restrictions upon resale imposed by state and federal securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">g) <U>Nonwaiver and Expenses</U>.&nbsp;&nbsp;No&nbsp;course
of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as a waiver of such right or otherwise
prejudice the Holder&rsquo;s rights, powers or remedies.&nbsp;&nbsp;Without limiting any other provision of this Warrant or the Purchase
Agreement, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results in any material damages
to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including, but
not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings, incurred by the Holder in collecting any amounts
due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">h) <U>Notices</U> .&nbsp;&nbsp;Any notice, request
or other document required or permitted to be given or delivered to the Holder by the Company shall be delivered in accordance with the
notice provisions of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">i) <U>Limitation of Liability</U>.&nbsp;No&nbsp;provision
hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant Shares, and No&nbsp;enumeration
herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase price of any Common
Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">j) <U>Remedies</U> .&nbsp;The Holder, in
addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific performance
of its rights under this Warrant.&nbsp;&nbsp;The Company agrees that monetary damages would not be adequate compensation for any loss
incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any
action for specific performance that a remedy at law would be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">k) <U>Successors and Assigns</U>.&nbsp;Subject
to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the benefit of and be binding
upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder.&nbsp;The provisions
of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable by the Holder
or holder of Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">l) <U>Amendment</U> .&nbsp;This Warrant
may be modified or amended or the provisions hereof waived with the written consent of the Company and holders of a majority of the then
outstanding Warrants (based on the number of Warrant Shares then underlying such Warrants), provided that if any amendment, modification
or waiver disproportionately and adversely impacts a Holder (or group of Holders), the consent of such disproportionately impacted Holder
(or group of Holders) shall also be required .</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">m) <U>Severability</U>.&nbsp;Wherever possible,
each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law and consistent with
the requirements of FINRA Rule 5110, but if any provision of this Warrant shall be prohibited by or invalid under applicable law or FINRA
Rule 5110, such provision shall be ineffective to the extent of such prohibition or invalidity and shall be reformed in accordance with
such law or rule, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">n) <U>Headings</U>.&nbsp;The headings used
in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">********************</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><I>(Signature Page Follows)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">IN WITNESS WHEREOF, the Company has caused this
Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>PERASO INC.</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; width: 35%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>NOTICE OF EXERCISE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To:[_______________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(1) The undersigned hereby elects to
purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised in full), and
tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(2) Payment shall take the form of (check applicable
box):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> &#9744; in lawful money of the United
States; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> &#9744; [if permitted the cancellation of
such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection 2(c), to exercise this Warrant
with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure set forth in subsection
2(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(3) Please issue said Warrant Shares in the name
of the undersigned or in such other name as is specified below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Warrant Shares shall be delivered to the following
DWAC Account Number:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(4) <U>Accredited
Investor</U>.&nbsp;&nbsp;The undersigned is an &ldquo;accredited investor&rdquo; as defined in Regulation D promulgated under the
Securities Act of 1933, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">[SIGNATURE OF HOLDER]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Investing Entity: ________________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Signature of Authorized Signatory of Investing
Entity</I>: __________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Authorized Signatory: ____________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Title of Authorized Signatory: _____________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Date: ________________________________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">ASSIGNMENT FORM</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>(To assign the foregoing Warrant, execute this form and supply required
information.&nbsp;&nbsp;Do not use this form to purchase shares.)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">FOR VALUE RECEIVED, the foregoing Warrant and all rights evidenced
thereby are hereby assigned to</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 50%; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please Print)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:</FONT></TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Phone Number:</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Email Address:</P></TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(Please Print)</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">______________________________________</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">______________________________________</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated: _______________ __, ______</FONT></TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s Signature:</FONT></TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s Address:</FONT></TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>5
<FILENAME>ea179675ex5-1_peraso.htm
<DESCRIPTION>OPINION OF MITCHELL SILBERBERG & KNUPP LLP
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 5.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt"><IMG SRC="ex5-1_001.jpg" ALT=""></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 80%">
    <P STYLE="font: small-caps 10pt Times New Roman, Times, Serif; margin: 0pt 0">Mitchell Silberberg <FONT STYLE="font-family: Times New Roman, Times, Serif">&amp;</FONT>
    Knupp llp</P>
    <P STYLE="font: small-caps 10pt Times New Roman, Times, Serif; margin: 0pt 0">A Law Partnership Including Professional Corporations</P></TD>
    <TD STYLE="width: 20%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">June 2, 2023</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">Peraso Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">2309 Bering Street</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">San Jose, CA 95131</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have acted as counsel to
Peraso Inc., a Delaware corporation (the &ldquo;Company&rdquo;), in connection with the offering of 2,250,000 shares of the Company&rsquo;s
common stock, par value $0.001 per share (the &ldquo;Offered Shares&rdquo;), pre-funded warrants (the &ldquo;Warrants&rdquo;) to purchase
up to 3,464,286 shares of Common Stock and the shares of the Company&rsquo;s common stock issuable upon exercise of the Warrants (the
&ldquo;Warrant Shares&rdquo;) to be offered and sold by the Company pursuant to a prospectus supplement, dated May 31, 2023, and the accompanying
base prospectus, dated August 9, 2021 (such documents, collectively, the &ldquo;Prospectus&rdquo;) that form part of the Company&rsquo;s
effective registration statement on Form&nbsp;S-3&nbsp;with the Securities and Exchange Commission (the &ldquo;Commission&rdquo;) (File&nbsp;No.&nbsp;333-258386)&nbsp;(the
&ldquo;Registration Statement&rdquo;). The Shares, the Warrants and the Warrant Shares are collectively referred to herein as the &ldquo;Securities.&rdquo;
The Securities will be issued pursuant to that certain Securities Purchase Agreement, dated May 31, 2023, between the Company and the
purchaser signatory thereto (the &ldquo;Securities Purchase Agreement&rdquo;). Capitalized terms used and not otherwise defined in this
opinion have the meanings given to them in the Securities Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This opinion letter is furnished
to you at your request to enable you to fulfill the requirements of Item 601(b)(5) of Regulation&nbsp;S-K,&nbsp;17 C.F.R. &sect; 229.601(b)(5),
in connection with the Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As counsel to the Company
in connection with this opinion letter, we have examined such corporate records, documents, and instruments of the Company and reviewed
such questions of law as we have deemed necessary for the purpose of rendering the opinions set forth herein and we have examined the
proceedings proposed to be taken by the Company relating to the issuance and sale of the Shares. We have also examined the Registration
Statement as filed with the Commission in accordance with the provisions of the Act, and the rules and regulations of the Commission thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have examined such documents
and considered such legal matters as we have deemed necessary and relevant as the basis for the opinions set forth below. With respect
to such examination, we have assumed the genuineness of all signatures, the authenticity of all documents submitted to us as originals,
the conformity to original documents of all documents submitted to us as reproduced or certified copies, and the authenticity of the originals
of those latter documents. As to questions of fact material to this opinion, we have, to the extent deemed appropriate, relied upon certain
representations of certain officers and employees of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-top: Black 1.5pt solid; width: 47%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="border-top: Black 1.5pt solid; width: 53%; text-align: left; font-size: 10pt">437 Madison Ave., 25th Floor, New York, New
    York 10022-7001<BR> Phone: (212) 509-3900&nbsp;&nbsp;Fax: (212) 509-7239 Website: <FONT STYLE="font-variant: small-caps; text-transform: none">www.msk.com</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt"><IMG SRC="ex5-1_001.jpg" ALT=""></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">June 2, 2023</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Page 2</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

</TD>
    <TD STYLE="width: 50%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="background-color: white">This
opinion letter is based as to matters of law solely on the Delaware General Corporation Law as in effect on the date hereof. We express
no opinion herein as to any other statutes, rules, or regulations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Based
upon, subject to and limited by the foregoing, we are of the opinion that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">1.</TD><TD STYLE="text-align: justify">As of the date hereof the Shares have been duly authorized and, when issued and sold upon payment in the
manner contemplated by the Securities Purchase Agreement and in accordance with the resolutions adopted by the Board of Directors of the
Company, will be validly issued, fully paid, and nonassessable.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">2.</TD><TD STYLE="text-align: justify">The Warrants, upon payment in the manner contemplated by the Securities Purchase Agreement, will be validly
issued, fully paid and nonassessable.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">3.</TD><TD STYLE="text-align: justify">The Warrant Shares issuable upon exercise of the Warrants, when sold, paid for and issued upon exercise
of the Warrants and upon receipt of payment of the exercise price thereof, if applicable, in accordance with the terms thereof, will be
duly and validly issued, fully paid and nonassessable.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">This
opinion letter has been prepared for use in connection with the filing by the Company of a Current Report on Form&nbsp;8-K&nbsp;relating
to the offer and sale of the Securities, which Form&nbsp;8-K&nbsp;will be incorporated by reference into the Registration Statement and
Prospectus, and speaks as of the date hereof. We assume no obligation to advise you of any changes in the foregoing subsequent to the
delivery of this letter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">We
hereby consent to the filing of this opinion letter as Exhibit 5.1 to the above-described Form&nbsp;8-K&nbsp;and to the reference to this
firm under the caption &ldquo;Legal Matters&rdquo; in the Prospectus. In giving this consent, we do not thereby admit that we are an &ldquo;expert&rdquo;
within the meaning of the Securities Act of 1933, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 40%">Very truly yours,</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>/s/ MITCHELL SILBERBERG &amp; KNUPP LLP</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>6
<FILENAME>ea179675ex10-1_peraso.htm
<DESCRIPTION>FORM OF SECURITIES PURCHASE AGREEMENT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 10.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECURITIES PURCHASE AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Securities Purchase Agreement
(this &ldquo;<U>Agreement</U>&rdquo;) is dated as of May 31, 2023, between Peraso Inc., a Delaware corporation (the &ldquo;<U>Company</U>
&rdquo;), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a &ldquo;<U>Purchaser</U>&rdquo;
and collectively, the &ldquo;<U>Purchasers</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>, subject to
the terms and conditions set forth in this Agreement and pursuant to (i) an effective registration statement under the Securities Act
(as defined below) as to the Shares (as defined below) and the Pre-Funded Warrants (as defined below) and (ii) an exemption from the registration
requirements of Section 5 of the Securities Act contained in Section 4(a)(2) thereof and/or Regulation D thereunder as to the Purchase
Warrants (as defined below), the Company desires to issue and sell to each Purchaser, and each Purchaser, severally and not jointly, desires
to purchase from the Company, securities of the Company as more fully described in this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>NOW, THEREFORE</B>, in
consideration of the mutual covenants contained in this Agreement, and for other good and valuable consideration, the receipt and adequacy
of which are hereby acknowledged, the Company and each Purchaser agree as follows:</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">ARTICLE
I</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">DEFINITIONS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.1 <U>Definitions</U>.
In addition to the terms defined elsewhere in this Agreement, for all purposes of this Agreement, the following terms have the meanings
set forth in this Section 1.1:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Acquiring Person</U>&rdquo;
shall have the meaning ascribed to such term in Section 4.5.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Action</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(j).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Affiliate</U>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person, as such terms are used in and construed under Rule 405 under the Securities Act. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<U>AFSLLP</U>&rdquo; means ArentFox Schiff
LLP with offices located at 1717 K Street, Washington, DC 20006.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Board of Directors</U>&rdquo;
means the board of directors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Business Day</U>&rdquo;
means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized or required by
law to remain closed; <FONT STYLE="background-color: white"><U>provided</U>, <U>however</U>, for clarification, commercial banks shall
not be deemed to be authorized or required by law to remain closed due to &ldquo;stay at home&rdquo;, &ldquo;shelter-in-place&rdquo;,
&ldquo;non-essential employee&rdquo;&nbsp; or any other similar orders or restrictions or the closure of any physical branch locations
at the direction of any governmental authority so long as the electronic funds transfer systems (including for wire transfers) of commercial
banks in The City of New York generally are open for use by customers on such day</FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Closing</U>&rdquo;
means the closing of the purchase and sale of the Shares and the Warrants pursuant to Section 2.1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Closing Date</U>&rdquo;
means the Trading Day on which all of the Transaction Documents have been executed and delivered by the applicable parties thereto, and
all conditions precedent to (i) the Purchasers&rsquo; obligations to pay the Subscription Amount and (ii) the Company&rsquo;s obligations
to deliver the Shares and Warrants, in each case, have been satisfied or waived.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Commission</U>&rdquo;
means the United States Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common Stock</U>&rdquo;
means the common stock of the Company, par value $0.001 per share, and any other class of securities into which such securities may hereafter
be reclassified or changed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common Stock Equivalents</U>&rdquo; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire at any time Common Stock, including,
without limitation, any debt, preferred stock, right, option, warrant or other instrument that is at any time convertible into or exercisable
or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Company Counsel</U>&rdquo;
means Mitchell Silberberg &amp; Knupp LLP with offices located at 437 Madison Ave., 25th Floor, New York, NY 10022.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Disclosure Schedules</U>&rdquo;
means the Disclosure Schedules of the Company delivered concurrently herewith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Disclosure Time</U>&rdquo;
means, (i) if this Agreement is signed on a day that is not a Trading Day or after 9:00 a.m. (New York City time) and before midnight
(New York City time) on any Trading Day, 9:30 a.m. (New York City time) on the Trading Day immediately following the date hereof, unless
otherwise instructed as to an earlier time by the Placement Agent, and (ii) if this Agreement is signed between midnight (New York City
time) and 9:29 a.m. (New York City time) on any Trading Day, no&nbsp;later than 9:30 a.m. (New York City time) on the date hereof, unless
otherwise instructed as to an earlier time by the Placement Agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Effective Date</U>&rdquo;
means the earliest of the date that (a) the initial Resale Registration Statement has been declared effective by the Commission, (b) all
of the Purchase Warrant Shares have been sold pursuant to Rule 144 or may be sold pursuant to Rule 144 without the requirement for the
Company to be in compliance with the current public information required under Rule 144 and without volume or manner-of-sale restrictions,
(c) following the one year anniversary of the Closing Date provided that a holder of Purchase Warrant Shares is not an Affiliate of the
Company, or (d) all of the Purchase Warrant Shares may be sold pursuant to an exemption from registration under Section 4(a)(1) of the
Securities Act without volume or manner-of-sale restrictions and Company Counsel has delivered to such holders a standing written unqualified
opinion that resales may then be made by such holders of the Purchase Warrant Shares pursuant to such exemption which opinion shall be
in form and substance reasonably acceptable to such holders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Evaluation Date</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(s).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Exchange Act</U>&rdquo;
means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Exempt Issuance</U>
&rdquo; means the issuance of (a) shares of Common Stock upon the exercise of options or warrants that are outstanding as of the effective
date of the Resale Registration Statement, (b) shares of Common Stock or Common Stock Equivalents to employees, consultants, officers
or directors of the Company pursuant to any stock or option plan duly adopted for such purpose, by a majority of the non-employee members
of the Board of Directors or a majority of the members of a committee of non-employee directors established for such purpose for services
rendered to the Company, (c) securities upon the exercise or exchange of or conversion of any Securities issued hereunder, warrants issued
to the Placement Agent in connection with the transactions contemplated by this Agreement and/or other securities exercisable or exchangeable
for or convertible into shares of Common Stock issued and outstanding on the date of this Agreement, provided that such securities have
not been amended since the date of this Agreement to increase the number of such securities or to decrease the exercise price, exchange
price or conversion price of such securities (other than in connection with stock splits or combinations) or to extend the term of such
securities, (d) securities issued pursuant to strategic transactions approved by a majority of the disinterested directors of the Company,
provided that such securities are issued as &ldquo;restricted securities&rdquo; (as defined in Rule 144) if issued during the prohibition
period in Section 4.12(a) herein and carry no&nbsp;registration rights that require or permit the filing of any registration statement
in connection therewith during the prohibition period in Section 4.12(a) herein and, provided that any such issuance shall only be to
a Person (or to the equityholders of a Person) which is, itself or through its subsidiaries, an operating company or an owner of an asset
in a business synergistic with the business of the Company and shall provide to the Company additional benefits in addition to the investment
of funds, but shall not include a transaction in which the Company is issuing securities primarily for the purpose of raising capital
or to an entity whose primary business is investing in securities, and (e) the filing of any registration statement on Form S-8 with respect
to the registration of securities to be issued pursuant to any stock or option plan described in clause (b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>FCPA</U>&rdquo;
means the Foreign Corrupt Practices Act of 1977, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>GAAP</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(h).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Indebtedness</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(bb).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Intellectual Property
Rights</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(p).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Legend Removal Date</U>&rdquo;
shall have the meaning ascribed to such term in Section 4.1(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Liens</U>&rdquo;
means a lien, charge pledge, security interest, encumbrance, right of first refusal, preemptive right or other restriction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Lock-Up Agreement</U>&rdquo;
means each Lock-Up Agreement, dated as of the date hereof, by and between the Placement Agent and each of the directors and officers,
in the form of <U>Exhibit A</U> attached hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Material Adverse
Effect</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Material Permits</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(n).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Participation Maximum</U>&rdquo;
shall have the meaning ascribed to such term in Section 4.11(a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Per Share Purchase
Price</U>&rdquo; equals $0.70, subject to adjustment for reverse and forward stock splits, stock dividends, stock combinations and other
similar transactions of the Common Stock that occur after the date of this Agreement, provided that the purchase price per Pre-Funded
Warrant shall be the Per Share Purchase Price minus $0.01.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company,
joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Placement Agent</U>&rdquo;
means The Benchmark Company, LLC, 150 East 58th St, 17th Floor, New York, NY 10155.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Pre-Funded Warrants</U>&rdquo;
means, collectively, the Pre-Funded Common Stock purchase warrants delivered to the Purchasers at the Closing in accordance with Section
2.2(a) hereof, which Pre-Funded Warrants shall be exercisable immediately and shall expire when exercised in full, in the form of <U>Exhibit
D</U> attached hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Pre-Funded Warrant
Shares</U>&rdquo; means the shares of Common Stock issuable upon exercise of the Pre-Funded Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Pro Rata Portion</U>&rdquo;
shall have the meaning ascribed to such term in Section 4.11(e).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Proceeding</U>&rdquo;
means an action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation or partial proceeding,
such as a deposition), whether commenced or threatened.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Public Information
Failure</U>&rdquo; shall have the meaning ascribed to such term in Section 4.2(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Public Information
Failure Payments</U>&rdquo; shall have the meaning ascribed to such term in Section 4.2(b) .</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Prospectus</U>&rdquo;
means the final prospectus filed for the Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Prospectus Supplement</U>&rdquo;
means the supplement to the Prospectus complying with Rule 424(b) of the Securities Act that is filed with the Commission and delivered
by the Company to each Purchaser at the Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Purchase Warrants</U>&rdquo;
means, collectively, the Common Stock purchase warrants delivered to the Purchasers at the Closing in accordance with Section 2.2(a) hereof,
which Purchase Warrants shall be exercisable commencing upon issuance, and have a term of exercise equal to five (5) years from issuance,
in the form of <U>Exhibit B</U> attached hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Purchase Warrant
Shares</U>&rdquo; means the shares of Common Stock issuable upon exercise of the Purchase Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Purchaser Party</U>&rdquo;
shall have the meaning ascribed to such term in Section 4.8.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Registration Statement</U>&rdquo;
means the effective registration statement with Commission file No. 333-258386 which registers the sale of the Shares, the Pre-Funded
Warrants and the Pre-Funded Warrant Shares to the Purchasers at the Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Registration Rights
Agreement</U>&rdquo; means the Registration Rights Agreement, dated on or about the date hereof, among the Company and the Purchasers,
in the form of <U>Exhibit C</U> attached hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Resale Registration
Statement</U>&rdquo; means a registration statement meeting the requirements set forth in the Registration Rights Agreement and covering
the resale by the Purchasers of the Purchase Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Required Approvals</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(e).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Rule 144</U>&rdquo;
means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time,
or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Rule 424</U>&rdquo;
means Rule 424 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time,
or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>SEC Reports</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(h).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Securities</U>&rdquo;
means the Shares, the Warrants and the Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Securities Act</U>&rdquo;
means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Shares</U>&rdquo;
means the shares of Common Stock issued or issuable to each Purchaser pursuant to this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Short Sales</U>&rdquo;
means all &ldquo;short sales&rdquo; as defined in Rule 200 of Regulation SHO under the Exchange Act (but shall not be deemed to include
locating and/or borrowing shares of Common Stock).&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Subscription Amount</U>&rdquo;
means, as to each Purchaser, the aggregate amount to be paid for Shares and Warrants purchased hereunder as specified below such Purchaser&rsquo;s
name on the signature page of this Agreement and next to the heading &ldquo;Subscription Amount,&rdquo; in United States dollars and in
immediately available funds.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Subsequent Financing</U>&rdquo;
shall have the meaning ascribed to such term in Section 4.11(a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Subsequent Financing
Notice</U>&rdquo; shall have the meaning ascribed to such term in Section 4.11(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Subsidiary</U>&rdquo;
means any subsidiary of the Company as set forth on <U>Schedule 3.1(a)</U> and shall, where applicable, also include any direct or indirect
subsidiary of the Company formed or acquired after the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Trading Day</U>&rdquo;
means a day on which the principal Trading Market is open for trading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Trading Market</U>&rdquo;
means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date in question: the
NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New York Stock Exchange, OTCQB
or OTCQX (or any successors to any of the foregoing).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Transaction Documents</U>&rdquo;
means this Agreement, the Warrants, the Registration Rights Agreement, the Lock-Up Agreements, all exhibits and schedules thereto and
hereto and any other documents or agreements executed in connection with the transactions contemplated hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Transfer Agent</U>&rdquo;
means Equiniti Trust Company, the current transfer agent of the Company, with a mailing address of 1110 Centre Pointe Curve Suite 101,
Mendota Heights, MN 55120 and any successor transfer agent of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Variable Rate Transaction</U>&rdquo;
shall have the meaning ascribed to such term in Section 4.12(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or
quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30
a.m. (New York City time) to 4:02 p.m. (New York City time)), (b)&nbsp; if OTCQB or OTCQX is not a Trading Market, the volume weighted
average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock
is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on the Pink Open Market
(or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common
Stock so reported, or (d)&nbsp;in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser
selected in good faith by the Purchasers of a majority in interest of the Securities then outstanding and reasonably acceptable to the
Company, the fees and expenses of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Warrants</U>&rdquo;
means, collectively, the Purchase Warrants and the Pre-Funded Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Warrant Shares</U>&rdquo;
means the Pre-Funded Warrant Shares and the Purchase Warrant Shares.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center">ARTICLE
II</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center">PURCHASE AND SALE</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.1 <U>Closing</U>. On
the Closing Date, upon the terms and subject to the conditions set forth herein, substantially concurrent with the execution and delivery
of this Agreement by the parties hereto, the Company agrees to sell, and the Purchasers, severally and not jointly, agree to purchase,
5,714,286 of Shares and Purchase Warrants to purchase 5,714,286 shares of Common Stock for an aggregate purchase price of $4,000,000,
<U>provided</U>, <U>however</U>, <U>that</U>, to the extent that a Purchaser determines, in its sole discretion, that such Purchaser (together
with such Purchaser&rsquo;s Affiliates, and any Person acting as a group together with such purchaser or any of such Purchaser&rsquo;s
Affiliates) would beneficially own in excess of the Beneficial Ownership Limitation, or as such Purchaser may otherwise choose, in lieu
of purchasing Shares such Purchaser may elect to purchase Pre-Funded Warrants in lieu of Shares in such manner to result in the same aggregate
purchase price being paid by such Purchaser to the Company. The &ldquo;Beneficial Ownership Limitation&rdquo; shall be 4.99% (or, at the
election of the Purchaser at the Closing, 9.99%) of the number of shares of the Common Stock outstanding immediately after giving effect
to the issuance of the Securities on the Closing Date. Each Purchaser&rsquo;s Subscription Amount as set forth on the signature
page hereto executed by such Purchaser shall be made available for &ldquo;Delivery Versus Payment&rdquo; settlement with the Company or
its designee. The Company shall deliver to each Purchaser its respective Shares and a Warrant as determined pursuant to Section 2.2(a),
and the Company and each Purchaser shall deliver the other items set forth in Section 2.2 deliverable at the Closing. Upon
satisfaction of the covenants and conditions set forth in Sections 2.2 and 2.3, the Closing shall occur at the offices of AFSLLC or such
other location as the parties shall mutually agree. Notwithstanding anything herein to the contrary, if at any time on or after the time
of execution of this Agreement by the Company and an applicable Purchaser, through and including the time immediately prior to the Closing
(the &ldquo;<U>Pre-Settlement Period</U>&rdquo;), such Purchaser sells to any Person all, or any portion, of the Shares to be issued hereunder
to such Purchaser at the Closing or upon exercise of any Warrant to be issued at the Closing (collectively, the &ldquo;<U>Pre-Settlement
Shares</U>&rdquo;), such Purchaser shall, automatically hereunder (without any additional required actions by such Purchaser or the Company),
be deemed to be unconditionally bound to purchase, such Pre-Settlement Shares to such Purchaser at the Closing; <U>provided</U>, that
the Company shall not be required to deliver any Pre-Settlement Shares to such Purchaser prior to the Company&rsquo;s receipt of the purchase
price of such Pre-Settlement Shares hereunder; and <U>provided</U>, <U>further</U>, that the Company hereby acknowledges and agrees that
the forgoing shall not constitute a representation or covenant by such Purchaser as to whether or not during the Pre-Settlement Period
such Purchaser shall sell any shares of Common Stock to any Person and that any such decision to sell any shares of Common Stock by such
Purchaser shall solely be made at the time such Purchaser elects to effect any such sale, if any. Unless otherwise directed by the Placement
Agent, settlement of the Shares shall occur via &ldquo;Delivery Versus Payment&rdquo; (&ldquo;<U>DVP</U>&rdquo;) (i.e., on the Closing
Date, the Company shall issue the Shares registered in the Purchasers&rsquo; names and addresses and released by the Transfer Agent directly
to the account(s) at the Placement Agent identified by each Purchaser; upon receipt of such Shares, the Placement Agent shall promptly
electronically deliver such Shares to the applicable Purchaser, and payment therefor shall be made by the Placement Agent (or its clearing
firm) by wire transfer to the Company). Notwithstanding the foregoing, with respect to any Notice(s) of Exercise (as defined in the Pre-Funded
Warrants) delivered on or prior to 12:00 p.m. (New York City time) on the Trading Day prior to the Closing Date, which may be delivered
at any time after the time of execution of the this Agreement, the Company agrees to deliver the Pre- Funded Warrant Shares subject to
such notice(s) by 4:00 p.m. (New York City time) on the Closing Date and the Closing Date shall be the Warrant Share Delivery Date (as
defined in the Pre-Funded Warrants) for purpose hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.2 <U>Deliveries</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(a) On
or prior to the Closing Date, the Company shall deliver or cause to be delivered to each Purchaser the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">(i) this
Agreement duly executed by the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">(ii) a
legal opinion of Company Counsel, directed to the Placement Agent and the Purchasers in a form reasonably acceptable to Company Counsel,
the Placement Agent and the Purchasers;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">(iii) certificates
executed by the Company&rsquo;s Chief Financial Officer, Chief Executive Officer and Secretary, directed to the Placement Agent and the
Purchasers in form and substance reasonably acceptable to the Placement Agent and the Purchasers;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">(iv) a
copy of the irrevocable instructions to the Transfer Agent instructing the Transfer Agent to deliver on an expedited basis via The Depository
Trust Company Deposit or Withdrawal at Custodian system Shares equal to such Purchaser&rsquo;s Subscription Amount divided by the Per
Share Purchase Price, registered in the name of such Purchaser;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">(v) a
Purchase Warrant registered in the name of such Purchaser to purchase up to a number of shares of Common Stock equal to 100% of such Purchaser&rsquo;s
Shares, with an exercise price equal to $0.70, subject to adjustment therein;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">(vi) for
each Purchaser of Pre-Funded Warrants pursuant to Section 2.1, a Pre-Funded Warrant registered in the name of such Purchaser to purchase
up to a number of shares of Common Stock equal to the portion of such Purchaser&rsquo;s Subscription Amount applicable to Pre-Funded Warrant
divided by the Per Share Purchase Price minus $0.01, with an exercise price equal to $0.01, subject to adjustment therein;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">(vii) the
Company shall have provided each Purchaser with the Company&rsquo;s wire instructions, on Company letterhead and executed by the Chief
Executive Officer or Chief Financial Officer;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">(viii) fully
executed Lock-Up Agreements from each director and officer of the Company; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">(ix) the
Registration Rights Agreement duly executed by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(b) On
or prior to the Closing Date, each Purchaser shall deliver or cause to be delivered to the Company, the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">(i) (i)
this Agreement duly executed by such Purchaser;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">(ii) (ii)
such Purchaser&rsquo;s Subscription Amount by wire transfer to the account specified in writing by the Company; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">(iii) (iii)
the Registration Rights Agreement duly executed by such Purchaser.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.3 <U>Closing
Conditions</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(a) The
obligations of the Company hereunder in connection with the Closing are subject to the following conditions being met:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">(i) the
accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse Effect,
in all respects) on the Closing Date of the representations and warranties of the Purchasers contained herein (unless as of a specific
date therein in which case they shall be accurate as of such date);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">(ii) all
obligations, covenants and agreements of each Purchaser required to be performed at or prior to the Closing Date shall have been performed
in all material respects; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">(iii) the
delivery by each Purchaser of the items set forth in Section 2.2(b) of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(b) The
respective obligations of the Purchasers hereunder in connection with the Closing are subject to the following conditions being met:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">(i) the
accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse Effect,
in all respects) when made and on the Closing Date of the representations and warranties of the Company contained herein (unless as of
a specific date therein in which case they shall be accurate as of such date);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">(ii) all
obligations, covenants and agreements of the Company required to be performed at or prior to the Closing Date shall have been performed
in all material respects;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">(iii) the
delivery by the Company of the items set forth in Section 2.2(a) of this Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">(iv) there
shall have been no&nbsp;Material Adverse Effect with respect to the Company since the date hereof; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">(v) from
the date hereof to the Closing Date, trading in the Common Stock shall not have been suspended by the Commission or the Company&rsquo;s
principal Trading Market, and, at any time prior to the Closing Date, trading in securities generally as reported by Bloomberg L.P. shall
not have been suspended or limited, or minimum prices shall not have been established on securities whose trades are reported by such
service, or on any Trading Market, nor shall a banking moratorium have been declared either by the United States or New York State authorities
nor shall there have occurred any material outbreak or escalation of hostilities or other national or international calamity of such magnitude
in its effect on, or any material adverse change in, any financial market which, in each case, in the reasonable judgment of such Purchaser,
makes it impracticable or inadvisable to purchase the Shares and Warrants at the Closing.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">&nbsp;</P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">ARTICLE
III</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">REPRESENTATIONS AND WARRANTIES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.1 <U>Representations
and Warranties of the Company</U>. Except as set forth in the Disclosure Schedules, which Disclosure Schedules shall be deemed a part
hereof and shall qualify any representation or otherwise made herein to the extent of the disclosure contained in the corresponding section
of the Disclosure Schedules, the Company hereby makes the following representations and warranties to each Purchaser:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(a) <U>Subsidiaries</U>. All
of the direct and indirect subsidiaries of the Company are set forth on <U>Schedule 3.1(a)</U>. Except as set forth on <U>Schedule
3.1(a)</U>, the Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear
of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid,
non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no&nbsp;subsidiaries,
all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(b) <U>Organization and
Qualification</U>. The Company and each of the Subsidiaries is an entity duly incorporated or otherwise organized, validly existing
and in good standing under the laws of the jurisdiction of its incorporation or organization, with the requisite power and authority
to own and use its properties and assets and to carry on its business as currently conducted. Neither the Company nor any Subsidiary
is in violation nor default of any of the provisions of its respective certificate or articles of incorporation, bylaws or other
organizational or charter documents. Each of the Company and the Subsidiaries is duly qualified to conduct business and is in good
standing as a foreign corporation or other entity in each jurisdiction in which the nature of the business conducted or property
owned by it makes such qualification necessary, except where the failure to be so qualified or in good standing, as the case may be,
could not have or reasonably be expected to result in: (i) a material adverse effect on the results of operations, assets, business,
prospects or condition (financial or otherwise) of the Company and the Subsidiaries, taken as a whole, or (ii) a material adverse
effect on the Company&rsquo;s ability to perform in any material respect on a timely basis its obligations under any Transaction
Document (any of (i) or (ii), a &ldquo;<U>Material Adverse Effect</U> &rdquo;) and no&nbsp;Proceeding has been instituted in any
such jurisdiction revoking, limiting or curtailing or seeking to revoke, limit or curtail such power and authority or
qualification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(c) <U>Authorization;
Enforcement</U>. The Company has the requisite corporate power and authority to enter into and to consummate the transactions
contemplated by this Agreement and each of the other Transaction Documents and otherwise to carry out its obligations hereunder and thereunder. The
execution and delivery of this Agreement and each of the other Transaction Documents by the Company and the consummation by it of the
transactions contemplated hereby and thereby have been duly authorized by all necessary action on the part of the Company and no&nbsp;further
action is required by the Company, the Board of Directors or the Company&rsquo;s stockholders in connection herewith or therewith other
than in connection with the Required Approvals. This Agreement and each other Transaction Document to which it is a party has
been (or upon delivery will have been) duly executed by the Company and, when delivered in accordance with the terms hereof and thereof,
will constitute the valid and binding obligation of the Company enforceable against the Company in accordance with its terms, except (i)
as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general
application affecting enforcement of creditors&rsquo; rights generally, (ii) as limited by laws relating to the availability of specific
performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited
by applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(d) <U>No&nbsp;Conflicts</U>.
The execution, delivery and performance by the Company of this Agreement and the other Transaction Documents to which it is a party, the
issuance and sale of the Securities and the consummation by it of the transactions contemplated hereby and thereby do not and will not
(i) conflict with or violate any provision of the Company&rsquo;s or any Subsidiary&rsquo;s certificate or articles of incorporation,
bylaws or other organizational or charter documents, or (ii) conflict with, or constitute a default (or an event that with notice or lapse
of time or both would become a default) under, result in the creation of any Lien upon any of the properties or assets of the Company
or any Subsidiary, or give to others any rights of termination, amendment, anti-dilution or similar adjustments, acceleration or cancellation
(with or without notice, lapse of time or both) of, any agreement, credit facility, debt or other instrument (evidencing a Company or
Subsidiary debt or otherwise) or other understanding to which the Company or any Subsidiary is a party or by which any property or asset
of the Company or any Subsidiary is bound or affected, or (iii) subject to the Required Approvals, conflict with or result in a violation
of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court or governmental authority to which
the Company or a Subsidiary is subject (including federal and state securities laws and regulations), or by which any property or asset
of the Company or a Subsidiary is bound or affected; except in the case of each of clauses (ii) and (iii), such as could not have or reasonably
be expected to result in a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(e) <U>Filings,
Consents and Approvals</U>. The Company is not required to obtain any consent, waiver, authorization or order of, give any
notice to, or make any filing or registration with, any court or other federal, state, local or other governmental authority or other
Person in connection with the execution, delivery and performance by the Company of the Transaction Documents, other than: (i) the filings
required pursuant to Section 4.4 of this Agreement, (ii) the filing with the Commission of the Prospectus Supplement, (iii) the filing
with the Commission pursuant to the Registration Rights&nbsp;Agreement, (iv) the notice and/or application(s) to each applicable Trading
Market for the issuance and sale of the Securities and the listing of the Shares and Warrant Shares for trading thereon in the time and
manner required thereby, and (v) the filing of Form D with the Commission and such filings as are required to be made under applicable
state securities laws (collectively, the &ldquo;<U>Required Approvals</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(f) <U>Issuance
of the Securities; Registration</U>. The Shares are duly authorized and, when issued and paid for in accordance with the applicable
Transaction Documents, will be duly and validly issued, fully paid and nonassessable, free and clear of all Liens imposed by the Company. The
Warrants are duly authorized and, when issued and paid for in accordance with the applicable Transaction Documents, will be a binding
obligation of the Company under the law of the jurisdiction governing the Warrants. The Warrant Shares, when issued in accordance with
the terms of the Warrants, will be validly issued, fully paid and nonassessable, free and clear of all Liens imposed by the Company. The
Company has reserved from its duly authorized capital stock the maximum number of shares of Common Stock issuable pursuant to this Agreement
and the Warrants. The Company has prepared and filed the Registration Statement in conformity with the requirements of the Securities
Act, which became effective on&nbsp;August 9, 2021, including the Prospectus, and such amendments and supplements thereto as may have
been required to the date of this Agreement. The Registration Statement is effective under the Securities Act and no&nbsp;stop
order preventing or suspending the effectiveness of the Registration Statement or suspending or preventing the use of the Prospectus has
been issued by the Commission and no&nbsp;proceedings for that purpose have been instituted or, to the knowledge of the Company, are threatened
by the Commission. The Company, if required by the rules and regulations of the Commission, shall file the Prospectus Supplement
with the Commission pursuant to Rule 424 (b). At the time the Registration Statement and any amendments thereto became effective,
at the date of this Agreement and at the Closing Date, the Registration Statement and any amendments thereto conformed and will conform
in all material respects to the requirements of the Securities Act and did not and will not contain any untrue statement of a material
fact or omit to state any material fact required to be stated therein or necessary to make the statements therein not misleading; and
the Prospectus, t he Prospectus Supplement and any amendments or supplements thereto, at the time the Prospectus, the Prospectus Supplement
or any amendment or supplement thereto was issued and at the Closing Date, conformed and will conform in all material respects to the
requirements of the Securities Act and did not and will not contain an untrue statement of a material fact or omit to state a material
fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading.
The Company was at the time of the filing of the Registration Statement eligible to use Form S-3. The Company is eligible to use Form
S-3 under the Securities Act and it meets the transaction requirements with respect to the aggregate market value of securities being
sold pursuant to this offering and during the twelve (12) months prior to this offering, as set forth in General Instruction I.B.6 of
Form S-3.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(g) <U>Capitalization</U>. The
capitalization of the Company as of May 30, 2023 is as set forth on <U>Schedule 3.1(g)</U>, which <U>Schedule 3.1(g)</U> shall also include
the number of shares of Common Stock owned beneficially, and of record, by Affiliates of the Company as of the date hereof. The
Company has not issued any capital stock since its most recently filed periodic report under the Exchange Act, other than pursuant to
the exercise of employee stock options under the Company&rsquo;s equity incentive plans, the issuance of shares of Common Stock to employees
pursuant to the Company&rsquo;s employee stock purchase plans and pursuant to the conversion and/or exercise of Common Stock Equivalents
outstanding as of the date of the most recently filed periodic report under the Exchange Act. No&nbsp;Person has any right
of first refusal, preemptive right, right of participation, or any similar right to participate in the transactions contemplated by the
Transaction Documents. Except as a result of the purchase and sale of the Securities and as set forth on <U>Schedule 3.1(g)</U>
, there are no&nbsp;outstanding options, warrants, scrip rights to subscribe to, calls or commitments of any character whatsoever relating
to, or securities, rights or obligations convertible into or exercisable or exchangeable for, or giving any Person any right to subscribe
for or acquire, any shares of Common Stock or the capital stock of any Subsidiary, or contracts, commitments, understandings or arrangements
by which the Company or any Subsidiary is or may become bound to issue additional shares of Common Stock or Common Stock Equivalents or
capital stock of any Subsidiary. The issuance and sale of the Securities will not obligate the Company or any Subsidiary to
issue shares of Common Stock or other securities to any Person (other than the Purchasers). There are no&nbsp;outstanding securities or
instruments of the Company or any Subsidiary with any provision that would result in an adjustment to the exercise, conversion, exchange
or reset price of such security or instrument upon an issuance of securities by the Company or any Subsidiary subsequent to the date hereof
.. Except as set forth on <U>Schedule 3.1(g) ,</U> t here are no&nbsp;outstanding securities or instruments of the Company or
any Subsidiary that contain any redemption or similar provisions, and there are no&nbsp;contracts, commitments, understandings or arrangements
by which the Company or any Subsidiary is or may become bound to redeem a security of the Company or such Subsidiary. The Company does
not have any stock appreciation rights or &ldquo;phantom stock&rdquo; plans or agreements or any similar plan or agreement. All of the
outstanding shares of capital stock of the Company are duly authorized, validly issued, fully paid and nonassessable, have been issued
in compliance with all federal and state securities laws, and none of such outstanding shares was issued in violation of any preemptive
rights or similar rights to subscribe for or purchase securities. No&nbsp;further approval or authorization of any stockholder,
the Board of Directors or others is required for the issuance and sale of the Securities. There are no&nbsp;stockholders agreements,
voting agreements or other similar agreements with respect to the Company&rsquo;s capital stock to which the Company is a party or, to
the knowledge of the Company, between or among any of the Company&rsquo;s stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(h) <U>SEC Reports;
Financial Statements</U>. The Company has filed all reports, schedules, forms, statements and other documents required to be filed
by the Company under the Securities Act and the Exchange Act, including pursuant to Section 13(a) or 15(d) thereof, for the two
years preceding the date hereof (or such shorter period as the Company was required by law or regulation to file such material) (the
foregoing materials, including the exhibits thereto and documents incorporated by reference therein, being collectively referred to
herein as the &ldquo;<U>SEC Reports</U> &rdquo;) on a timely basis or has received a valid extension of such time of filing and has
filed any such SEC Reports prior to the expiration of any such extension. As of their respective dates, the SEC Reports complied in
all material respects with the requirements of the Securities Act and the Exchange Act, as applicable, and none of the SEC Reports,
when filed, contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein or
necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading. The
Company has never been an issuer subject to Rule 144(i) under the Securities Act. The financial statements of the Company included
in the SEC Reports comply in all material respects with applicable accounting requirements and the rules and regulations of the
Commission with respect thereto as in effect at the time of filing. Such financial statements have been prepared in accordance with
United States generally accepted accounting principles applied on a consistent basis during the periods involved (&ldquo;<U>GAAP </U>&rdquo;),
except as may be otherwise specified in such financial statements or the notes thereto and except that unaudited financial
statements may not contain all footnotes required by GAAP, and fairly present in all material respects the financial position of the
Company and its consolidated Subsidiaries as of and for the dates thereof and the results of operations and cash flows for the
periods then ended, subject, in the case of unaudited statements, to normal, immaterial, year-end audit adjustments.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i) <U>Material
Changes; Undisclosed Events, Liabilities or Developments</U>. Since the date of the latest unaudited financial statements included
within the SEC Reports, except as set forth on <U>Schedule 3.1(i)</U>, (i) there has been no&nbsp;event, occurrence or development that
has had or that could reasonably be expected to result in a Material Adverse Effect, (ii) the Company has not incurred any liabilities
(contingent or otherwise) other than (A) trade payables and accrued expenses incurred in the ordinary course of business consistent with
past practice and (B) liabilities not required to be reflected in the Company&rsquo; s financial statements pursuant to GAAP or disclosed
in filings made with the Commission, (iii) the Company has not altered its method of accounting, (iv) the Company has not declared or
made any dividend or distribution of cash or other property to its stockholders or purchased, redeemed or made any agreements to purchase
or redeem any shares of its capital stock and (v) the Company has not issued any equity securities to any officer, director or Affiliate,
except pursuant to existing Company equity incentive plans. The Company does not have pending before the Commission any request
for confidential treatment of information. Except for the issuance of the Securities contemplated by this Agreement or as set
forth on <U>Schedule 3.1(i )</U>, no&nbsp;event, liability , fact, circumstance, occurrence or development has occurred or exists or is
reasonably expected to occur or exist with respect to the Company or its Subsidiaries or their respective businesses , prospects, properties,
operations, assets or financial condition that would be required to be disclosed by the Company under applicable securities laws at the
time this representation is made or deemed made that has not been publicly disclosed at least 1 Trading Day prior to the date that this
representation is made.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(j) <U>Litigation</U>. There
is no&nbsp;action, suit, inquiry, notice of violation, proceeding or investigation pending or, to the knowledge of the Company, threatened
against or affecting the Company, any Subsidiary or any of their respective properties before or by any court, arbitrator, governmental
or administrative agency or regulatory authority (federal, state, county, local or foreign) (collectively, an &ldquo;<U>Action</U>&rdquo;). Neither
the Company nor any Subsidiary, nor to the knowledge of the Company, any director or officer thereof, is or has been the subject of any
Action involving a claim of violation of or liability under federal or state securities laws or a claim of breach of fiduciary duty. There
has not been, and to the knowledge of the Company, there is not pending or threatened, any investigation by the Commission of the Company
or any current or former director or officer of the Company. The Commission has not issued any stop order or other order suspending
the effectiveness of any registration statement filed by the Company or any Subsidiary under the Exchange Act or the Securities Act. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(k) <U>Labor
Relations</U>. No&nbsp;material labor dispute exists or, to the knowledge of the Company, is imminent with respect to any of
the employees of the Company, which could reasonably be expected to result in a Material Adverse Effect. None of the Company&rsquo;s
or its Subsidiaries&rsquo; employees is a member of a union that relates to such employee&rsquo;s relationship with the Company or such
Subsidiary, and neither the Company nor any of its Subsidiaries is a party to a collective bargaining agreement, and the Company and its
Subsidiaries believe that their relationships with their employees are good. To the knowledge of the Company, no executive
officer of the Company or any Subsidiary is, or is now expected to be, in violation of any material term of any employment contract, confidentiality,
disclosure or proprietary information agreement or non-competition agreement, or any other contract or agreement or any restrictive covenant
in favor of any third party, and the continued employment of each such executive officer does not subject the Company or any of its Subsidiaries
to any liability with respect to any of the foregoing matters. The Company and its Subsidiaries are in material compliance
with all U.S. federal, state, local and foreign laws and regulations relating to employment and employment practices, terms and conditions
of employment and wages and hours, except where the failure to be in compliance could not, individually or in the aggregate, reasonably
be expected to have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(l) <U>Compliance</U>. Neither
the Company nor any Subsidiary: (i) is in default under or in violation of (and no&nbsp;event has occurred that has not been waived that,
with notice or lapse of time or both, would result in a default by the Company or any Subsidiary under), nor has the Company or any Subsidiary
received notice of a claim that it is in default under or that it is in violation of, any indenture, loan or credit agreement or any other
agreement or instrument to which it is a party or by which it or any of its properties is bound (whether or not such default or violation
has been waived), (ii) is in violation of any judgment, decree, or order of any court, arbitrator or other governmental authority or (iii)
is or has been in violation of any statute, rule, ordinance or regulation of any governmental authority, including without limitation
all foreign, federal, state and local laws relating to taxes, environmental protection, occupational health and safety, product quality
and safety and employment and labor matters, except in each case as could not have or reasonably be expected to result in a Material Adverse
Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(m) <U>Environmental
Laws</U>. The Company and its Subsidiaries (i) are in compliance with all federal, state, local and foreign laws relating to
pollution or protection of human health or the environment (including ambient air, surface water, groundwater, land surface or
subsurface strata), including laws relating to emissions, discharges, releases or threatened releases of chemicals, pollutants,
contaminants, or toxic or hazardous substances or wastes (collectively, &ldquo;<U>Hazardous Materials</U>&rdquo;) into the
environment, or otherwise relating to the manufacture, processing, distribution, use, treatment, storage, disposal, transport or
handling of Hazardous Materials, as well as all authorizations, codes, decrees, demands, or demand letters, injunctions, judgments,
licenses, notices or notice letters, orders, permits, plans or regulations, issued, entered, promulgated or approved thereunder
(&ldquo; <U>Environmental Laws</U>&rdquo;); (ii) have received all permits licenses or other approvals required of them under
applicable Environmental Laws to conduct their respective businesses; and (iii) are in compliance with all terms and conditions of
any such permit, license or approval where in each clause (i), (ii) and (iii), the failure to so comply could be reasonably expected
to have, individually or in the aggregate, a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(n) <U>Regulatory
Permits</U>. The Company and the Subsidiaries possess all certificates, authorizations and permits issued by the appropriate
federal, state, local or foreign regulatory authorities necessary to conduct their respective businesses as described in the SEC
Reports, except where the failure to possess such permits could not reasonably be expected to result in a Material Adverse Effect
(&ldquo; <U>Material Permits</U>&rdquo; ), and neither the Company nor any Subsidiary has received any notice of proceedings
relating to the revocation or modification of any Material Permit.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(o) <U>Title
to Assets</U>. The Company and the Subsidiaries have good and marketable title in fee simple to all real property owned by
them and good and marketable title in all personal property owned by them that is material to the business of the Company and the Subsidiaries,
in each case free and clear of all Liens, except for (i) Liens as do not materially affect the value of such property and do not materially
interfere with the use made and proposed to be made of such property by the Company and the Subsidiaries and (ii) Liens for the payment
of federal, state or other taxes, for which appropriate reserves have been made therefor in accordance with GAAP and the payment of which
is neither delinquent nor subject to penalties. Any real property and facilities held under lease by the Company and the Subsidiaries
are held by them under valid, subsisting and enforceable leases with which the Company and the Subsidiaries are in compliance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(p) <U>Intellectual
Property</U>. The Company and the Subsidiaries have, or have rights to use, all patents, patent applications, trademarks, trademark
applications, service marks, trade names, trade secrets, inventions, copyrights, licenses and other intellectual property rights and similar
rights necessary or required for use in connection with their respective businesses as described in the SEC Reports and which the failure
to so have could have a Material Adverse Effect (collectively, the &ldquo;<U>Intellectual Property Rights</U>&rdquo;). Except
as disclosed in the SEC Reports, none of, and neither the Company nor any Subsidiary has received a notice (written or otherwise) that
any of, the Intellectual Property Rights has expired, terminated or been abandoned, or is expected to expire or terminate or be abandoned,
within two (2) years from the date of this Agreement. Except as disclosed in the SEC Reports, neither the Company nor any Subsidiary
has received, since the date of the latest unaudited financial statements included within the SEC Reports, a written notice of a claim
or otherwise has any knowledge that the Intellectual Property Rights violate or infringe upon the rights of any Person, except as could
not have or reasonably be expected to not have a Material Adverse Effect. To the knowledge of the Company, all such Intellectual
Property Rights are enforceable and there is no&nbsp;existing infringement by another Person of any of the Intellectual Property Rights,
<FONT STYLE="background-color: white">except as could not have or reasonably be expected to result in a Material Adverse Effect</FONT>. The
Company and its Subsidiaries have taken reasonable security measures to protect the secrecy, confidentiality and value of all of their
intellectual properties, except where failure to do so could not, individually or in the aggregate, reasonably be expected to have a Material
Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(q) <U>Insurance</U>. The
Company and the Subsidiaries are insured by insurers of recognized financial responsibility against such losses and risks and in such
amounts as are prudent and customary in the businesses in which the Company and the Subsidiaries are engaged, including, but not limited
to, directors and officers insurance coverage at least equal to the aggregate Subscription Amount. Neither the Company nor
any Subsidiary has any reason to believe that it will not be able to renew its existing insurance coverage as and when such coverage expires
or to obtain similar coverage from similar insurers as may be necessary to continue its business without a significant increase in cost.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(r) <U>Transactions
with Affiliates and Employees</U>. Except as set forth on <U>Schedule 3.1(r)</U>, none of the officers or directors of the
Company or any Subsidiary and, to the knowledge of the Company, none of the employees of the Company or any Subsidiary is presently a
party to any transaction with the Company or any Subsidiary (other than for services as employees, officers and directors), including
any contract, agreement or other arrangement providing for the furnishing of services to or by, providing for rental of real or personal
property to or from, providing for the borrowing of money from or lending of money to or otherwise requiring payments to or from any officer,
director or such employee or, to the knowledge of the Company, any entity in which any officer, director, or any such employee has a substantial
interest or is an officer, director, trustee, stockholder, member or partner, in each case in excess of $120,000 other than for (i) payment
of salary or consulting fees for services rendered, (ii) reimbursement for expenses incurred on behalf of the Company and (iii) other
employee benefits, including stock option agreements under any equity incentive plan of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(s) <U>Sarbanes-Oxley;
Internal Accounting Controls</U>. The Company and the Subsidiaries are in compliance with any and all applicable requirements
of the Sarbanes-Oxley Act of 2002 that are applicable to it as of the date hereof, and any and all applicable rules and regulations promulgated
by the Commission thereunder that are effective as of the date hereof and as of the Closing Date. The Company and the Subsidiaries
maintain a system of internal accounting controls sufficient to provide reasonable assurance that: (i) transactions are executed in accordance
with management&rsquo;s general or specific authorizations, (ii) transactions are recorded as necessary to permit preparation of financial
statements in conformity with GAAP and to maintain asset accountability, (iii) access to assets is permitted only in accordance with management&rsquo;s
general or specific authorization, and (iv) the recorded accountability for assets is compared with the existing assets at reasonable
intervals and appropriate action is taken with respect to any differences. The Company and the Subsidiaries have established disclosure
controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the Company and the Subsidiaries and designed such
disclosure controls and procedures to ensure that information required to be disclosed by the Company in the reports it files or submits
under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Commission&rsquo;s rules
and forms. The Company&rsquo;s certifying officers have evaluated the effectiveness of the disclosure controls and procedures
of the Company and the Subsidiaries as of the end of the period covered by the most recently filed periodic report under the Exchange
Act (such date, the &ldquo;<U>Evaluation Date</U>&rdquo;). The Company presented in its most recently filed periodic report
under the Exchange Act the conclusions of the certifying officers about the effectiveness of the disclosure controls and procedures based
on their evaluations as of the Evaluation Date. Since the Evaluation Date, there have been no&nbsp;changes in the internal
control over financial reporting (as such term is defined in the Exchange Act) of the Company and its Subsidiaries that have materially
affected, or is reasonably likely to materially affect, the internal control over financial reporting of the Company and its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(t) <U>Certain
Fees</U>. Except for the fees payable to the Placement Agent in connection with the transactions contemplated by the Transaction
Documents as set forth in the Prospectus Supplement, no brokerage or finder &rsquo;s fees or commissions are or will be payable by the
Company or&nbsp;any Subsidiary to any broker, financial advisor or consultant, finder, placement agent, investment banker, bank or other
Person with respect to the transactions contemplated by the Transaction Documents. The Purchasers shall have no&nbsp;obligation
with respect to any fees or with respect to any claims made by or on behalf of other Persons for fees of a type contemplated in this Section
that may be due in connection with the transactions contemplated by the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(u) <U>Private
Placement</U>. Assuming the accuracy of the Purchasers&rsquo; representations and warranties set forth in Section 3.2, no&nbsp;registration
under the Securities Act is required for the offer and sale of the Purchase Warrants and the Purchase Warrant Shares by the Company to
the Purchasers as contemplated hereby. The issuance and sale of the Securities hereunder does not contravene the rules and regulations
of the Trading Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(v) <U>Investment
Company</U>. The Company is not, and is not an Affiliate of, and immediately after receipt of payment for the Shares and the Warrants,
will not be or be an Affiliate of, an &ldquo;investment company&rdquo; within the meaning of the Investment Company Act of 1940, as amended. The
Company shall conduct its business in a manner so that it will not become an &ldquo;investment company&rdquo; subject to registration
under the Investment Company Act of 1940, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(w) <U>Registration
Rights</U>. Except as set forth on <U>Schedule 3.1(w)</U> and other than each of the Purchasers, no&nbsp;Person has any right
to cause the Company or any Subsidiary to effect the registration under the Securities Act of any securities of the Company or any Subsidiary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(x) <U>Listing
and Maintenance Requirements</U>. The Common Stock is registered pursuant to Section 12(b) or 12(g) of the Exchange Act, and
the Company has taken no&nbsp;action designed to, or which to its knowledge is likely to have the effect of, terminating the registration
of the Common Stock under the Exchange Act nor has the Company received any notification that the Commission is contemplating terminating
such registration. The Company has not, in the 12 months preceding the date hereof, received notice from any Trading Market
on which the Common Stock is or has been listed or quoted to the effect that the Company is not in compliance with the listing or maintenance
requirements of such Trading Market. The Common Stock is currently eligible for electronic transfer through the Depository Trust Company
or another established clearing corporation and the Company is current in payment of the fees to the Depository Trust Company (or such
other established clearing corporation) in connection with such electronic transfer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(y) <U>Application
of Takeover Protections</U>. The Company and the Board of Directors have taken all necessary action, if any, in order to render
inapplicable any control share acquisition, business combination, poison pill (including any distribution under a rights agreement) or
other similar anti-takeover provision under the Company&rsquo;s certificate of incorporation (or similar charter documents) or the laws
of its state of incorporation that is or could become applicable to the Purchasers as a result of the Purchasers and the Company fulfilling
their obligations or exercising their rights under the Transaction Documents, including without limitation as a result of the Company&rsquo;s
issuance of the Securities and the Purchasers&rsquo; ownership of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(z) <U>Disclosure</U>. Except
with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents, the Company confirms
that neither it nor any other Person acting on its behalf has provided any of the Purchasers or their agents or counsel with any information
that it believes constitutes or might constitute material, non-public information.  The Company understands and confirms that
the Purchasers will rely on the foregoing representation in effecting transactions in securities of the Company. All of the
disclosure furnished by or on behalf of the Company to the Purchasers regarding the Company and its Subsidiaries, their respective businesses
and the transactions contemplated hereby, including the Disclosure Schedules to this Agreement, is true and correct and does not contain
any untrue statement of a material fact or omit to state any material fact necessary in order to make the statements made therein, in
the light of the circumstances under which they were made, not misleading. The press releases disseminated by the Company during the twelve
months preceding the date of this Agreement taken as a whole do not contain any untrue statement of a material fact or omit to state a
material fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under
which they were made and when made, not misleading. The Company acknowledges and agrees that no&nbsp;Purchaser makes or has
made any representations or warranties with respect to the transactions contemplated hereby other than those specifically set forth in
Section 3.2 hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(aa) <U>No&nbsp;Integrated
Offering</U>. Assuming the accuracy of the Purchasers&rsquo; representations and warranties set forth in Section 3.2, neither the Company,
nor any of its Affiliates, nor any Person acting on its or their behalf has, directly or indirectly, made any offers or sales of any security
or solicited any offers to buy any security, under circumstances that would cause this offering of the Securities to be integrated with
prior offerings by the Company for purposes of (i) the Securities Act which would require the registration of the Purchase Warrants or
Purchase Warrant Shares under the Securities Act, or (ii) any applicable shareholder approval provisions of any Trading Market on which
any of the securities of the Company are listed or designated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(bb) <U>Solvency</U>.
Based on the consolidated financial condition of the Company as of the Closing Date, after giving effect to the receipt by the
Company of the proceeds from the sale of the Securities hereunder, (i) the fair saleable value of the Company&rsquo;s assets exceeds
the amount that will be required to be paid on or in respect of the Company&rsquo;s existing debts and other liabilities (including
known contingent liabilities) as they mature, (ii) the Company&rsquo;s assets do not constitute unreasonably small capital to carry
on its business as now conducted and as proposed to be conducted including its capital needs taking into account the particular
capital requirements of the business conducted by the Company, consolidated and projected capital requirements and capital
availability thereof, and (iii) the current cash flow of the Company, together with the proceeds the Company would receive, were it
to liquidate all of its assets, after taking into account all anticipated uses of the cash, would be sufficient to pay all amounts
on or in respect of its liabilities when such amounts are required to be paid. The Company does not intend to incur debts beyond its
ability to pay such debts as they mature (taking into account the timing and amounts of cash to be payable on or in respect of its
debt). The Company has no&nbsp;knowledge of any facts or circumstances which lead it to believe that it will file for reorganization
or liquidation under the bankruptcy or reorganization laws of any jurisdiction within one year from the Closing Date. <U>Schedule
3.1(bb)</U> sets forth as of March 31, 2023 all outstanding secured and unsecured Indebtedness of the Company or any Subsidiary, or
for which the Company or any Subsidiary has commitments. For the purposes of this Agreement, &ldquo; <U>Indebtedness</U>&rdquo;
means (x) any liabilities for borrowed money or amounts owed in excess of $50,000 (other than trade accounts payable incurred in the
ordinary course of business), (y) all guaranties, endorsements and other contingent obligations in respect of indebtedness of
others, whether or not the same are or should be reflected in the Company&rsquo;s consolidated balance sheet (or the notes thereto),
except guaranties by endorsement of negotiable instruments for deposit or collection or similar transactions in the ordinary course
of business; and (z) the present value of any lease payments in excess of $50,000 due under leases required to be capitalized in
accordance with GAAP. Neither the Company nor any Subsidiary is in default with respect to any Indebtedness.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(cc) <U>Tax Status</U>.
Except for matters that would not, individually or in the aggregate, have or reasonably be expected to result in a Material Adverse
Effect, the Company and its Subsidiaries each (i) has made or filed all United States federal, state and local income and all
foreign income and franchise tax returns, reports and declarations required by any jurisdiction to which it is subject, (ii) has
paid all taxes and other governmental assessments and charges that are material in amount, shown or determined to be due on such
returns, reports and declarations and (iii) has set aside on its books provision reasonably adequate for the payment of all material
taxes for periods subsequent to the periods to which such returns, reports or declarations apply. There are
no&nbsp;unpaid taxes in any material amount claimed to be due by the taxing authority of any jurisdiction, and the officers of the
Company or of any Subsidiary know of no&nbsp;basis for any such claim.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(dd) <U>No&nbsp;General
Solicitation</U>. Neither the Company nor any Person acting on behalf of the Company has offered or sold any of the Purchase
Warrants or Purchase Warrant Shares by any form of general solicitation or general advertising. The Company has offered the
Purchase Warrants and Purchase Warrant Shares for sale only to the Purchasers and certain other &ldquo;accredited investors&rdquo; within
the meaning of Rule 501 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ee) <U>Foreign Corrupt
Practices.</U> Neither the Company nor any Subsidiary, nor to the knowledge of the Company or any Subsidiary, any agent or
other person acting on behalf of the Company or any Subsidiary, has (i) directly or indirectly, used any funds for unlawful
contributions, gifts, entertainment or other unlawful expenses related to foreign or domestic political activity, (ii) made any
unlawful payment to foreign or domestic government officials or employees or to any foreign or domestic political parties or
campaigns from corporate funds, (iii) failed to disclose fully any contribution made by the Company or any Subsidiary (or made by
any person acting on its behalf of which the Company is aware) which is in violation of law or (iv) taken any action that would
reasonably be expected to subject the Company to any damage or penalty in any criminal or governmental litigation or proceeding
under any provision of FCPA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ff) <U>Accountants</U>. The
Company&rsquo;s accounting firm is set forth on <U>Schedule 3.1(ff)</U> of the Disclosure Schedules. To the knowledge and belief
of the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express
its opinion with respect to the financial statements to be included in the Company&rsquo;s Annual Report for the fiscal year ending December
31, 2023.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(gg) <U>No&nbsp;Disagreements
with Accountants and Lawyers</U>. There are no&nbsp;disagreements of any kind presently existing, or reasonably anticipated by the Company
to arise, between the Company and the accountants and lawyers formerly or presently employed by the Company and the Company is current
with respect to any fees owed to its accountants and lawyers which could affect the Company&rsquo;s ability to perform any of its obligations
under any of the Transaction Documents. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(hh) <U>Acknowledgment
Regarding Purchasers&rsquo; Purchase of Securities</U>. The Company acknowledges and agrees that each of the Purchasers is
acting solely in the capacity of an arm&rsquo;s length purchaser with respect to the Transaction Documents and the transactions contemplated
thereby. The Company further acknowledges that no&nbsp;Purchaser is acting as a financial advisor or fiduciary of the Company (or in any
similar capacity) with respect to the Transaction Documents and the transactions contemplated thereby and any advice given by any Purchaser
or any of their respective representatives or agent in connection with the Transaction Documents and the transactions contemplated thereby
is merely incidental to the Purchasers&rsquo; purchase of the Securities. The Company further represents to each Purchaser
that the Company&rsquo;s decision to enter into this Agreement and the other Transaction Documents has been based solely on the independent
evaluation of the transactions contemplated hereby by the Company and its representatives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ii) <U>Acknowledgment
Regarding Purchaser&rsquo;s Trading Activity.</U> Anything in this Agreement or elsewhere herein to the contrary notwithstanding
(except for Sections 3.2(g) and 4.13 hereof), it is understood and acknowledged by the Company that: (i) none of the Purchasers has
been asked by the Company to agree, nor has any Purchaser agreed, to desist from purchasing or selling, long and/or short,
securities of the Company, or &ldquo;derivative&rdquo; securities based on securities issued by the Company or to hold the
Securities for any specified term, (ii) past or future open market or other transactions by any Purchaser, specifically including,
without limitation, Short Sales or &ldquo;derivative&rdquo; transactions, before or after the closing of this or future private
placement transactions, may negatively impact the market price of the Company&rsquo;s publicly-traded securities, (iii) any
Purchaser, and counter-parties in &ldquo;derivative&rdquo; transactions to which any such Purchaser is a party, directly or
indirectly, presently may have a &ldquo;short&rdquo; position in the Common Stock and (iv) each Purchaser shall not be deemed to
have any affiliation with or control over any arm&rsquo;s length counter-party in any &ldquo;derivative&rdquo; transaction. The
Company further understands and acknowledges that (y) one or more Purchasers may engage in hedging activities at various times
during the period that the Securities are outstanding, including, without limitation, during the periods that the value of the
Warrant Shares deliverable with respect to Securities are being determined , and ( z) such hedging activities (if any) could reduce
the value of the existing stockholders&rsquo; equity interests in the Company at and after the time that the hedging activities are
being conducted. The Company acknowledges that such aforementioned hedging activities do not constitute a breach of any of the
Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(jj) <U>Regulation M Compliance.</U>&nbsp;
The Company has not, and to its knowledge no&nbsp;one acting on its behalf has, (i) taken, directly or indirectly, any action designed
to cause or to result in the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale
of any of the Securities, (ii) sold, bid for, purchased, or paid any compensation for soliciting purchases of, any of the Securities,
or (iii) paid or agreed to pay to any Person any compensation for soliciting another to purchase any other securities of the Company,
other than, in the case of clauses (ii) and (iii), compensation paid to the Placement Agent in connection with the placement of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(kk) <U>Stock Option Plans</U>.
Each stock option granted by the Company under the Company&rsquo;s equity incentive plans was granted (i) in accordance with the terms
of the Company&rsquo;s equity incentive plans and (ii) with an exercise price at least equal to the fair market value of the Common Stock
on the date such stock option would be considered granted under GAAP and applicable law. No&nbsp;stock option granted under the Company&rsquo;s
equity incentive plans has been backdated. The Company has not knowingly granted, and there is no&nbsp;and has been no&nbsp;Company
policy or practice to knowingly grant, stock options prior to, or otherwise knowingly coordinate the grant of stock options with, the
release or other public announcement of material information regarding the Company or its Subsidiaries or their financial results or prospects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ll) <U>Office of Foreign
Assets Control</U>. Neither the Company nor any Subsidiary nor, to the Company&rsquo;s knowledge, any director, officer, agent,
employee or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign
Assets Control of the U.S. Treasury Department (&ldquo; <U>OFAC</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(mm) <U>U.S. Real Property
Holding Corporation</U>. The Company is not and has never been a U.S. real property holding corporation within the meaning
of Section 897 of the Internal Revenue Code of 1986, as amended, and the Company shall so certify upon Purchaser&rsquo;s request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(nn) <U>Bank Holding
Company Act</U>. Neither the Company nor any of its Subsidiaries or Affiliates is subject to the Bank Holding Company Act of 1956,
as amended (the &ldquo;<U> BHCA</U>&rdquo;), and to regulation by the Board of Governors of the Federal Reserve System (the
&ldquo;<U> Federal Reserve</U>&rdquo;). Neither the Company nor any of its Subsidiaries or Affiliates owns or controls, directly or
indirectly, five percent (5%) or more of the outstanding shares of any class of voting securities or twenty-five percent or more of
the total equity of a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve. Neither the Company
nor any of its Subsidiaries or Affiliates exercises a controlling influence over the management or policies of a bank or any entity
that is subject to the BHCA and to regulation by the Federal Reserve.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(oo) <U>Money
Laundering</U>. The operations of the Company and its Subsidiaries are and have been conducted at all times in compliance in
all material respects with applicable financial record-keeping and reporting requirements of the Currency and Foreign Transactions Reporting
Act of 1970, as amended, applicable money laundering statutes and applicable rules and regulations thereunder (collectively, the &ldquo;
<U>Money Laundering Laws</U>&rdquo;), and no&nbsp; Action or Proceeding by or before any court or governmental agency, authority or body
or any arbitrator involving the Company or any Subsidiary with respect to the Money Laundering Laws is pending or, to the knowledge of
the Company or any Subsidiary, threatened.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(pp) <U>No&nbsp;Disqualification
Events</U>. &nbsp;With respect to the Securities to be offered and sold hereunder in reliance on Rule 506 under the Securities Act, none
of the Company, any of its predecessors, any affiliated issuer, any director, executive officer, other officer of the Company participating
in the offering hereunder, any beneficial owner of 20% or more of the Company&rsquo;s outstanding voting equity securities, calculated
on the basis of voting power, nor any promoter (as that term is defined in Rule 405 under the Securities Act) connected with the Company
in any capacity at the time of sale (each, an &ldquo;<U>Issuer Covered Person</U>&rdquo; and, together, &ldquo;<U>Issuer Covered Persons</U>&rdquo;)
is subject to any of the &ldquo;Bad Actor&rdquo; disqualifications described in Rule 506(d)(1)(i) to (viii) under the Securities Act (a
&ldquo;<U>Disqualification Event</U>&rdquo;), except for a Disqualification Event covered by Rule 506(d)(2) or (d)(3). The Company has
exercised reasonable care to determine whether any Issuer Covered Person is subject to a Disqualification Event. The Company has complied,
to the extent applicable, with its disclosure obligations under Rule 506(e), and has furnished to the Purchasers a copy of any disclosures
provided thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(qq) <U>Other Covered Persons</U>.
Other than the Placement Agent, the Company is not aware of any person (other than any Issuer Covered Person) that has been or will be
paid (directly or indirectly) remuneration for solicitation of purchasers in connection with the sale of any Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(rr) <U>Notice of Disqualification
Events</U>. The Company will notify the Purchasers and the Placement Agent in writing, prior to the Closing Date of (i) any Disqualification
Event relating to any Issuer Covered Person and (ii) any event that would, with the passage of time, become a Disqualification Event relating
to any Issuer Covered Person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.2 <U>Representations
and Warranties of the Purchasers</U>. Each Purchaser, for itself and for no&nbsp;other Purchaser, hereby represents and warrants
as of the date hereof and as of the Closing Date to the Company as follows (unless as of a specific date therein, in which case they shall
be accurate as of such date):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(a) <U>Organization;
Authority</U>. Such Purchaser is either an individual or an entity duly incorporated or formed, validly existing and in good
standing under the laws of the jurisdiction of its incorporation or formation with full right, corporate, partnership, limited liability
company or similar power and authority to enter into and to consummate the transactions contemplated by the Transaction Documents and
otherwise to carry out its obligations hereunder and thereunder. The execution and delivery of the Transaction Documents and performance
by such Purchaser of the transactions contemplated by the Transaction Documents have been duly authorized by all necessary corporate,
partnership, limited liability company or similar action, as applicable, on the part of such Purchaser. Each Transaction Document
to which it is a party has been duly executed by such Purchaser, and when delivered by such Purchaser in accordance with the terms hereof,
will constitute the valid and legally binding obligation of such Purchaser, enforceable against it in accordance with its terms, except
( i) as limited by general equitable principle s and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general
application affecting enforcement of creditors&rsquo; rights generally, (ii) as limited by laws relating to the availability of specific
performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited
by applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(b) <U>Own
Account; Understandings or Arrangements</U>. Such Purchaser is acquiring the Securities as principal for its own account and
has no&nbsp;direct or indirect arrangement or understandings with any other persons to distribute or regarding the distribution of such
Securities (this representation and warranty not limiting such Purchaser&rsquo;s right to sell the Securities pursuant to the Resale Registration
Statement or otherwise in compliance with applicable federal and state securities laws). Such Purchaser is acquiring the Securities
hereunder in the ordinary course of its business. Such Purchaser understands that the Purchase Warrants and the Purchase Warrant
Shares are &ldquo;restricted securities&rdquo; and have not been registered under the Securities Act or any applicable state securities
law and is acquiring such Securities as principal for his, her or its own account and not with a view to or for distributing or reselling
such Securities or any part thereof in violation of the Securities Act or any applicable state securities law, has no&nbsp;present intention
of distributing any of such Securities in violation of the Securities Act or any applicable state securities law and has no&nbsp;direct
or indirect arrangement or understandings with any other persons to distribute or regarding the distribution of such Securities in violation
of the Securities Act or any applicable state securities law (this representation and warranty not limiting such Purchaser&rsquo;s right
to sell such Securities pursuant to a registration statement or otherwise in compliance with applicable federal and state securities laws).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(c) <U>Purchaser
Status</U>. At the time such Purchaser was offered the Securities, it was, and as of the date hereof it is, and on each date
on which it exercises any Purchase Warrants, it will be either: (i) an &ldquo;accredited investor&rdquo; as defined in Rule 501(a)(1),
(a)(2), (a)(3), (a)(7), (a)(8), (a)(9), (a)(12), or (a)(13) under the Securities Act or (ii) a &ldquo;qualified institutional buyer&rdquo;
as defined in Rule 144A(a) under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(d) <U>Experience
of Such Purchaser</U>. Such Purchaser, either alone or together with its representatives, has such knowledge, sophistication
and experience in business and financial matters so as to be capable of evaluating the merits and risks of the prospective investment
in the Securities, and has so evaluated the merits and risks of such investment. Such Purchaser is able to bear the economic
risk of an investment in the Securities and, at the present time, is able to afford a complete loss of such investment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(e) <U>General
Solicitation</U>. Such Purchaser is not, to such Purchaser&rsquo;s knowledge, purchasing the Purchase Warrants or Purchase
Warrant Shares as a result of any advertisement, article, notice or other communication regarding the Purchase Warrants or the Purchase
Warrant Shares published in any newspaper, magazine or similar media or broadcast over television or radio or presented at any seminar
or, to the knowledge of such Purchaser, any other general solicitation or general advertisement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(f) <U>Access
to Information</U>. Such Purchaser acknowledges that it has had the opportunity to review the Transaction Documents (including all exhibits
and schedules thereto) and the SEC Reports and has been afforded (i) the opportunity to ask such questions as it has deemed necessary
of, and to receive answers from, representatives of the Company concerning the terms and conditions of the offering of the Securities
and the merits and risks of investing in the Securities; (ii) access to information about the Company and its financial condition, results
of operations, business, properties, management and prospects sufficient to enable it to evaluate its investment; and (iii) the opportunity
to obtain such additional information that the Company possesses or can acquire without unreasonable effort or expense that is necessary
to make an informed investment decision with respect to the investment.&nbsp; Such Purchaser acknowledges and agrees that neither the
Placement Agent nor any Affiliate of the Placement Agent has provided such Purchaser with any information or advice with respect to the
Securities nor is such information or advice necessary or desired.&nbsp; Neither the Placement Agent nor any Affiliate has made or makes
any representation as to the Company or the quality of the Securities and the Placement Agent and any Affiliate may have acquired non-public
information with respect to the Company which such Purchaser agrees need not be provided to it.&nbsp; In connection with the issuance
of the Securities to such Purchaser, neither the Placement Agent nor any of its Affiliates has acted as a financial advisor or fiduciary
to such Purchaser.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(g) <U>Certain
Transactions and Confidentiality</U>. Other than consummating the transactions contemplated hereunder, such Purchaser has not,
nor has any Person acting on behalf of or pursuant to any understanding with such Purchaser, directly or indirectly executed any purchases
or sales, including Short Sales,&nbsp;of the securities of the Company during the period commencing as of the time that such Purchaser
first received a term sheet (written or oral) from the Company or any other Person representing the Company setting forth the material
terms of the transactions contemplated hereunder and ending immediately prior to the execution hereof. Notwithstanding the
foregoing, in the case of a Purchaser that is a multi-managed investment vehicle whereby separate portfolio managers manage separate portions
of such Purchaser&rsquo;s assets and the portfolio managers have no&nbsp;direct knowledge of the investment decisions made by the portfolio
managers managing other portions of such Purchaser&rsquo;s assets, the representation set forth above shall only apply with respect to
the portion of assets managed by the portfolio manager that made the investment decision to purchase the Securities covered by this Agreement. Other
than to other Persons party to this Agreement or to such Purchaser&rsquo;s representatives, including, without limitation, its officers,
directors, partners, legal and other advisors, employees, Agent and Affiliates, such Purchaser has maintained the confidentiality of all
disclosures made to it in connection with this transaction (including the existence and terms of this transaction). Notwithstanding the
foregoing, for the avoidance of doubt, nothing contained herein shall constitute a representation or warranty, or preclude any actions,
with respect to locating or borrowing shares in order to effect Short Sales or similar transactions in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company acknowledges and agrees that the representations
contained in this Section 3.2 shall not modify, amend or affect such Purchaser&rsquo;s right to rely on the Company&rsquo;s representations
and warranties contained in this Agreement or any representations and warranties contained in any other Transaction Document or any other
document or instrument executed and/or delivered in connection with this Agreement or the consummation of the transactions contemplated
hereby. Notwithstanding the foregoing, for the avoidance of doubt, nothing contained herein shall constitute a representation
or warranty, or preclude any actions, with respect to locating or borrowing shares in order to effect Short Sales or similar transactions
in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">ARTICLE
IV</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">OTHER AGREEMENTS OF THE PARTIES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.1 <U>Transfer
Restrictions; Removal of Legends</U>. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(a) The
Purchase Warrants and Purchase Warrant Shares may only be disposed of in compliance with state and federal securities laws. In
connection with any transfer of Purchase Warrants or Purchase Warrant Shares other than pursuant to an effective registration statement
or Rule 144, to the Company or to an Affiliate of a Purchaser or in connection with a pledge as contemplated in Section 4.1(b), the Company
may require the transferor thereof to provide to the Company an opinion of counsel selected by the transferor and reasonably acceptable
to the Company, the form and substance of which opinion shall be reasonably satisfactory to the Company, to the effect that such transfer
does not require registration of such transferred Warrant under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(b) The
Purchasers agree to the imprinting, so long as is required by this Section 4.1, of a legend on any of the Purchase Warrants or Purchase
Warrant Shares in the following form:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">NEITHER THIS SECURITY NOR THE SECURITIES INTO
WHICH THIS SECURITY IS EXERCISABLE HAS BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY
STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &ldquo;SECURITIES ACT&rdquo;),
AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT
TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE
WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION
WITH A BONA FIDE MARGIN ACCOUNT WITH A REGISTERED BROKER-DEALER OR OTHER LOAN WITH A FINANCIAL INSTITUTION THAT IS AN &ldquo;ACCREDITED
INVESTOR&rdquo; AS DEFINED IN RULE 501(a) UNDER THE SECURITIES ACT OR OTHER LOAN SECURED BY SUCH SECURITIES.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company acknowledges and agrees that a
Purchaser may from time to time pledge pursuant to a bona fide margin agreement with a registered broker-dealer or grant a security
interest in some or all of the Securities to a financial institution that is an &ldquo; accredited investor&rdquo; as defined in
Rule 501(a) under the Securities Act and, if required under the terms of such arrangement, such Purchaser may transfer pledged or
secured Securities to the pledgees or secured parties. Such a pledge or transfer would not be subject to approval of the Company and
no&nbsp;legal opinion of legal counsel of the pledgee, secured party or pledgor shall be required in connection therewith. Further,
no&nbsp;notice shall be required of such pledge. At the appropriate Purchaser &rsquo;s expense, the Company will execute and deliver
such reasonable documentation as a pledgee or secured party of Securities may reasonably request in connection with a pledge or
transfer of the Securities, including, if the Securities are subject to registration pursuant to the Registration Rights Agreement,
the preparation and filing of any required prospectus supplement under Rule 424(b)(3) under the Securities Act or other applicable
provision of the Securities Act to appropriately amend the list of Selling Stockholders (as defined in the Registration Rights
Agreement) thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(c) Certificates
evidencing the Purchase Warrant Shares, if any, shall not contain any legend (including the legend set forth in Section 4.1(b)
hereof), (i) while a registration statement (including the Resale Registration Statement) covering the resale of such security is
effective under the Securities Act, (ii) following any sale of such Purchase Warrant Shares pursuant to Rule 144 (assuming cashless
exercise of the Purchase Warrants), (iii) if such Purchase Warrant Shares are eligible for sale under Rule 144 (assuming cashless
exercise of the Purchase Warrants) or (iv) if such legend is not required under applicable requirements of the Securities Act
(including judicial interpretations and pronouncements issued by the staff of the Commission). The Company shall cause its counsel
to issue a legal opinion to the Transfer Agent or the Purchaser promptly after the Effective Date if required by the Transfer Agent
to effect the removal of the legend hereunder, or if requested by a Purchaser, respectively. If all or any portion of a Purchase
Warrant is exercised at a time when there is an effective registration statement to cover the resale of the Purchase Warrant Shares,
or if such Purchase Warrant Shares may be sold under Rule 144 and the Company is then in compliance with the current public
information required under Rule 144 (assuming cashless exercise of the Purchase Warrants), or if the Purchase Warrant Shares may be
sold under Rule 144 without the requirement for the Company to be in compliance with the current public information required under
Rule 144 as to such Purchase Warrant Shares or if such legend is not otherwise required under applicable requirements of the
Securities Act (including judicial interpretations and pronouncements issued by the staff of the Commission) then such Purchase
Warrant Shares shall be issued free of all legends. The Company agrees that following the Effective Date, it will, no&nbsp;later
than the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period (as
defined below) following the delivery by a Purchaser to the Company or the Transfer Agent of a certificate representing Purchase
Warrant Shares issued with a restrictive legend (such date, the &ldquo;<U>Legend Removal Date </U>&rdquo;), deliver or cause to be
delivered to such Purchaser a certificate representing such shares that is free from all restrictive and other legends. The Company
may not make any notation on its records or give instructions to the Transfer Agent that enlarge the restrictions on transfer set
forth in this Section 4. Certificates for Purchase Warrant Shares subject to legend removal hereunder shall be transmitted by the
Transfer Agent to the Purchaser by crediting the account of the Purchaser&rsquo;s prime broker with the Depository Trust Company
System as directed by such Purchaser. As used herein, &ldquo;<U>Standard Settlement Period</U>&rdquo; means the standard settlement
period, expressed in a number of Trading Days, on the Company&rsquo;s primary Trading Market with respect to the Common Stock as in
effect on the date of delivery of a certificate representing Purchase Warrant Shares issued with a restrictive legend.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(d) In
addition to such Purchaser&rsquo;s other available remedies, the Company shall pay to a Purchaser, in cash, (i) as partial liquidated
damages and not as a penalty, for each $1,000 of Purchase Warrant Shares (based on the VWAP of the Common Stock on the date such Purchase
Warrant Shares are submitted to the Transfer Agent) delivered for removal of the restrictive legend and subject to Section 4.1(c), $10
per Trading Day (increasing to $20 per Trading Day five (5) Trading Days after such damages have begun to accrue) for each Trading Day
after the Legend Removal Date until such certificate is delivered without a legend and (ii) if the Company fails to (a) issue and deliver
(or cause to be delivered) to a Purchaser by the Legend Removal Date a certificate representing the Purchase Warrant Shares so delivered
to the Company by such Purchaser that is free from all restrictive and other legends and (b) if after the Legend Removal Date such Purchaser
purchases (in an open market transaction or otherwise) shares of Common Stock to deliver in satisfaction of a sale by such Purchaser of
all or any portion of the number of shares of Common Stock, or a sale of a number of shares of Common Stock equal to all or any portion
of the number of shares of Common Stock that such Purchaser anticipated receiving from the Company without any restrictive legend, then,
an amount equal to the excess of such Purchaser&rsquo;s total purchase price (including brokerage commissions and other out-of-pocket
expenses, if any) for the shares of Common Stock so purchased (including brokerage commissions and other out-of-pocket expenses, if any)
(the &ldquo;<U>Buy-In Price</U>&rdquo;) over the product of (A) such number of Purchase Warrant Shares that the Company was required
to deliver to such Purchaser by the Legend Removal Date multiplied by (B) the lowest closing sale price of the Common Stock on any Trading
Day during the period commencing on the date of the delivery by such Purchaser to the Company of the applicable Purchase Warrant Shares
and ending on the date of such delivery and payment under this clause (ii).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(e) Each
Purchaser, severally and not jointly with the other Purchasers, agrees with the Company that such Purchaser will sell any Securities pursuant
to either the registration requirements of the Securities Act, including any applicable prospectus delivery requirements, or an exemption
therefrom, and that if Securities are sold pursuant to a Resale Registration Statement, they will be sold in compliance with the plan
of distribution set forth therein, and acknowledges that the removal of the restrictive legend from certificates representing Securities
as set forth in this Section&nbsp;4.1 is predicated upon the Company&rsquo;s reliance upon this understanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.2 <U>Furnishing
of Information; Public Information</U>. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(a) Until
the earliest of the time that (i) no&nbsp;Purchaser owns Securities or (ii) the Purchase Warrants have expired, the Company covenants
to use commercially reasonable efforts to maintain the registration of the Common Stock under Section 12(b) or 12(g) of the Exchange Act
and to timely file (or obtain extensions in respect thereof and file within the applicable grace period) all reports required to be filed
by the Company after the date hereof pursuant to the Exchange Act even if the Company is not then subject to the reporting requirements
of the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(b) At
any time during the period commencing from the six (6) month anniversary of the date hereof and ending at such time that all of the Purchase
Warrant Shares may be sold without the requirement for the Company to be in compliance with Rule 144(c)(1) and otherwise without restriction
or limitation pursuant to Rule 144, if the Company (i) shall fail for any reason to satisfy the current public information requirement
under Rule 144(c) or (ii) has ever been an issuer described in Rule 144(i)(1)(i) or becomes an issuer in the future, and the Company shall
fail to satisfy any condition set forth in Rule 144(i)(2) (a &ldquo;<U>Public Information Failure</U>&rdquo;) then, in addition to such
Purchaser&rsquo;s other available remedies, the Company shall pay to a Purchaser, in cash, as partial liquidated damages and not as a
penalty, by reason of any such delay in or reduction of its ability to sell the Purchase Warrant Shares, an amount in cash equal to two
percent (2.0%) of the aggregate Subscription Amount of such Purchaser&rsquo;s Securities on the day of a Public Information Failure and
on every thirtieth (30<FONT STYLE="font-size: 10pt"><SUP>th</SUP></FONT> ) day (pro rated for periods totaling less than thirty days)
thereafter until the earlier of (a) the date such Public Information Failure is cured and (b) such time that such public information is
no&nbsp;longer required for the Purchasers to transfer the Purchase Warrant Shares pursuant to Rule 144.&nbsp; The payments to which a
Purchaser shall be entitled pursuant to this Section 4.2(b) are referred to herein as &ldquo;<U>Public Information Failure Payments</U>.&rdquo;&nbsp;
Public Information Failure Payments shall be paid on the earlier of (i) the last day of the calendar month during which such Public Information
Failure Payments are incurred and (ii) the third (3<FONT STYLE="font-size: 10pt"><SUP>rd</SUP></FONT>) Business Day after the event or
failure giving rise to the Public Information Failure Payments is cured.&nbsp; In the event the Company fails to make Public Information
Failure Payments in a timely manner, such Public Information Failure Payments shall bear interest at the rate of 1.5% per month (prorated
for partial months) until paid in full. Nothing herein shall limit such Purchaser&rsquo;s right to pursue actual damages for the Public
Information Failure, and such Purchaser shall have the right to pursue all remedies available to it at law or in equity including, without
limitation, a decree of specific performance and/or injunctive relief.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.3 <U>Integration</U>.
The Company shall not sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any security (as defined in
Section 2 of the Securities Act) that would be integrated with the offer or sale of the Purchase Warrants or Purchase Warrant Shares
in a manner that would require the registration under the Securities Act of the sale of the Purchase Warrants or Purchase Warrant
Shares or that would be integrated with the offer or sale of the Purchase Warrants or Purchase Warrant Shares for purposes of the
rules and regulations of any Trading Market such that it would require shareholder approval prior to the closing of such other
transaction unless shareholder approval is obtained before the closing of such subsequent transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.4 <U>Securities
Laws Disclosure; Publicity</U>. The Company shall (a) by the Disclosure Time, issue a press release disclosing the material
terms of the transactions contemplated hereby, and (b) file a Current Report on Form 8-K, including the Transaction Documents as exhibits
thereto, with the Commission within the time required by the Exchange Act. From and after the issuance of such press release,
the Company represents to the Purchasers that it shall have publicly disclosed all material, non-public information delivered to any of
the Purchasers by the Company or any of its Subsidiaries, or any of their respective officers, directors, employees or Agent in connection
with the transactions contemplated by the Transaction Documents. In addition, effective upon the issuance of such press release, the Company
acknowledges and agrees that any and al l confidentiality or similar obligations under any agreement, whether written or oral, between
the Company, any of its Subsidiaries or any of their respective officers, directors, Agent, employees or Affiliates on the one hand, and
any of the Purchasers or any of their Affiliates on the other hand, shall terminate. The Company and each Purchaser shall consult with
each other in issuing any other press releases with respect to the transactions contemplated hereby, and neither the Company nor any Purchaser
shall issue any such press release nor otherwise make any such public statement without the prior consent of the Company, with respect
to any such press release of any Purchaser, or without the prior consent of each Purchaser, with respect to any such press release of
the Company, which consent shall not unreasonably be withheld or delayed, except if such disclosure is required by law, in which case
the disclosing party shall promptly provide the other party with prior notice of such public statement or communication. Notwithstanding
the foregoing, the Company shall not publicly disclose the name of any Purchaser, or include the name of any Purchaser in any filing with
the Commission or any regulatory agency or Trading Market, without the prior written consent of such Purchaser, except (a) as required
by federal securities law in connection with ( i) any registration statement contemplated by the Registration Rights Agreement and (ii)
the filing of final Transaction Documents with the Commission and (b) to the extent such disclosure is required by law or Trading Market
regulations, in which case the Company shall provide the Purchasers with prior notice of such disclosure permitted under this clause (b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.5 <U>Shareholder
Rights Plan</U>. No&nbsp;claim will be made or enforced by the Company or, with the consent of the Company, any other Person, that
any Purchaser is an &ldquo; <U>Acquiring Person</U>&rdquo; under any control share acquisition, business combination, poison pill
(including any distribution under a rights agreement) or similar anti-takeover plan or arrangement in effect or hereafter adopted by
the Company, or that any Purchaser could be deemed to trigger the provisions of any such plan or arrangement, by virtue of receiving
Securities under the Transaction Documents or under any other agreement between the Company and the Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.6 <U>Non-Public
Information</U>. Except with respect to the material terms and conditions of the transactions contemplated by the Transaction
Documents, which shall be disclosed pursuant to Section 4.4, the Company covenants and agrees that neither it, nor any other Person acting
on its behalf will provide any Purchaser or its Agent or counsel with any information that constitutes, or the Company reasonably believes
constitutes, material non-public information, unless prior thereto such Purchaser shall have consented to the receipt of such information
and agreed with the Company to keep such information confidential. The Company understands and confirms that each Purchaser
shall be relying on the foregoing covenant in effecting transactions in securities of the Company. To the extent that the Company,
any of its Subsidiaries, or any of their respective officers, directors, Agent, employees or Affiliates delivers any material, non-public
information to a Purchaser without such Purchaser&rsquo;s consent, the Company hereby covenants and agrees that such Purchaser shall not
have any duty of confidentiality to the Company, any of its Subsidiaries, or any of their respective officers, directors, Agent, employees
or Affiliates, or a duty to the Company, any of its Subsidiaries or any of their respective officers, directors, Agent , employees or
Affiliates not to trade on the basis of, such material, non-public information, provided that the Purchaser shall remain subject to applicable
law. To the extent that any notice provided pursuant to any Transaction Document constitutes, or contains, material, non-public information
regarding the Company or any Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Current
Report on Form 8-K. The Company understands and confirms that each Purchaser shall be relying on the foregoing covenant in
effecting transactions in securities of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.7 <U>Use
of Proceeds</U>. Except as set forth on <U>Schedule 4.7</U> attached hereto, the Company shall use the net proceeds from the
sale of the Securities hereunder for working capital purposes and shall not use such proceeds: (a) for the satisfaction of any portion
of the Company&rsquo;s debt (other than payment of trade payables in the ordinary course of the Company&rsquo;s business and prior practices),
(b) for the redemption of any Common Stock or Common Stock Equivalents, (c) for the settlement of any outstanding litigation or (d) in
violation of FCPA or OFAC regulations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.8 <U>Indemnification
of Purchasers</U>. Subject to the provisions of this Section 4.8, the Company will indemnify and hold each Purchaser and its
directors, officers, shareholders, members, partners, employees and Agent (and any other Persons with a functionally equivalent role of
a Person holding such titles notwithstanding a lack of such title or any other title), each Person who controls such Purchaser (within
the meaning of Section 15 of the Securities Act and Section 20 of the Exchange Act), and the directors, officers, shareholders, Agent,
members, partners or employees (and any other Persons with a functionally equivalent role of a Person holding such titles notwithstanding
a lack of such title or any other title) of such controlling persons (each, a &ldquo;<U>Purchaser Party</U>&rdquo;) harmless from any
and all losses, liabilities, obligations, claims, contingencies, damages, costs and expenses, including all judgments, amounts paid in
settlements, court costs and reasonable attorneys&rsquo; fees and costs of investigation that any such Purchaser Party may suffer or incur
as a result of or relating to (a) any breach of any of the representations, warranties, covenants or agreements made by the Company in
this Agreement or in the other Transaction Documents or (b) any action instituted against the Purchaser Parties in any capacity, or any
of them or their respective Affiliates, by any stockholder of the Company who is not an Affiliate of such Purchaser Party, with respect
to any of the transactions contemplated by the Transaction Documents (unless such action is solely based upon a material breach of such
Purchaser Party&rsquo;s representations, warranties or covenants under the Transaction Documents or any agreements or understandings such
Purchaser Party may have with any such stockholder or any violations by such Purchaser Party of state or federal securities laws or any
conduct by such Purchaser Party which is finally judicially determined to constitute fraud, gross negligence or willful misconduct). If
any action shall be brought against any Purchaser Party in respect of which indemnity may be sought pursuant to this Agreement, such Purchaser
Party shall promptly notify the Company in writing, and the Company shall have the right to assume the defense thereof with counsel of
its own choosing reasonably acceptable to the Purchaser Party. Any Purchaser Party shall have the right to employ separate
counsel in any such action and participate in the defense thereof, but the fees and expenses of such counsel shall be at the expense of
such Purchaser Party except to the extent that (i) the employment thereof has been specifically authorized by the Company in writing,
(ii) the Company has failed after a reasonable period of time to assume such defense and to employ counsel or (iii) in such action there
is, in the reasonable opinion of counsel, a material conflict on any material issue between the position of the Company and the position
of such Purchaser Party , in which case the Company shall be responsible for the reasonable fees and expenses of no&nbsp;more than one
such separate counsel. The Company will not be liable to any Purchaser Party under this Agreement (y) for any settlement by
a Purchaser Party effected without the Company&rsquo;s prior written consent, which shall not be unreasonably withheld or delayed; or
(z) to the extent , but only to the extent that a loss, claim, damage or liability is attributable to any Purchaser Party&rsquo; s breach
of any of the representations, warranties, covenants or agreements made by such Purchaser Party in this Agreement or in the other Transaction
Documents. The indemnification required by this Section 4.8 shall be made by periodic payments of the amount thereof during the course
of the investigation or defense, as and when bills are received or are incurred. The indemnity agreements contained herein shall be in
addition to any cause of action or similar right of any Purchaser Party against the Company or others and any liabilities the Company
may be subject to pursuant to law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.9 <U>Reservation
of Common Stock</U>. As of the date hereof, the Company has reserved and the Company shall continue to reserve and keep available at all
times, free of preemptive rights, a sufficient number of shares of Common Stock for the purpose of enabling the Company to issue Shares
pursuant to this Agreement and Warrant Shares pursuant to any exercise of the Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.10 <U>Listing
of Common Stock</U>. The Company hereby agrees to use commercially reasonable efforts to maintain the listing or quotation of the Common
Stock on the Trading Market on which it is currently listed, and concurrently with the Closing, the Company shall apply to list or quote
all of the Shares and Warrant Shares on such Trading Market and promptly secure the listing of all of the Shares and Warrant Shares on
such Trading Market. The Company further agrees, if the Company applies to have the Common Stock traded on any other Trading Market, it
will then include in such application all of the Shares and Warrant Shares, and will take such other action as is necessary to cause all
of the Shares and Warrant Shares to be listed or quoted on such other Trading Market as promptly as possible. The Company will
then take all action reasonably necessary to continue the listing and trading of its Common Stock on a Trading Market and will comply
in all respects with the Company&rsquo;s reporting, filing and other obligations under the bylaws or rules of the Trading Market. The
Company agrees to maintain the eligibility of the Common Stock for electronic transfer through the Depository Trust Company or another
established clearing corporation, including, without limitation, by timely payment of fees to the Depository Trust Company or such other
established clearing corporation in connection with such electronic transfer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.11 <U>Participation
in Future Financing</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(a) (a)
From the date hereof until the date that is the six (6) month anniversary of the Closing Date, upon any issuance by the Company or any
of its Subsidiaries of Common Stock or Common Stock Equivalents for cash consideration, or a combination of units thereof (a &ldquo;<U>Subsequent
Financing</U>&rdquo;), each Purchaser shall have the right to participate in up to an amount of the Subsequent Financing equal to 30%
of the Subsequent Financing (the &ldquo;<U>Participation Maximum</U>&rdquo;) on the same terms, conditions and price provided for in the
Subsequent Financing.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(b) At least three (3)
Trading Days prior to the Trading Day of the expected announcement of the Subsequent Financing , the Company shall deliver to each
Purchaser a written notice of its intention to effect a Subsequent Financing (&ldquo;<U>Pre-Notice </U>&rdquo; ), which Pre-Notice
shall ask such Purchaser if it wants to review the details of such financing (such additional notice, a &ldquo;<U>Subsequent
Financing Notice </U>&rdquo;). Upon the request of a Purchaser, and only upon a request by such Purchaser, for a Subsequent
Financing Notice, the Company shall promptly , but no&nbsp;later than one (1) Trading Day after such request, deliver a Subsequent
Financing Notice to such Purchaser.&nbsp; The Subsequent Financing Notice shall describe in reasonable detail the proposed terms of
such Subsequent Financing, the amount of proceeds intended to be raised thereunder and the Person or Persons through or with whom
such Subsequent Financing is proposed to be effected and shall include a term sheet or similar document relating thereto as an
attachment. If a Purchaser does not, on or prior to 5:00 pm (New York City time) on the third (3rd) Trading Day following receipt of
the Pre-Notice, deliver notice to the Company consenting to the receipt of non-public information about the Company, the
Company&rsquo;s obligations pursuant to this Section 4.11 with respect to such Purchaser shall cease with respect to the Subsequent
Financing which is the subject of such Pre-Notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(c) Any
Purchaser desiring to participate in such Subsequent Financing must provide written notice to the Company by not later than 5:00 pm (New
York City time) on the third (3rd) Trading Day following the date on which the Pre-Notice is delivered to such Purchaser that such Purchaser
is willing to participate in the Subsequent Financing, the amount of such Purchaser&rsquo;s participation, and representing and warranting
that such Purchaser has such funds ready, willing, and available for investment on the terms set forth in the Subsequent Financing Notice. If
the Company receives no&nbsp;such notice from a Purchaser as of such time, such Purchaser shall be deemed to have notified the Company
that it does not elect to participate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(d) If
by 5:00 p.m. (New York City time) on the third (3rd) Trading Day following the date on which the Pre-Notice is delivered to all the Purchasers,
notifications by the Purchasers of their willingness to participate in the Subsequent Financing (or to cause their designees to participate)
is, in the aggregate, less than the total amount of the Subsequent Financing, then the Company may effect the remaining portion of such
Subsequent Financing on the terms and with the Persons set forth in the Subsequent Financing Notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(e) If
by 5:00 p.m. (New York City time) on the third (3rd) Trading Day following the date on which the Pre-Notice is delivered to all the Purchasers,
the Company receives responses to a Subsequent Financing Notice from Purchasers seeking to purchase more than the aggregate amount of
the Participation Maximum, each such Purchaser shall have the right to purchase its Pro Rata Portion (as defined below) of the Participation
Maximum.&nbsp; &ldquo;<U>Pro Rata Portion</U>&rdquo; means the ratio of (x) the Subscription Amount of Securities purchased on the Closing
Date by a Purchaser participating under this Section 4.11 and (y) the sum of the aggregate Subscription Amounts of Securities purchased
on the Closing Date by all Purchasers participating under this Section 4.11.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(f) The
Company must provide the Purchasers with a second Subsequent Financing Notice, and the Purchasers will again have the right of participation
set forth above in this Section 4.11, if the Subsequent Financing subject to the initial Subsequent Financing Notice is not consummated
for any reason on the terms set forth in such Subsequent Financing Notice within thirty (30 ) Trading Days after the date of the initial
Subsequent Financing Notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(g) The
Company and each Purchaser agree that if any Purchaser elects to participate in a Subsequent Financing, neither the subsequent placement
agreement with respect to such Subsequent Financing nor any other transaction documents related thereto shall include any term or provision
whereby such Purchaser shall be required to agree to any restrictions on trading as to any securities of the Company or be required to
consent to any amendment to or termination of, or grant any waiver, release or the like under or in connection with, any agreement previously
entered into with the Company or any instrument received from the Company. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(h) Notwithstanding
anything to the contrary in this Section 4.11 and unless otherwise agreed to by such Purchaser, the Company shall either confirm in writing
to such Purchaser that the transaction with respect to the Subsequent Financing has been abandoned or shall publicly disclose its intention
to issue the securities in the Subsequent Financing, in either case in such a manner such that such Purchaser will not be in possession
of any material, non-public information, by the tenth (10<FONT STYLE="font-size: 10pt"><SUP>th</SUP></FONT>) Business Day following delivery
of the Subsequent Financing Notice. If by such tenth (10<FONT STYLE="font-size: 10pt"><SUP>th</SUP></FONT> ) Business Day,
no&nbsp;public disclosure regarding a transaction with respect to the Subsequent Financing has been made, and no&nbsp;notice regarding
the abandonment of such transaction has been received by such Purchaser, such transaction shall be deemed to have been abandoned and such
Purchaser shall not be deemed to be in possession of any material, non-public information with respect to the Company or any of its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i) Notwithstanding
the foregoing, this Section 4.11 shall not apply in respect of an Exempt Issuance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.12 <U>Subsequent
Equity Sales</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(a) From
the date hereof until 90 days after the Closing Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement
to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents or (ii) file any registration
statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(b) From
the date hereof until the earlier of (a) such time as no&nbsp;Purchaser holds any of the Warrants or (b) twelve months from the date hereof,
the Company shall be prohibited from effecting or entering into an agreement to effect any issuance by the Company or any of its Subsidiaries
of Common Stock or Common Stock Equivalents (or a combination of units thereof) involving a Variable Rate Transaction. &ldquo;<U>Variable
Rate Transaction</U>&rdquo; means a transaction in which the Company (i) issues or sells any debt or equity securities that are convertible
into, exchangeable or exercisable for, or include the right to receive, additional shares of Common Stock either (A) at a conversion price,
exercise price or exchange rate or other price that is based upon , and/or varies with , the trading prices of or quotations for the shares
of Common Stock at any time after the initial issuance of such debt or equity securities or (B) with a conversion, exercise or exchange
price that is subject to being reset at some future date after the initial issuance of such debt or equity security or upon the occurrence
of specified or contingent events directly or indirectly related to the business of the Company or the market for the Common Stock or
(ii) enters into , or effects a transaction under, a ny agreement, including, but not limited to, an equity line of credit, whereby the
Company may issue securities at a future determined price. Any Purchaser shall be entitled to obtain injunctive relief against
the Company to preclude any such issuance, which remedy shall be in addition to any right to collect damages.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(c) Until
six months from the date hereof, the Company shall be prohibited from effecting or entering into an agreement to effect any issuance by
the Company or any of its Subsidiaries of Common Stock or Common Stock Equivalents (or a combination of units thereof) involving an &ldquo;ATM&rdquo;
offering, that is an offering of Common Stock into its existing trading market for the Common Stock at a price or prices related to the
then-market price of the Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(d) Notwithstanding
the foregoing, this Section 4.12 shall not apply in respect of an Exempt Issuance, except that no&nbsp;Variable Rate Transaction shall
be an Exempt Issuance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.13 <U>Equal
Treatment of Purchasers</U>. No&nbsp;consideration (including any modification of any Transaction Document) shall be offered
or paid to any Person to amend or consent to a waiver or modification of any provision of the Transaction Documents unless the same consideration
is also offered to all of the parties to the Transaction Documents. For clarification purposes, this provision constitutes
a separate right granted to each Purchaser by the Company and negotiated separately by each Purchaser, and is intended for the Company
to treat the Purchasers as a class and shall not in any way be construed as the Purchasers acting in concert or as a group with respect
to the purchase, disposition or voting of Securities or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.14 <U>Certain
Transactions and Confidentiality</U>. Each Purchaser, severally and not jointly with the other Purchasers, covenants that neither it,
nor any Affiliate acting on its behalf or pursuant to any understanding with it will execute any purchases or sales, including Short Sales,
of any of the Company&rsquo;s securities during the period commencing with the execution of this Agreement and ending at such time that
the transactions contemplated by this Agreement are first publicly announced pursuant to the initial press release as described in Section
4.4. Each Purchaser, severally and not jointly with the other Purchasers, covenants that until such time as the transactions contemplated
by this Agreement are publicly disclosed by the Company pursuant to the initial press release as described in Section 4.4, such Purchaser
will maintain the confidentiality of the existence and terms of this transaction and the information included in the Disclosure Schedules.&nbsp;
Notwithstanding the foregoing and notwithstanding anything contained in this Agreement to the contrary, the Company expressly acknowledges
and agrees that (i) no&nbsp;Purchaser makes any representation, warranty or covenant hereby that it will not engage in effecting transactions
in any securities of the Company after the time that the transactions contemplated by this Agreement are first publicly announced pursuant
to the initial press release as described in Section 4.4 , (ii) no&nbsp;Purchaser shall be restricted or prohibited from effecting any
transactions in any securities of the Company in accordance with applicable securities laws from and after the time that the transactions
contemplated by this Agreement are first publicly announced pursuant to the initial press release as described in Section 4.4 and (iii)
no&nbsp;Purchaser shall have any duty of confidentiality or duty not to trade in the securities of the Company to the Company or its Subsidiaries
after the issuance of the initial press release as described in Section 4.4 .&nbsp; Notwithstanding the foregoing, in the case of a Purchaser
that is a multi-managed investment vehicle whereby separate portfolio managers manage separate portions of such Purchaser&rsquo;s assets
and the portfolio managers have no&nbsp;direct knowledge of the investment decisions made by the portfolio managers managing other portions
of such Purchaser&rsquo;s assets, the covenant set forth above shall only apply with respect to the portion of assets managed by the portfolio
manager that made the investment decision to purchase the Securities covered by this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.15 <U>Form
D; Blue Sky Filings</U>. The Company agrees to timely file a Form D with respect to the Securities as required under Regulation
D and to provide a copy thereof, promptly upon request of any Purchaser. The Company shall take such action as the Company shall reasonably
determine is necessary in order to obtain an exemption for, or to qualify the Securities for, sale to the Purchasers at the Closing under
applicable securities or &ldquo;Blue Sky&rdquo; laws of the states of the United States, and shall provide evidence of such actions promptly
upon request of any Purchaser.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.16 <U>Capital
Changes. </U>Except to maintain compliance with the rules of The Nasdaq Stock Market, until the one-year anniversary of the
Closing Date, the Company shall not undertake a reverse or forward stock split or reclassification of the Common Stock without the prior
written consent of the Purchasers holding a majority in interest of the Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.17 <U>Acknowledgment
of Dilution</U>. The Company acknowledges that the issuance of the Securities may result in dilution of the outstanding shares
of Common Stock, which dilution may be substantial under certain market conditions. The Company further acknowledges that its
obligations under the Transaction Documents, including, without limitation, its obligation to issue the Shares and Warrant Shares pursuant
to the Transaction Documents, are unconditional and absolute and not subject to any right of set off, counterclaim, delay or reduction,
regardless of the effect of any such dilution or any claim the Company may have against any Purchaser and regardless of the dilutive effect
that such issuance may have on the ownership of the other stockholders of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.18 <U>Exercise
Procedures</U>. The form of Notice of Exercise included in the Warrants set forth the totality of the procedures required of
the Purchasers in order to exercise the Warrants. No&nbsp;additional legal opinion, other information or instructions shall
be required of the Purchasers to exercise their Warrants. Without limiting the preceding sentences, no&nbsp;ink-original Notice
of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise
form be required in order to exercise the Warrants. The Company shall honor exercises of the Warrants and shall deliver Warrant
Shares in accordance with the terms, conditions and time periods set forth in the Transaction Documents.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">ARTICLE
V</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in">MISCELLANEOUS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.1 <U>Termination</U>.&nbsp;
This Agreement may be terminated by any Purchaser, as to such Purchaser&rsquo;s obligations hereunder only and without any effect whatsoever
on the obligations between the Company and the other Purchasers, by written notice to the other parties, if the Closing has not been consummated
on or before the fifth (5 <FONT STYLE="font-size: 10pt"><SUP>th</SUP></FONT>) Trading Day following the date hereof; <U>provided</U> ,
<U>however</U> , that no&nbsp;such termination will affect the right of any party to sue for any breach by any other party (or parties).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 27; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.2 <U>Fees
and Expenses</U>. Except as expressly set forth in the Transaction Documents to the contrary, each party shall pay the fees
and expenses of its advisers, counsel, accountants and other experts, if any, and all other expenses incurred by such party incident to
the negotiation, preparation, execution, delivery and performance of this Agreement. The Company shall pay all Transfer Agent
fees (including, without limitation, any fees required for same-day processing of any instruction letter delivered by the Company and
any exercise notice delivered by a Purchaser), stamp taxes and other taxes and duties levied in connection with the delivery of any Securities
to the Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.3 <U>Entire
Agreement</U>. The Transaction Documents, together with the exhibits and schedules thereto, the Prospectus and the Prospectus
Supplement, contain the entire understanding of the parties with respect to the subject matter hereof and thereof and supersede all prior
agreements and understandings, oral or written, with respect to such matters, which the parties acknowledge have been merged into such
documents, exhibits and schedules.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.4 <U>Notices</U>. Any
and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in writing and shall be
deemed given and effective on the earliest of: (a) the time of transmission, if such notice or communication is delivered via facsimile
at the facsimile number or email attachment at the email address as set forth on the signature pages attached hereto at or prior to 5:30
p.m. (New York City time) on a Trading Day, (b) the next Trading Day after the time of transmission, if such notice or communication is
delivered via facsimile at the facsimile number or email attachment at the email address as set forth on the signature pages attached
hereto on a day that is not a Trading Day or later than 5:30 p.m. (New York City time) on any Trading Day, (c) the second (2 <FONT STYLE="font-size: 10pt"><SUP>nd</SUP></FONT>)
Trading Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service or (d) upon actual receipt
by the party to whom such notice is required to be given. The address for such notices and communications shall be as set forth
on the signature pages attached hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.5 <U>Amendments;
Waivers</U>. No&nbsp;provision of this Agreement may be waived, modified, supplemented or amended except in a written instrument
signed, in the case of an amendment, by the Company and Purchasers which purchased at least 50.1% in interest of the Shares based on the
initial Subscription Amounts hereunder (or, prior to the Closing, the Company and each Purchaser) or, in the case of a waiver, by the
party against whom enforcement of any such waived provision is sought, provided that if any amendment, modification or waiver disproportionately
and adversely impacts a Purchaser (or group of Purchasers), the consent of such disproportionately impacted Purchaser (or group of Purchasers)
shall also be required. No&nbsp;waiver of any default with respect to any provision, condition or requirement of this Agreement
shall be deemed to be a continuing waiver in the future or a waiver of any subsequent default or a waiver of any other provision, condition
or requirement hereof, nor shall any delay or omission of any party to exercise any right hereunder in any manner impair the exercise
of any such right. Any proposed amendment or waiver that disproportionately, materially and adversely affects the rights and obligations
of any Purchaser relative to the comparable rights and obligations of the other Purchasers shall require the prior written consent of
such adversely affected Purchaser. Any amendment effected in accordance with this Section 5.5 shall be binding upon each Purchaser and
holder of Securities and the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.6 <U>Headings</U>. The
headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed to limit or affect any of
the provisions hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.7 <U>Successors
and Assigns</U>. This Agreement shall be binding upon and inure to the benefit of the parties and their successors and permitted
assigns. The Company may not assign this Agreement or any rights or obligations hereunder without the prior written consent
of each Purchaser (other than by merger). Any Purchaser may assign any or all of its rights under this Agreement to any Person
to whom such Purchaser assigns or transfers any Securities, provided that such transferee agrees in writing to be bound, with respect
to the transferred Securities, by the provisions of the Transaction Documents that apply to the &ldquo;Purchasers.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 28; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.8 <U>No&nbsp;Third-Party
Beneficiaries</U>. The Placement Agent shall be the third party beneficiaries of the representations and warranties of the
Company in Section 3.1 and the representations and warranties of the Purchasers in Section 3.2. This Agreement is intended
for the benefit of the parties hereto and their respective successors and permitted assigns and is not for the benefit of, nor may any
provision hereof be enforced by, any other Person, except as otherwise set forth in Section 4.8 and this Section 5.8.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.9 <U>Governing
Law</U>. All questions concerning the construction, validity, enforcement and interpretation of the Transaction Documents shall
be governed by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles
of conflicts of law thereof. Each party agrees that all legal Proceedings concerning the interpretations, enforcement and defense
of the transactions contemplated by this Agreement and any other Transaction Documents (whether brought against a party hereto or its
respective affiliates, directors, officers, shareholders, partners, members, employees or Agent) shall be commenced exclusively in the
state and federal courts sitting in the City of New York. Each party hereby irrevocably submits to the exclusive jurisdiction
of the state and federal courts sitting in the City of New York, Borough of Manhattan for the adjudication of any dispute hereunder or
in connection herewith or with any transaction contemplated hereby or discussed herein (including with respect to the enforcement of any
of the Transaction Documents), and hereby irrevocably waives, and agrees not to assert in any Action or Proceeding, any claim that it
is not personally subject to the jurisdiction of any such court, that such Action or Proceeding is improper or is an inconvenient venue
for such Proceeding. Each party hereby irrevocably waives personal service of process and consents to process being served
in any such Action or Proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery)
to such party at the address in effect for notices to it under this Agreement and agrees that such service shall constitute good and sufficient
service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process
in any other manner permitted by law.  If any party shall commence an Action or Proceeding to enforce any provisions of the
Transaction Documents, then, in addition to the obligations of the Company under Section 4.8, the prevailing party in such Action or Proceeding
shall be reimbursed by the non-prevailing party for its reasonable attorneys&rsquo; fees and other costs and expenses incurred with the
investigation, preparation and prosecution of such Action or Proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.10 <U>Survival</U>. The
representations and warranties contained herein shall survive the Closing and the delivery of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.11 <U>Execution</U>. This
Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one and the same agreement
and shall become effective when counterparts have been signed by each party and delivered to each other party, it being understood that
the parties need not sign the same counterpart. In the event that any signature is delivered by facsimile transmission or by
e-mail delivery of a &ldquo;.pdf&rdquo; format data file, such signature shall create a valid and binding obligation of the party executing
(or on whose behalf such signature is executed) with the same force and effect as if such facsimile or &ldquo;.pdf&rdquo; signature page
were an original thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.12 <U>Severability</U>. If
any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to be invalid, illegal, void
or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full force and effect
and shall in no&nbsp;way be affected, impaired or invalidated, and the parties hereto shall use their commercially reasonable efforts
to find and employ an alternative means to achieve the same or substantially the same result as that contemplated by such term, provision,
covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would have executed the remaining
terms, provisions, covenants and restrictions without including any of such that may be hereafter declared invalid, illegal, void or unenforceable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.13 <U>Rescission
and Withdrawal Right</U>. Notwithstanding anything to the contrary contained in (and without limiting any similar provisions
of) any of the other Transaction Documents, whenever any Purchaser exercises a right, election, demand or option under a Transaction Document
and the Company does not timely perform its related obligations within the periods therein provided, then such Purchaser may rescind or
withdraw, in its sole discretion from time to time upon written notice to the Company, any relevant notice, demand or election in whole
or in part without prejudice to its future actions and rights; <U>provided</U>, <U>however</U>, that, in the case of a rescission of an
exercise of a Warrant, the applicable Purchaser shall be required to return any shares of Common Stock subject to any such rescinded exercise
notice concurrently with the return to such Purchaser of the aggregate exercise price paid to the Company for such shares and the restoration
of such Purchaser&rsquo;s right to acquire such shares pursuant to such Purchaser&rsquo;s Warrant (including, issuance of a replacement
warrant certificate evidencing such restored right).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 29; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.14 <U>Replacement
of Securities</U>. If any certificate or instrument evidencing any Securities is mutilated, lost, stolen or destroyed, the
Company shall issue or cause to be issued in exchange and substitution for and upon cancellation thereof (in the case of mutilation),
or in lieu of and substitution therefor, a new certificate or instrument, but only upon receipt of evidence reasonably satisfactory to
the Company of such loss, theft or destruction. The applicant for a new certificate or instrument under such circumstances
shall also pay any reasonable third-party costs (including customary indemnity) associated with the issuance of such replacement Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.15 <U>Remedies</U>. In
addition to being entitled to exercise all rights provided herein or granted by law, including recovery of damages, each of the Purchasers
and the Company will be entitled to specific performance under the Transaction Documents. The parties agree that monetary damages
may not be adequate compensation for any loss incurred by reason of any breach of obligations contained in the Transaction Documents and
hereby agree to waive and not to assert in any Action for specific performance of any such obligation the defense that a remedy at law
would be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.16 <U>Payment
Set Aside</U>. To the extent that the Company makes a payment or payments to any Purchaser pursuant to any Transaction Document
or a Purchaser enforces or exercises its rights thereunder, and such payment or payments or the proceeds of such enforcement or exercise
or any part thereof are subsequently invalidated, declared to be fraudulent or preferential, set aside, recovered from, disgorged by or
are required to be refunded, repaid or otherwise restored to the Company, a trustee, receiver or any other Person under any law (including,
without limitation, any bankruptcy law, state or federal law, common law or equitable cause of action), then to the extent of any such
restoration the obligation or part thereof originally intended to be satisfied shall be revived and continued in full force and effect
as if such payment had not been made or such enforcement or setoff had not occurred.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.17 <U>Independent
Nature of Purchasers&rsquo; Obligations and Rights</U>. The obligations of each Purchaser under any Transaction Document are
several and not joint with the obligations of any other Purchaser, and no&nbsp;Purchaser shall be responsible in any way for the performance
or non-performance of the obligations of any other Purchaser under any Transaction Document. Nothing contained herein or in
any other Transaction Document, and no&nbsp;action taken by any Purchaser pursuant hereto or thereto, shall be deemed to constitute the
Purchasers as a partnership, an association, a joint venture or any other kind of entity, or create a presumption that the Purchasers
are in any way acting in concert or as a group with respect to such obligations or the transactions contemplated by the Transaction Documents. Each
Purchaser shall be entitled to independently protect and enforce its rights including, without limitation, the rights arising out of this
Agreement or out of the other Transaction Documents, and it shall not be necessary for any other Purchaser to be joined as an additional
party in any Proceeding for such purpose. Each Purchaser has been represented by its own separate legal counsel in its review
and negotiation of the Transaction Documents. The Company has elected to provide all Purchasers with the same terms and Transaction
Documents for the convenience of the Company and not because it was required or requested to do so by any of the Purchasers. It is expressly
understood and agreed that each provision contained in this Agreement and in each other Transaction Document is between the Company and
a Purchaser, solely, and not between the Company and the Purchasers collectively and not between and among the Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.18 <U>Liquidated
Damages</U>.&nbsp; The Company&rsquo;s obligations to pay any partial liquidated damages or other amounts owing under the Transaction
Documents is a continuing obligation of the Company and shall not terminate until all unpaid partial liquidated damages and other amounts
have been paid notwithstanding the fact that the instrument or security pursuant to which such partial liquidated damages or other amounts
are due and payable shall have been canceled.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.19 <U>Saturdays,
Sundays, Holidays, etc.</U> If the last or appointed day for the taking of any action or the expiration of any right required or granted
herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.20 <U>Construction</U>.
The parties agree that each of them and/or their respective counsel have reviewed and had an opportunity to revise the Transaction Documents
and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved against the drafting party shall
not be employed in the interpretation of the Transaction Documents or any amendments thereto. In addition, each and every reference to
share prices and shares of Common Stock in any Transaction Document shall be subject to adjustment for reverse and forward stock splits,
stock dividends, stock combinations and other similar transactions of the Common Stock that occur after the date of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.21 <U>WAIVER
OF JURY TRIAL</U>. IN ANY ACTION, SUIT, OR PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY OTHER PARTY, THE
PARTIES EACH KNOWINGLY AND INTENTIONALLY, TO THE GREATEST EXTENT PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY, UNCONDITIONALLY, IRREVOCABLY
AND EXPRESSLY WAIVES FOREVER TRIAL BY JURY.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>(Signature Pages Follow)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>


<!-- Field: Page; Sequence: 30; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">IN WITNESS WHEREOF, the parties hereto have caused this Securities
Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated above.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PERASO Inc.</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Address for Notice:</U></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Peraso Inc.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2309 Bering Drive</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 30%">&nbsp;</TD>
    <TD STYLE="width: 20%">&nbsp;</TD>
    <TD STYLE="width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">San Jose, CA 95131</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fax:</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">With a copy to (which shall not constitute notice):</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mitchell Silberberg &amp; Knupp LLP</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">437 Madison Ave., 25th Floor,</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New York, NY 10022</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attn:Blake Baron, Esquire</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Facsimile: (917) 546-7686</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">SIGNATURE PAGE FOR PURCHASER FOLLOWS]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 31; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[PURCHASER SIGNATURE PAGES TO</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">PERASO INC. SECURITIES PURCHASE AGREEMENT]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the undersigned
have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated
above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Purchaser: ________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Signature of Authorized Signatory of Purchaser</I>:
__________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Authorized Signatory: ____________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Title of Authorized Signatory: _____________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Email Address of Authorized Signatory: ______________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Address for Notice to Purchaser:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Address for Delivery of Securities to Purchaser (if not same as address
for notice):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Subscription Amount: $_________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Shares: _________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Pre-Funded Warrant Shares: ______________  </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Purchase Warrant Shares: ______________  </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Beneficial Ownership Blocker &#9744; 4.99% or &#9744; 9.99%</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">EIN Number: _______________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[SIGNATURE PAGES CONTINUE]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 32 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><U>FORM OF LOCK-UP AGREEMENT</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>7
<FILENAME>ea179675ex10-2_peraso.htm
<DESCRIPTION>FORM OF REGISTRATION RIGHTS AGREEMENT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin: 0pt 0"><B>Exhibit 10.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">EXHIBIT B</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">REGISTRATION RIGHTS AGREEMENT</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">This Registration Rights Agreement
(this &ldquo;<U>Agreement</U>&rdquo;) is made and entered into as of June 2, 2022, between Peraso Inc., a Delaware corporation (the
&ldquo;<U>Company</U>&rdquo;), and each of the several purchasers signatory hereto (each such purchaser, a &ldquo;Purchaser&rdquo; and,
collectively, the &ldquo;Purchasers&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">This Agreement is made pursuant
to the Securities Purchase Agreement, dated as of May 31, 2023, between the Company and each Purchaser (the &ldquo;<U>Purchase Agreement</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">The Company and each Purchaser
hereby agrees as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">1.</TD><TD STYLE="text-align: justify"><U>Definitions</U>.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><B>Capitalized terms used
and not otherwise defined herein that are defined in the Purchase Agreement shall have the meanings given such terms in the Purchase Agreement.</B>
As used in this Agreement, the following terms shall have the following meanings:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Advice</U>&rdquo;
shall have the meaning set forth in Section 6(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Effectiveness
Date</U>&rdquo; means, with respect to the Initial Registration Statement required to be filed hereunder, the 30<SUP>th</SUP> calendar
day following the date hereof (or, in the event of a substantive review by the Commission or the ongoing review of the SEC Reports, the
5<SUP>th</SUP> Trading Day following the later of: (i) the date the Company is notified by the Commission that the Initial Registration
Statement will not be reviewed and (ii) the Initial Registration Statement and the SEC Reports are no longer subject to further review
and comments) and with respect to any additional Registration Statements which may be required pursuant to Section 2(c) or Section 3(c),
the 45<SUP>th</SUP> calendar day following the date on which an additional Registration Statement is required to be filed hereunder (or,
in the event of a &ldquo;full review&rdquo; by the Commission, the 90<SUP>th</SUP> calendar day following the date such additional Registration
Statement is required to be filed hereunder); <U>provided</U>, <U>however</U>, that in the event the Company is notified by the Commission
that one or more of the above Registration Statements will not be reviewed or is no longer subject to further review and comments, the
Effectiveness Date as to such Registration Statement shall be the fifth Trading Day following the date on which the Company is so notified
if such date precedes the dates otherwise required above, provided, further, if such Effectiveness Date falls on a day that is not a Trading
Day, then the Effectiveness Date shall be the next succeeding Trading Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Effectiveness
Period</U>&rdquo; shall have the meaning set forth in Section 2(a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Event</U>&rdquo;
shall have the meaning set forth in Section 2(d).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Event
Date</U>&rdquo; shall have the meaning set forth in Section 2(d).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Filing
Date</U>&rdquo; means, with respect to the Initial Registration Statement required hereunder, the 15<SUP>th</SUP> calendar day following
the date hereof and, with respect to any additional Registration Statements which may be required pursuant to Section 2(c) or Section
3(c), the earliest practical date on which the Company is permitted by SEC Guidance to file such additional Registration Statement related
to the Registrable Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Holder</U>&rdquo;
or &ldquo;<U>Holders</U>&rdquo; means the holder or holders, as the case may be, from time to time of Registrable Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Indemnified
Party</U>&rdquo; shall have the meaning set forth in Section 5(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Indemnifying
Party</U>&rdquo; shall have the meaning set forth in Section 5(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Initial
Registration Statement</U>&rdquo; means the initial Registration Statement filed pursuant to this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Losses</U>&rdquo;
shall have the meaning set forth in Section 5(a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Plan of
Distribution</U>&rdquo; shall have the meaning set forth in Section 2(a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Prospectus</U>&rdquo;
means the prospectus included in a Registration Statement (including, without limitation, a prospectus that includes any information previously
omitted from a prospectus filed as part of an effective registration statement in reliance upon Rule 430A promulgated by the Commission
pursuant to the Securities Act), as amended or supplemented by any prospectus supplement, with respect to the terms of the offering of
any portion of the Registrable Securities covered by a Registration Statement, and all other amendments and supplements to the Prospectus,
including post-effective amendments, and all material incorporated by reference or deemed to be incorporated by reference in such Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Registrable
Securities</U>&rdquo; means, as of any date of determination, (a) all Warrant Shares then issued and issuable upon exercise of the Purchase
Warrants (assuming on such date the Purchase Warrants are exercised in full without regard to any exercise limitations therein), and (b)
any securities issued or then issuable upon any stock split, dividend or other distribution, recapitalization or similar event with respect
to the foregoing; <U>provided, however</U>, that any such Registrable Securities shall cease to be Registrable Securities (and the Company
shall not be required to maintain the effectiveness of any, or file another, Registration Statement hereunder with respect thereto) for
so long as (a) a Registration Statement with respect to the sale of such Registrable Securities is declared effective by the Commission
under the Securities Act and such Registrable Securities have been disposed of by the Holder in accordance with such effective Registration
Statement, (b) such Registrable Securities have been previously sold in accordance with Rule 144, or (c) such securities become eligible
for resale without volume or manner-of-sale restrictions and without current public information pursuant to Rule 144 as set forth in a
written opinion letter to such effect, addressed, delivered and acceptable to the Transfer Agent and the affected Holders (assuming that
such securities and any securities issuable upon exercise, conversion or exchange of which, or as a dividend upon which, such securities
were issued or are issuable, were at no time held by any Affiliate of the Company, and all Purchase Warrants are exercised by &ldquo;cashless
exercise&rdquo; as provided in Section 2(c) of each of the Purchase Warrants), as reasonably determined by the Company, upon the advice
of counsel to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Registration
Statement</U>&rdquo; means any registration statement required to be filed hereunder pursuant to Section 2(a) and any additional registration
statements contemplated by Section 2(c) or Section 3(c), including (in each case) the Prospectus, amendments and supplements to any such
registration statement or Prospectus, including pre- and post-effective amendments, all exhibits thereto, and all material incorporated
by reference or deemed to be incorporated by reference in any such registration statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Rule 415</U>&rdquo;
means Rule 415 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time,
or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Rule 424</U>&rdquo;
means Rule 424 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time,
or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Selling
Stockholder Questionnaire</U>&rdquo; shall have the meaning set forth in Section 3(a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>SEC Guidance</U>&rdquo;
means (i) any publicly-available written or oral guidance of the Commission staff, or any comments, requirements or requests of the Commission
staff and (ii) the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">2.</TD><TD STYLE="text-align: justify"><U>Shelf Registration</U>.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left">(a)</TD><TD STYLE="text-align: justify">On or prior to each Filing Date, the Company shall prepare
and file with the Commission a Registration Statement covering the resale of all of the Registrable Securities that are not then registered
on an effective Registration Statement for an offering to be made on a continuous basis pursuant to Rule 415. Each Registration Statement
filed hereunder shall be on Form S-1, or Form S-3 if the Company is eligible to use Form S-3 without regard to the limitation provided
for in Instruction I.B.6. and shall contain (unless otherwise directed by at least 85% in interest of the Holders) substantially the
&ldquo;<U>Plan of Distribution</U>&rdquo; attached hereto as <U>Annex A</U> and substantially the &ldquo;<U>Selling Stockholder</U>&rdquo;
section attached hereto as <U>Annex B</U>; <U>provided</U>, <U>however</U>, that no Holder shall be required to be named as an &ldquo;underwriter&rdquo;
without such Holder&rsquo;s express prior written consent. Subject to the terms of this Agreement, the Company shall use its best efforts
to cause a Registration Statement filed under this Agreement (including, without limitation, under Section 3(c)) to be declared effective
under the Securities Act as promptly as possible after the filing thereof, but in any event no later than the applicable Effectiveness
Date, and shall use its best efforts to keep such Registration Statement continuously effective under the Securities Act until the date
that all Registrable Securities covered by such Registration Statement (i) have been sold, thereunder or pursuant to Rule 144, or (ii)
may be sold without volume or manner-of-sale restrictions pursuant to Rule 144 and without the requirement for the Company to be in compliance
with the current public information requirement under Rule 144, as determined by the counsel to the Company pursuant to a written opinion
letter to such effect, addressed and acceptable to the Transfer Agent and the affected Holders (the &ldquo;<U>Effectiveness Period</U>&rdquo;).
The Company shall telephonically request effectiveness of a Registration Statement as of 5:00 p.m. (New York City time) on a Trading
Day. The Company shall immediately notify the Holders via facsimile or by e-mail of the effectiveness of a Registration Statement on
the same Trading Day that the Company telephonically confirms effectiveness with the Commission, which shall be the date requested for
effectiveness of such Registration Statement. The Company shall, by 9:30 a.m. (New York City time) on the Trading Day after the effective
date of such Registration Statement, file a final Prospectus with the Commission as required by Rule 424. Failure to so notify the Holder
within one (1) Trading Day of such notification of effectiveness or failure to file a final Prospectus as foresaid shall be deemed an
Event under Section 2(d).</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left">(b)</TD><TD STYLE="text-align: justify">Notwithstanding the registration obligations set forth in
Section 2(a), if the Commission informs the Company that all of the Registrable Securities cannot, as a result of the application of
Rule 415, be registered for resale as a secondary offering on a single registration statement, the Company agrees to promptly inform
each of the Holders thereof and use its commercially reasonable efforts to file amendments to the Initial Registration Statement as required
by the Commission, covering the maximum number of Registrable Securities permitted to be registered by the Commission, on Form S-3 or
such other form available to register for resale the Registrable Securities as a secondary offering, subject to the provisions of Section
2(e); with respect to filing on Form S-3 or other appropriate form, and subject to the provisions of Section 2(d) with respect to the
payment of liquidated damages; <U>provided</U>, <U>however</U>, that prior to filing such amendment, the Company shall be obligated to
use diligent efforts to advocate with the Commission for the registration of all of the Registrable Securities in accordance with the
SEC Guidance, including without limitation, Compliance and Disclosure Interpretation 612.09.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left">(c)</TD><TD STYLE="text-align: justify">Notwithstanding any other provision of this Agreement and
subject to the payment of liquidated damages pursuant to Section 2(d), if the Commission or any SEC Guidance sets forth a limitation
on the number of Registrable Securities permitted to be registered on a particular Registration Statement as a secondary offering (and
notwithstanding that the Company used diligent efforts to advocate with the Commission for the registration of all or a greater portion
of Registrable Securities), unless otherwise directed in writing by a Holder as to its Registrable Securities, the number of Registrable
Securities to be registered on such Registration Statement will be reduced as follows:</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in; text-align: left">a.</TD><TD STYLE="text-align: justify">First, the Company shall reduce or eliminate any securities
to be included other than Registrable Securities; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in; text-align: left">b.</TD><TD STYLE="text-align: justify">Second, the Company shall reduce Registrable Securities represented
by Warrant Shares (applied, in the case that some Warrant Shares may be registered, to the Holders on a pro rata basis based on the total
number of unregistered Warrant Shares held by such Holders).</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">In the event of a cutback hereunder,
the Company shall give the Holder at least five (5) Trading Days prior written notice along with the calculations as to such Holder&rsquo;s
allotment. In the event the Company amends the Initial Registration Statement in accordance with the foregoing, the Company will use its
best efforts to file with the Commission, as promptly as allowed by Commission or SEC Guidance provided to the Company or to registrants
of securities in general, one or more registration statements on Form S-3 or such other form available to register for resale those Registrable
Securities that were not registered for resale on the Initial Registration Statement, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left">(d)</TD><TD STYLE="text-align: justify">If: (i) the Initial Registration Statement is not filed on
or prior to its Filing Date (if the Company files the Initial Registration Statement without affording the Holders the opportunity to
review and comment on the same as required by Section 3(a) herein, the Company shall be deemed to have not satisfied this clause (i)),
or (ii) the Company fails to file with the Commission a request for acceleration of a Registration Statement in accordance with Rule
461 promulgated by the Commission pursuant to the Securities Act, within five Trading Days of the date that the Company is notified (orally
or in writing, whichever is earlier) by the Commission that such Registration Statement will not be &ldquo;reviewed&rdquo; or will not
be subject to further review, or (iii) prior to the effective date of a Registration Statement, the Company fails to file a pre-effective
amendment and otherwise respond in writing to comments made by the Commission in respect of such Registration Statement within ten (10)
calendar days after the receipt of comments by or notice from the Commission that such amendment is required in order for such Registration
Statement to be declared effective, or (iv) a Registration Statement registering for resale all of the Registrable Securities is not
declared effective by the Commission by the Effectiveness Date of the Initial Registration Statement, or (v) after the effective date
of a Registration Statement, such Registration Statement ceases for any reason to remain continuously effective as to all Registrable
Securities included in such Registration Statement, or the Holders are otherwise not permitted to utilize the Prospectus therein to resell
such Registrable Securities, for more than ten (10) consecutive calendar days or more than an aggregate of fifteen (15) calendar days
(which need not be consecutive calendar days) during any 12-month period (any such failure or breach being referred to as an &ldquo;<U>Event</U>&rdquo;,
and for purposes of clauses (i) and (iv), the date on which such Event occurs, and for purpose of clause (ii) the date on which such
five (5) Trading Day period is exceeded, and for purpose of clause (iii) the date which such ten (10) calendar day period is exceeded,
and for purpose of clause (v) the date on which such ten (10) or fifteen (15) calendar day period, as applicable, is exceeded being referred
to as &ldquo;<U>Event Date</U>&rdquo;), then, in addition to any other rights the Holders may have hereunder or under applicable law,
on each such Event Date and on each monthly anniversary of each such Event Date (if the applicable Event shall not have been cured by
such date) until the applicable Event is cured, the Company shall pay to each Holder an amount in cash, as partial liquidated damages
and not as a penalty, equal to the product of 2.0% multiplied by the aggregate Subscription Amount paid by such Holder pursuant to the
Purchase Agreement. The parties agree that the maximum aggregate liquidated damages payable to a Holder under this Agreement shall be
8% of the aggregate Subscription Amount paid by such Holder pursuant to the Purchase Agreement. If the Company fails to pay any partial
liquidated damages pursuant to this Section in full within seven days after the date payable, the Company will pay interest thereon at
a rate of 12% per annum (or such lesser maximum amount that is permitted to be paid by applicable law) to the Holder, accruing daily
from the date such partial liquidated damages are due until such amounts, plus all such interest thereon, are paid in full. The partial
liquidated damages pursuant to the terms hereof shall apply on a daily pro rata basis for any portion of a month prior to the cure of
an Event.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left">(e)</TD><TD STYLE="text-align: justify">If Form S-3 is not available for the registration of the
resale of Registrable Securities hereunder, the Company shall (i) register the resale of the Registrable Securities on another appropriate
form and (ii) undertake to register the Registrable Securities on Form S-3 as soon as such form is available, provided that the Company
shall maintain the effectiveness of the Registration Statement then in effect until such time as a Registration Statement on Form S-3
covering the Registrable Securities has been declared effective by the Commission.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left">(f)</TD><TD STYLE="text-align: justify">Notwithstanding anything to the contrary contained herein,
in no event shall the Company be permitted to name any Holder or affiliate of a Holder as any Underwriter without the prior written consent
of such Holder.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">3.</TD><TD STYLE="text-align: justify"><U>Registration Procedures</U>.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">In connection with the Company&rsquo;s
registration obligations hereunder, the Company shall:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Not less than five (5) Trading Days prior to the filing of each Registration Statement and not less than three (3) Trading Days
prior to the filing of any related Prospectus or any amendment or supplement thereto (including any document that would be incorporated
or deemed to be incorporated therein by reference), the Company shall (i) furnish to each Holder copies of all such documents proposed
to be filed, which documents (other than those incorporated or deemed to be incorporated by reference) will be subject to the review of
such Holders, and (ii) cause its officers and directors, counsel and independent registered public accountants to respond to such inquiries
as shall be necessary, in the reasonable opinion of respective counsel to each Holder, to conduct a reasonable investigation within the
meaning of the Securities Act. The Company shall not file a Registration Statement or any such Prospectus or any amendments or supplements
thereto to which the Holders of a majority of the Registrable Securities shall reasonably object in good faith, provided that, the Company
is notified of such objection in writing no later than five (5) Trading Days after the Holders have been so furnished copies of a Registration
Statement or one (1) Trading Day after the Holders have been so furnished copies of any related Prospectus or amendments or supplements
thereto. Each Holder agrees to furnish to the Company a completed questionnaire in the form attached to this Agreement as <U>Annex B</U>
(a &ldquo;<U>Selling Stockholder Questionnaire</U>&rdquo;) on a date that is not less than two (2) Trading Days prior to the Filing Date
or by the end of the fourth (4<SUP>th</SUP>) Trading Day following the date on which such Holder receives draft materials in accordance
with this Section.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>(i) Prepare and file with the Commission such amendments, including post-effective amendments, to a Registration Statement and
the Prospectus used in connection therewith as may be necessary to keep a Registration Statement continuously effective as to the applicable
Registrable Securities for the Effectiveness Period and prepare and file with the Commission such additional Registration Statements in
order to register for resale under the Securities Act all of the Registrable Securities, (ii) cause the related Prospectus to be amended
or supplemented by any required Prospectus supplement (subject to the terms of this Agreement), and, as so supplemented or amended, to
be filed pursuant to Rule 424, (iii) respond as promptly as reasonably possible to any comments received from the Commission with respect
to a Registration Statement or any amendment thereto and provide as promptly as reasonably possible to the Holders true and complete copies
of all correspondence from and to the Commission relating to a Registration Statement (provided that, the Company shall excise any information
contained therein which would constitute material non-public information regarding the Company or any of its Subsidiaries), and (iv) comply
in all material respects with the applicable provisions of the Securities Act and the Exchange Act with respect to the disposition of
all Registrable Securities covered by a Registration Statement during the applicable period in accordance (subject to the terms of this
Agreement) with the intended methods of disposition by the Holders thereof set forth in such Registration Statement as so amended or in
such Prospectus as so supplemented.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>If during the Effectiveness Period, the number of Registrable Securities at any time exceeds 100% of the number of shares of Common
Stock then registered in a Registration Statement, then the Company shall file as soon as reasonably practicable, but in any case prior
to the applicable Filing Date, an additional Registration Statement covering the resale by the Holders of not less than the number of
such Registrable Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Notify the Holders of Registrable Securities to be sold (which notice shall, pursuant to clauses (iii) through (vi) hereof, be
accompanied by an instruction to suspend the use of the Prospectus until the requisite changes have been made) as promptly as reasonably
possible (and, in the case of (i)(A) below, not less than one (1) Trading Day prior to such filing) and (if requested by any such Person)
confirm such notice in writing no later than one (1) Trading Day following the day (i)(A) when a Prospectus or any Prospectus supplement
or post-effective amendment to a Registration Statement is proposed to be filed, (B) when the Commission notifies the Company whether
there will be a &ldquo;review&rdquo; of such Registration Statement and whenever the Commission comments in writing on such Registration
Statement, and (C) with respect to a Registration Statement or any post-effective amendment, when the same has become effective, (ii)
of any request by the Commission or any other federal or state governmental authority for amendments or supplements to a Registration
Statement or Prospectus or for additional information, (iii) of the issuance by the Commission or any other federal or state governmental
authority of any stop order suspending the effectiveness of a Registration Statement covering any or all of the Registrable Securities
or the initiation of any Proceedings for that purpose, (iv) of the receipt by the Company of any notification with respect to the suspension
of the qualification or exemption from qualification of any of the Registrable Securities for sale in any jurisdiction, or the initiation
or threatening of any Proceeding for such purpose, (v) of the occurrence of any event or passage of time that makes the financial statements
included in a Registration Statement ineligible for inclusion therein or any statement made in a Registration Statement or Prospectus
or any document incorporated or deemed to be incorporated therein by reference untrue in any material respect or that requires any revisions
to a Registration Statement, Prospectus or other documents so that, in the case of a Registration Statement or the Prospectus, as the
case may be, it will not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein
or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading, and (vi) of the
occurrence or existence of any pending corporate development with respect to the Company that the Company believes may be material and
that, in the determination of the Company, makes it not in the best interest of the Company to allow continued availability of a Registration
Statement or Prospectus; <U>provided</U>, <U>however</U>, that in no event shall any such notice contain any information which would constitute
material, non-public information regarding the Company or any of its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Use its best efforts to avoid the issuance of, or, if issued, obtain the withdrawal of (i) any order stopping or suspending the
effectiveness of a Registration Statement, or (ii) any suspension of the qualification (or exemption from qualification) of any of the
Registrable Securities for sale in any jurisdiction, at the earliest practicable moment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(f) <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furnish
to each Holder, without charge, at least one conformed copy of each such Registration Statement and each amendment thereto,
including financial statements and schedules, all documents incorporated or deemed to be incorporated therein by reference to the
extent requested by such Person, and all exhibits to the extent requested by such Person (including those previously furnished or
incorporated by reference) promptly after the filing of such documents with the Commission, provided that any such item which is
available on the EDGAR system (or successor thereto) need not be furnished in physical form.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(g)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Subject to the terms of this Agreement, the Company hereby consents to the use of such Prospectus and each amendment or supplement
thereto by each of the selling Holders in connection with the offering and sale of the Registrable Securities covered by such Prospectus
and any amendment or supplement thereto, except after the giving of any notice pursuant to Section 3(d).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(h)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT> Prior to any resale of Registrable Securities by a Holder, use its commercially reasonable efforts to register or qualify or cooperate
with the selling Holders in connection with the registration or qualification (or exemption from the Registration or qualification) of
such Registrable Securities for the resale by the Holder under the securities or Blue Sky laws of such jurisdictions within the United
States as any Holder reasonably requests in writing, to keep each registration or qualification (or exemption therefrom) effective during
the Effectiveness Period and to do any and all other acts or things reasonably necessary to enable the disposition in such jurisdictions
of the Registrable Securities covered by each Registration Statement, provided that the Company shall not be required to qualify generally
to do business in any jurisdiction where it is not then so qualified, subject the Company to any material tax in any such jurisdiction
where it is not then so subject or file a general consent to service of process in any such jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(i) If
requested by a Holder, cooperate with such Holder to facilitate the timely preparation and delivery of certificates representing
Registrable Securities to be delivered to a transferee pursuant to a Registration Statement, which certificates shall be free, to
the extent permitted by the Purchase Agreement, of all restrictive legends, and to enable such Registrable Securities to be in such
denominations and registered in such names as any such Holder may request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(j) Upon the occurrence
of any event contemplated by Section 3(d), as promptly as reasonably possible under the circumstances taking into account the Company&rsquo;s
good faith assessment of any adverse consequences to the Company and its stockholders of the premature disclosure of such event, prepare
a supplement or amendment, including a post-effective amendment, to a Registration Statement or a supplement to the related Prospectus
or any document incorporated or deemed to be incorporated therein by reference, and file any other required document so that, as thereafter
delivered, neither a Registration Statement nor such Prospectus will contain an untrue statement of a material fact or omit to state
a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which
they were made, not misleading. If the Company notifies the Holders in accordance with clauses (iii) through (vi) of Section 3(d) above
to suspend the use of any Prospectus until the requisite changes to such Prospectus have been made, then the Holders shall suspend use
of such Prospectus. The Company will use its best efforts to ensure that the use of the Prospectus may be resumed as promptly as is practicable.
The Company shall be entitled to exercise its right under this Section 3(j) to suspend the availability of a Registration Statement and
Prospectus, subject to the payment of partial liquidated damages otherwise required pursuant to Section 2(d), for a period not to exceed
60 calendar days (which need not be consecutive days) in any 12-month period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(k)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Otherwise use commercially reasonable efforts to comply with all applicable rules and regulations of the Commission under the Securities
Act and the Exchange Act, including, without limitation, Rule 172 under the Securities Act, file any final Prospectus, including any supplement
or amendment thereof, with the Commission pursuant to Rule 424 under the Securities Act, promptly inform the Holders in writing if, at
any time during the Effectiveness Period, the Company does not satisfy the conditions specified in Rule 172 and, as a result thereof,
the Holders are required to deliver a Prospectus in connection with any disposition of Registrable Securities and take such other actions
as may be reasonably necessary to facilitate the registration of the Registrable Securities hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(l) The
Company shall use its best efforts to maintain eligibility for use of Form S-3 (or any successor form thereto) for the registration
of the resale of Registrable Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(m) The
Company may require each selling Holder to furnish to the Company a certified statement as to the number of shares of Common Stock
beneficially owned by such Holder and, if required by the Commission, the natural persons thereof that have voting and dispositive
control over the shares. During any periods that the Company is unable to meet its obligations hereunder with respect to the
registration of the Registrable Securities solely because any Holder fails to furnish such information within three Trading Days of
the Company&rsquo;s request, any liquidated damages that are accruing at such time as to such Holder only shall be tolled and any
Event that may otherwise occur solely because of such delay shall be suspended as to such Holder only, until such information is
delivered to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt 0; text-align: justify">4.  <U>Registration
Expenses</U>. All fees and expenses incident to the performance of or compliance with, this Agreement by the Company shall be borne by
the Company whether or not any Registrable Securities are sold pursuant to a Registration Statement. The fees and expenses referred to
in the foregoing sentence shall include, without limitation, (i) all registration and filing fees (including, without limitation, fees
and expenses of the Company&rsquo;s counsel and independent registered public accountants) (A) with respect to filings made with the Commission,
(B) with respect to filings required to be made with any Trading Market on which the Common Stock is then listed for trading, and (C)
in compliance with applicable state securities or Blue Sky laws reasonably agreed to by the Company in writing (including, without limitation,
fees and disbursements of counsel for the Company in connection with Blue Sky qualifications or exemptions of the Registrable Securities),
(ii) printing expenses (including, without limitation, expenses of printing certificates for Registrable Securities), (iii) messenger,
telephone and delivery expenses, (iv) fees and disbursements of counsel for the Company, (v) Securities Act liability insurance, if the
Company so desires such insurance, and (vi) fees and expenses of all other Persons retained by the Company in connection with the consummation
of the transactions contemplated by this Agreement. In addition, the Company shall be responsible for all of its internal expenses incurred
in connection with the consummation of the transactions contemplated by this Agreement (including, without limitation, all salaries and
expenses of its officers and employees performing legal or accounting duties), the expense of any annual audit and the fees and expenses
incurred in connection with the listing of the Registrable Securities on any securities exchange as required hereunder. In no event shall
the Company be responsible for any broker or similar commissions of any Holder or, except to the extent provided for in the Transaction
Documents, any legal fees or other costs of the Holders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">5.</TD><TD STYLE="text-align: justify"><U>Indemnification</U>.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Indemnification by the Company</U>. The Company shall, notwithstanding any termination of this Agreement, indemnify and hold
harmless each Holder, the officers, directors, members, partners, agents, brokers (including brokers who offer and sell Registrable Securities
as principal as a result of a pledge or any failure to perform under a margin call of Common Stock), investment advisors and employees
(and any other Persons with a functionally equivalent role of a Person holding such titles, notwithstanding a lack of such title or any
other title) of each of them, each Person who controls any such Holder (within the meaning of Section 15 of the Securities Act or Section
20 of the Exchange Act) and the officers, directors, members, stockholders, partners, agents and employees (and any other Persons with
a functionally equivalent role of a Person holding such titles, notwithstanding a lack of such title or any other title) of each such
controlling Person, to the fullest extent permitted by applicable law, from and against any and all losses, claims, damages, liabilities,
costs (including, without limitation, reasonable attorneys&rsquo; fees) and expenses (collectively, &ldquo;<U>Losses</U>&rdquo;), as incurred,
arising out of or relating to (1) any untrue or alleged untrue statement of a material fact contained in a Registration Statement, any
Prospectus or any form of prospectus or in any amendment or supplement thereto or in any preliminary prospectus, or arising out of or
relating to any omission or alleged omission of a material fact required to be stated therein or necessary to make the statements therein
(in the case of any Prospectus or supplement thereto, in light of the circumstances under which they were made) not misleading or (2)
any violation or alleged violation by the Company of the Securities Act, the Exchange Act or any state securities law, or any rule or
regulation thereunder, in connection with the performance of its obligations under this Agreement, except to the extent, but only to the
extent, that (i) such untrue statements or omissions are based solely upon information regarding such Holder furnished in writing to the
Company by such Holder expressly for use therein, or to the extent that such information relates to such Holder or such Holder&rsquo;s
proposed method of distribution of Registrable Securities and was reviewed and expressly approved in writing by such Holder expressly
for use in a Registration Statement, such Prospectus or in any amendment or supplement thereto (it being understood that the Holder has
approved Annex A hereto for this purpose) or (ii) in the case of an occurrence of an event of the type specified in Section 3(d)(iii)-(vi),
the use by such Holder of an outdated, defective or otherwise unavailable Prospectus after the Company has notified such Holder in writing
that the Prospectus is outdated, defective or otherwise unavailable for use by such Holder and prior to the receipt by such Holder of
the Advice contemplated in Section 6(c). The Company shall notify the Holders promptly of the institution, threat or assertion of any
Proceeding arising from or in connection with the transactions contemplated by this Agreement of which the Company is aware. Such indemnity
shall remain in full force and effect regardless of any investigation made by or on behalf of such indemnified person and shall survive
the transfer of any Registrable Securities by any of the Holders in accordance with Section 6(f).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Indemnification by Holders</U>. Each Holder shall, severally and not jointly, indemnify and hold harmless the Company, its directors,
officers, agents and employees, each Person who controls the Company (within the meaning of Section 15 of the Securities Act and Section
20 of the Exchange Act), and the directors, officers, agents or employees of such controlling Persons, to the fullest extent permitted
by applicable law, from and against all Losses, as incurred, to the extent arising out of or based solely upon: any untrue or alleged
untrue statement of a material fact contained in any Registration Statement, any Prospectus, or in any amendment or supplement thereto
or in any preliminary prospectus, or arising out of or relating to any omission or alleged omission of a material fact required to be
stated therein or necessary to make the statements therein (in the case of any Prospectus or supplement thereto, in light of the circumstances
under which they were made) not misleading (i) to the extent, but only to the extent, that such untrue statement or omission is contained
in any information so furnished in writing by such Holder to the Company expressly for inclusion in such Registration Statement or such
Prospectus or (ii) to the extent, but only to the extent, that such information relates to such Holder&rsquo;s information provided in
the Selling Stockholder Questionnaire or the proposed method of distribution of Registrable Securities and was reviewed and expressly
approved in writing by such Holder expressly for use in a Registration Statement (it being understood that the Holder has approved Annex
A hereto for this purpose), such Prospectus or in any amendment or supplement thereto. In no event shall the liability of a selling Holder
be greater in amount than the dollar amount of the proceeds (net of all expenses paid by such Holder in connection with any claim relating
to this Section 5 and the amount of any damages such Holder has otherwise been required to pay by reason of such untrue statement or omission)
received by such Holder upon the sale of the Registrable Securities included in the Registration Statement giving rise to such indemnification
obligation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Conduct of Indemnification Proceedings</U>. If any Proceeding shall be brought or asserted against any Person entitled to indemnity
hereunder (an &ldquo;<U>Indemnified Party</U>&rdquo;), such Indemnified Party shall promptly notify the Person from whom indemnity is
sought (the &ldquo;<U>Indemnifying Party</U>&rdquo;) in writing, and the Indemnifying Party shall have the right to assume the defense
thereof, including the employment of counsel reasonably satisfactory to the Indemnified Party and the payment of all fees and expenses
incurred in connection with defense thereof, provided that the failure of any Indemnified Party to give such notice shall not relieve
the Indemnifying Party of its obligations or liabilities pursuant to this Agreement, except (and only) to the extent that it shall be
finally determined by a court of competent jurisdiction (which determination is not subject to appeal or further review) that such failure
shall have materially and adversely prejudiced the Indemnifying Party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">An Indemnified
Party shall have the right to employ separate counsel in any such Proceeding and to participate in the defense thereof, but the fees and
expenses of such counsel shall be at the expense of such Indemnified Party or Parties unless: (1) the Indemnifying Party has agreed in
writing to pay such fees and expenses, (2) the Indemnifying Party shall have failed promptly to assume the defense of such Proceeding
and to employ counsel reasonably satisfactory to such Indemnified Party in any such Proceeding, or (3) the named parties to any such Proceeding
(including any impleaded parties) include both such Indemnified Party and the Indemnifying Party, and counsel to the Indemnified Party
shall reasonably believe that a material conflict of interest is likely to exist if the same counsel were to represent such Indemnified
Party and the Indemnifying Party (in which case, if such Indemnified Party notifies the Indemnifying Party in writing that it elects to
employ separate counsel at the expense of the Indemnifying Party, the Indemnifying Party shall not have the right to assume the defense
thereof and the reasonable fees and expenses of no more than one separate counsel shall be at the expense of the Indemnifying Party).
The Indemnifying Party shall not be liable for any settlement of any such Proceeding effected without its written consent, which consent
shall not be unreasonably withheld or delayed. No Indemnifying Party shall, without the prior written consent of the Indemnified Party,
effect any settlement of any pending Proceeding in respect of which any Indemnified Party is a party, unless such settlement includes
an unconditional release of such Indemnified Party from all liability on claims that are the subject matter of such Proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">Subject to the
terms of this Agreement, all reasonable fees and expenses of the Indemnified Party (including reasonable fees and expenses to the extent
incurred in connection with investigating or preparing to defend such Proceeding in a manner not inconsistent with this Section) shall
be paid to the Indemnified Party, as incurred, within ten Trading Days of written notice thereof to the Indemnifying Party, provided that
the Indemnified Party shall promptly reimburse the Indemnifying Party for that portion of such fees and expenses applicable to such actions
for which such Indemnified Party is finally determined by a court of competent jurisdiction (which determination is not subject to appeal
or further review) not to be entitled to indemnification hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Contribution</U>. If the indemnification under Section 5(a) or 5(b) is unavailable to an Indemnified Party or insufficient to
hold an Indemnified Party harmless for any Losses, then each Indemnifying Party shall contribute to the amount paid or payable by such
Indemnified Party, in such proportion as is appropriate to reflect the relative fault of the Indemnifying Party and Indemnified Party
in connection with the actions, statements or omissions that resulted in such Losses as well as any other relevant equitable considerations.
The relative fault of such Indemnifying Party and Indemnified Party shall be determined by reference to, among other things, whether any
action in question, including any untrue or alleged untrue statement of a material fact or omission or alleged omission of a material
fact, has been taken or made by, or relates to information supplied by, such Indemnifying Party or Indemnified Party, and the parties&rsquo;
relative intent, knowledge, access to information and opportunity to correct or prevent such action, statement or omission. The amount
paid or payable by a party as a result of any Losses shall be deemed to include, subject to the limitations set forth in this Agreement,
any reasonable attorneys&rsquo; or other fees or expenses incurred by such party in connection with any Proceeding to the extent such
party would have been indemnified for such fees or expenses if the indemnification provided for in this Section was available to such
party in accordance with its terms.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">The parties hereto
agree that it would not be just and equitable if contribution pursuant to this Section 5(d) were determined by pro rata allocation or
by any other method of allocation that does not take into account the equitable considerations referred to in the immediately preceding
paragraph. In no event shall the contribution obligation of a Holder of Registrable Securities be greater in amount than the dollar amount
of the proceeds (net of all expenses paid by such Holder in connection with any claim relating to this Section 5 and the amount of any
damages such Holder has otherwise been required to pay by reason of such untrue or alleged untrue statement or omission or alleged omission)
received by it upon the sale of the Registrable Securities giving rise to such contribution obligation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">The indemnity and
contribution agreements contained in this Section are in addition to any liability that the Indemnifying Parties may have to the Indemnified
Parties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">6.</TD><TD STYLE="text-align: justify"><U>Miscellaneous</U>.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Remedies</U>. In the event of a breach by the Company or by a Holder of any of their respective obligations under this Agreement,
each Holder or the Company, as the case may be, in addition to being entitled to exercise all rights granted by law and under this Agreement,
including recovery of damages, shall be entitled to specific performance of its rights under this Agreement. Each of the Company and each
Holder agrees that monetary damages would not provide adequate compensation for any losses incurred by reason of a breach by it of any
of the provisions of this Agreement and hereby further agrees that, in the event of any action for specific performance in respect of
such breach, it shall not assert or shall waive the defense that a remedy at law would be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>No Piggyback on Registrations; Prohibition on Filing Other Registration Statements</U>. Except as set forth on <U>Schedule 3.1(w)</U>
attached to the Purchase Agreement, neither the Company nor any of its security holders (other than the Holders in such capacity pursuant
hereto) may include securities of the Company in any Registration Statements other than the Registrable Securities. The Company shall
not file any other registration statements until all Registrable Securities are registered pursuant to a Registration Statement that is
declared effective by the Commission, provided that this Section 6(b) shall not prohibit the Company from filing amendments to registration
statements filed prior to the date of this Agreement so long as no new securities are registered on any such existing registration statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Discontinued Disposition</U>. By its acquisition of Registrable Securities, each Holder agrees that, upon receipt of a notice
from the Company of the occurrence of any event of the kind described in Section 3(d)(iii) through (vi), such Holder will forthwith discontinue
disposition of such Registrable Securities under a Registration Statement until it is advised in writing (the &ldquo;<U>Advice</U>&rdquo;)
by the Company that the use of the applicable Prospectus (as it may have been supplemented or amended) may be resumed. The Company will
use its best efforts to ensure that the use of the Prospectus may be resumed as promptly as is practicable. The Company agrees and acknowledges
that any periods during which the Holder is required to discontinue the disposition of the Registrable Securities hereunder shall be subject
to the provisions of Section 2(d).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Amendments and Waivers</U>. The provisions of this Agreement, including the provisions of this sentence, may not be amended,
modified or supplemented, and waivers or consents to departures from the provisions hereof may not be given, unless the same shall be
in writing and signed by the Company and the Holders of 50.1% or more of the then outstanding Registrable Securities (for purposes of
clarification, this includes any Registrable Securities issuable upon exercise or conversion of any Security), provided that, if any amendment,
modification or waiver disproportionately and adversely impacts a Holder (or group of Holders), the consent of such disproportionately
impacted Holder (or group of Holders) shall be required. If a Registration Statement does not register all of the Registrable Securities
pursuant to a waiver or amendment done in compliance with the previous sentence, then the number of Registrable Securities to be registered
for each Holder shall be reduced pro rata among all Holders and each Holder shall have the right to designate which of its Registrable
Securities shall be omitted from such Registration Statement. Notwithstanding the foregoing, a waiver or consent to depart from the provisions
hereof with respect to a matter that relates exclusively to the rights of a Holder or some Holders and that does not directly or indirectly
affect the rights of other Holders may be given only by such Holder or Holders of all of the Registrable Securities to which such waiver
or consent relates; <U>provided</U>, <U>however</U>, that the provisions of this sentence may not be amended, modified, or supplemented
except in accordance with the provisions of the first sentence of this Section 6(d). No consideration shall be offered or paid to any
Person to amend or consent to a waiver or modification of any provision of this Agreement unless the same consideration also is offered
to all of the parties to this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Notices</U>. Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall
be delivered as set forth in the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">  &nbsp;
</FONT><U>Successors and Assigns</U>. This Agreement shall inure to the benefit of and be binding upon the successors and permitted assigns
of each of the parties and shall inure to the benefit of each Holder. The Company may not assign (except by merger) its rights or obligations
hereunder without the prior written consent of all of the Holders of the then outstanding Registrable Securities. Each Holder may assign
their respective rights hereunder in the manner and to the Persons as permitted under Section 5.7 of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(g)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>No Inconsistent Agreements</U>. Neither the Company nor any of its Subsidiaries has entered, as of the date hereof, nor shall
the Company or any of its Subsidiaries, on or after the date of this Agreement, enter into any agreement with respect to its securities,
that would have the effect of impairing the rights granted to the Holders in this Agreement or otherwise conflicts with the provisions
hereof. Except as set forth on <U>Schedule 6(i)</U>, neither the Company nor any of its Subsidiaries has previously entered into any agreement
granting any registration rights with respect to any of its securities to any Person that have not been satisfied in full.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(h)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Execution and Counterparts</U>. This Agreement may be executed in two or more counterparts, all of which when taken together
shall be considered one and the same agreement and shall become effective when counterparts have been signed by each party and delivered
to the other party, it being understood that both parties need not sign the same counterpart. In the event that any signature is delivered
by facsimile transmission or by e-mail delivery of a &ldquo;.pdf&rdquo; format data file, such signature shall create a valid and binding
obligation of the party executing (or on whose behalf such signature is executed) with the same force and effect as if such facsimile
or &ldquo;.pdf&rdquo; signature page were an original thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(i) <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT><U>Governing
Law</U>. All questions concerning the construction, validity, enforcement and interpretation of this Agreement shall be determined
in accordance with the provisions of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(j) <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT><U>Cumulative
Remedies</U>. The remedies provided herein are cumulative and not exclusive of any other remedies provided by law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(k) <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT><U>
Severability</U>. If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to
be invalid, illegal, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein
shall remain in full force and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use
their commercially reasonable efforts to find and employ an alternative means to achieve the same or substantially the same result
as that contemplated by such term, provision, covenant or restriction. It is hereby stipulated and declared to be the intention of
the parties that they would have executed the remaining terms, provisions, covenants and restrictions without including any of such
that may be hereafter declared invalid, illegal, void or unenforceable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(l) <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT><U>Headings</U>.
The headings in this Agreement are for convenience only, do not constitute a part of the Agreement and shall not be deemed to limit
or affect any of the provisions hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(m) <U>Independent
Nature of Holders&rsquo; Obligations and Rights</U>. The obligations of each Holder hereunder are several and not joint with the
obligations of any other Holder hereunder, and no Holder shall be responsible in any way for the performance of the obligations of
any other Holder hereunder. Nothing contained herein or in any other agreement or document delivered at any closing, and no action
taken by any Holder pursuant hereto or thereto, shall be deemed to constitute the Holders as a partnership, an association, a joint
venture or any other kind of group or entity, or create a presumption that the Holders are in any way acting in concert or as a
group or entity with respect to such obligations or the transactions contemplated by this Agreement or any other matters, and the
Company acknowledges that the Holders are not acting in concert or as a group, and the Company shall not assert any such claim, with
respect to such obligations or transactions. Each Holder shall be entitled to protect and enforce its rights, including without
limitation the rights arising out of this Agreement, and it shall not be necessary for any other Holder to be joined as an
additional party in any proceeding for such purpose. The use of a single agreement with respect to the obligations of the Company
contained was solely in the control of the Company, not the action or decision of any Holder, and was done solely for the
convenience of the Company and not because it was required or requested to do so by any Holder. It is expressly understood and
agreed that each provision contained in this Agreement is between the Company and a Holder, solely, and not between the Company and
the Holders collectively and not between and among Holders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">********************</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-weight: normal"><I>(Signature
Pages Follow)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">IN WITNESS WHEREOF, the parties
have executed this Registration Rights Agreement as of the date first written above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase"><B>PERASO INC.</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; font-size: 10pt">By:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; width: 4%">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; width: 36%">Name:</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">Title:</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">[SIGNATURE PAGE OF HOLDERS FOLLOWS]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase">[SIGNATURE
PAGE OF HOLDERS]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Name of Holder: __________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Signature of Authorized Signatory of Holder</I>: __________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Name of Authorized Signatory: _________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Title of Authorized Signatory: __________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[SIGNATURE PAGES CONTINUE]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B><U>Annex A</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>Plan of Distribution</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Each Selling Stockholder
(the &ldquo;<U>Selling Stockholders</U>&rdquo;) of the securities and any of their pledgees, assignees and successors-in-interest may,
from time to time, sell any or all of their securities covered hereby on the Trading Market or any other stock exchange, mark<FONT STYLE="font-family: Times New Roman, Times, Serif">et
or trading facility on which the securities are traded or in private transactions. These sales may be at fixed or negotiated prices.
A Selling Stockholder may use any one or more of the following methods when selling securities:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 0.5in"></TD><TD STYLE="text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">ordinary
                                            brokerage transactions and transactions in which the broker-dealer solicits purchasers;</FONT></TD></TR></TABLE>

<P STYLE="text-align: justify; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 0.5in"></TD><TD STYLE="text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">block
                                            trades in which the broker-dealer will attempt to sell the securities as agent but may position
                                            and resell a portion of the block as principal to facilitate the transaction;</FONT></TD></TR></TABLE>

<P STYLE="text-align: justify; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 0.5in"></TD><TD STYLE="text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">purchases
                                            by a broker-dealer as principal and resale by the broker-dealer for its account;</FONT></TD></TR></TABLE>

<P STYLE="text-align: justify; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 0.5in"></TD><TD STYLE="text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">an
                                            exchange distribution in accordance with the rules of the applicable exchange;</FONT></TD></TR></TABLE>

<P STYLE="text-align: justify; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 0.5in"></TD><TD STYLE="text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">privately
                                            negotiated transactions;</FONT></TD></TR></TABLE>

<P STYLE="text-align: justify; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 0.5in"></TD><TD STYLE="text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">settlement
                                            of short sales;</FONT></TD></TR></TABLE>

<P STYLE="text-align: justify; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 0.5in"></TD><TD STYLE="text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">in
                                            transactions through broker-dealers that agree with the Selling Stockholders to sell a specified
                                            number of such securities at a stipulated price per security;</FONT></TD></TR></TABLE>

<P STYLE="text-align: justify; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 0.5in"></TD><TD STYLE="text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">through
                                            the writing or settlement of options or other hedging transactions, whether through an options
                                            exchange or otherwise;</FONT></TD></TR></TABLE>

<P STYLE="text-align: justify; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 0.5in"></TD><TD STYLE="text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">a
                                            combination of any such methods of sale; or</FONT></TD></TR></TABLE>

<P STYLE="text-align: justify; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 0.5in"></TD><TD STYLE="text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">any
                                            other method permitted pursuant to applicable law.</FONT></TD></TR></TABLE>

<P STYLE="text-align: justify; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
Selling Stockholders may also sell sec</FONT>urities under Rule 144 or any other exemption from registration under the Securities Act
of 1933, as amended (the &ldquo;<U>Securities Act</U>&rdquo;), if available, rather than under this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Broker-dealers engaged by
the Selling Stockholders may arrange for other brokers-dealers to participate in sales. Broker-dealers may receive commissions or discounts
from the Selling Stockholders (or, if any broker-dealer acts as agent for the purchaser of securities, from the purchaser) in amounts
to be negotiated, but, except as set forth in a supplement to this Prospectus, in the case of an agency transaction not in excess of a
customary brokerage commission in compliance with FINRA Rule 2121; and in the case of a principal transaction a markup or markdown in
compliance with FINRA Rule 2121.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In connection with the sale
of the securities or interests therein, the Selling Stockholders may enter into hedging transactions with broker-dealers or other financial
institutions, which may in turn engage in short sales of the securities in the course of hedging the positions they assume. The Selling
Stockholders may also sell securities short and deliver these securities to close out their short positions, or loan or pledge the securities
to broker-dealers that in turn may sell these securities. The Selling Stockholders may also enter into option or other transactions with
broker-dealers or other financial institutions or create one or more derivative securities which require the delivery to such broker-dealer
or other financial institution of securities offered by this prospectus, which securities such broker-dealer or other financial institution
may resell pursuant to this prospectus (as supplemented or amended to reflect such transaction).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Selling Stockholders and
any broker-dealers or agents that are involved in selling the securities may be deemed to be &ldquo;underwriters&rdquo; within the meaning
of the Securities Act in connection with such sales. In such event, any commissions received by such broker-dealers or agents and any
profit on the resale of the securities purchased by them may be deemed to be underwriting commissions or discounts under the Securities
Act. Each Selling Stockholder has informed the Company that it does not have any written or oral agreement or understanding, directly
or indirectly, with any person to distribute the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company is required to
pay certain fees and expenses incurred by the Company incident to the registration of the securities. The Company has agreed to indemnify
the Selling Stockholders against certain losses, claims, damages and liabilities, including liabilities under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We agreed to keep this prospectus
effective until the earlier of (i) the date on which the securities may be resold by the Selling Stockholders without registration and
without regard to any volume or manner-of-sale limitations by reason of Rule 144, without the requirement for the Company to be in compliance
with the current public information under Rule 144 under the Securities Act or any other rule of similar effect or (ii) all of the securities
have been sold pursuant to this prospectus or Rule 144 under the Securities Act or any other rule of similar effect. The resale securities
will be sold only through registered or licensed brokers or dealers if required under applicable state securities laws. In addition, in
certain states, the resale securities covered hereby may not be sold unless they have been registered or qualified for sale in the applicable
state or an exemption from the registration or qualification requirement is available and is complied with.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under applicable rules and
regulations under the Exchange Act, any person engaged in the distribution of the resale securities may not simultaneously engage in market
making activities with respect to the common stock for the applicable restricted period, as defined in Regulation M, prior to the commencement
of the distribution. In addition, the Selling Stockholders will be subject to applicable provisions of the Exchange Act and the rules
and regulations thereunder, including Regulation M, which may limit the timing of purchases and sales of the common stock by the Selling
Stockholders or any other person. We will make copies of this prospectus available to the Selling Stockholders and have informed them
of the need to deliver a copy of this prospectus to each purchaser at or prior to the time of the sale (including by compliance with Rule
172 under the Securities Act).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 15; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SELLING SHAREHOLDERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The common stock being offered
by the selling shareholders are those previously issued to the selling shareholders, and those issuable to the selling shareholders, upon
exercise of the warrants. For additional information regarding the issuances of those shares of common stock and warrants, see &ldquo;Private
Placement of Warrants&rdquo; above. We are registering the shares of common stock in order to permit the selling shareholders to offer
the shares for resale from time to time. Except for the ownership of the shares of common stock and the warrants, the selling shareholders
have not had any material relationship with us within the past three years.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The table below lists the
selling shareholders and other information regarding the beneficial ownership of the shares of common stock by each of the selling shareholders.
The second column lists the number of shares of common stock beneficially owned by each selling shareholder, based on its ownership of
the shares of common stock and warrants, as of ________, 2022, assuming exercise of the warrants held by the selling shareholders on that
date, without regard to any limitations on exercises.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The third column lists the
shares of common stock being offered by this prospectus by the selling shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In accordance with the terms
of a registration rights agreement with the selling shareholders, this prospectus generally covers the resale of the sum of the maximum
number of shares of common stock issuable upon exercise of the related warrants, determined as if the outstanding warrants were exercised
in full as of the trading day immediately preceding the date this registration statement was initially filed with the SEC, each as of
the trading day immediately preceding the applicable date of determination and all subject to adjustment as provided in the registration
right agreement, without regard to any limitations on the exercise of the warrants. The fourth column assumes the sale of all of the shares
offered by the selling shareholders pursuant to this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under the terms of the warrants,
a selling shareholder may not exercise any such warrants to the extent such exercise would cause such selling shareholder, together with
its affiliates and attribution parties, to beneficially own a number of shares of common stock which would exceed 4.99% or 9.99%, as applicable,
of our then outstanding common stock following such exercise, excluding for purposes of such determination shares of common stock issuable
upon exercise of such warrants which have not been exercised. The number of shares in the second and fourth columns do not reflect this
limitation. The selling shareholders may sell all, some or none of their shares in this offering. See &quot;Plan of Distribution.&quot;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: center; width: 24%; font-size: 10pt; vertical-align: bottom"><FONT STYLE="font-size: 10pt"><B>Name of Selling
    Shareholder</B></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; vertical-align: bottom; width: 24%; font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>Number of shares
    of<BR>
    Common Stock Owned<BR>
    Prior to Offering</B></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; vertical-align: bottom; width: 25%; font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>Maximum Number
    of<BR>
    shares of Common Stock<BR>
    to be Sold Pursuant to this<BR>
    Prospectus</B></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; vertical-align: bottom; width: 24%; font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>Number of shares
    of<BR>
    Common Stock Owned<BR>
    After Offering</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: center; font-size: 10pt; vertical-align: bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt; text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt; text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: center; font-size: 10pt; vertical-align: bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt; text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt; text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: center; font-size: 10pt; vertical-align: bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt; text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt; text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt; text-align: center">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"></P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in"><B>Annex C</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase">[___________________]</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Selling Stockholder Notice and Questionnaire</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The undersigned beneficial
owner of common stock (the &ldquo;<U>Registrable Securities</U>&rdquo;) of Peraso Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;),
understands that the Company has filed or intends to file with the Securities and Exchange Commission (the &ldquo;<U>Commission</U>&rdquo;)
a registration statement (the &ldquo;<U>Registration Statement</U>&rdquo;) for the registration and resale under Rule 415 of the Securities
Act of 1933, as amended (the &ldquo;<U>Securities Act</U>&rdquo;), of the Registrable Securities, in accordance with the terms of the
Registration Rights Agreement (the &ldquo;<U>Registration Rights Agreement</U>&rdquo;) to which this document is annexed. A copy of the
Registration Rights Agreement is available from the Company upon request at the address set forth below. All capitalized terms not otherwise
defined herein shall have the meanings ascribed thereto in the Registration Rights Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Certain legal consequences
arise from being named as a selling stockholder in the Registration Statement and the related prospectus. Accordingly, holders and beneficial
owners of Registrable Securities are advised to consult their own securities law counsel regarding the consequences of being named or
not being named as a selling stockholder in the Registration Statement and the related prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">NOTICE</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The undersigned beneficial
owner (the &ldquo;<U>Selling Stockholder</U>&rdquo;) of Registrable Securities hereby elects to include the Registrable Securities owned
by it in the Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The undersigned hereby provides the following
information to the Company and represents and warrants that such information is accurate:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">QUESTIONNAIRE</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <B>1.</B> <B>Name.</B></P>



<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">Full Legal Name of Selling Stockholder</TD></TR></TABLE>

<P STYLE="text-align: justify; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 1pt; width: 1in; font-size: 10pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: justify">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 0.5in"></TD><TD STYLE="text-align: justify; width: 0.5in"><FONT STYLE="font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Full Legal Name of Registered Holder (if not the same as (a) above) through
which Registrable Securities are held:</FONT></TD></TR></TABLE>

<P STYLE="text-align: justify; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 1pt; width: 1in; font-size: 10pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: justify">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 0.5in"></TD><TD STYLE="text-align: justify; width: 0.5in"><FONT STYLE="font-size: 10pt">(c)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Full Legal Name of Natural Control Person (which means a natural person
who directly or indirectly alone or with others has power to vote or dispose of the securities covered by this Questionnaire):</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 1in; font-size: 10pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: justify">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -1in"><B>2. Address for Notices to Selling Stockholder:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -1in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; width: 100%; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">Telephone:<U></U></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">Fax:</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">Contact Person:</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -1in"><B>3. Broker-Dealer Status:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -1in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">Are you a broker-dealer?</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.75in; text-align: justify"> Yes &#9744;   No &#9744; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">If &ldquo;yes&rdquo; to Section 3(a), did you receive your Registrable Securities
as compensation for investment banking services to the Company?</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.75in; text-align: justify"> Yes   &#9744; No &#9744;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> <FONT STYLE="font-size: 10pt">Note: If
&ldquo;no&rdquo; to Section 3(b), the Commission&rsquo;s staff has indicated that you should be identified as an underwriter in the Registration
Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -1in"></P>

<!-- Field: Page; Sequence: 19; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -1in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">Are you an affiliate of a broker-dealer?</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.75in; text-align: justify"> Yes  &#9744; No &#9744;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">(d)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">If you are an affiliate of a broker-dealer, do you certify that you purchased
the Registrable Securities in the ordinary course of business, and at the time of the purchase of the Registrable Securities to be resold,
you had no agreements or understandings, directly or indirectly, with any person to distribute the Registrable Securities?</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.75in; text-align: justify"> Yes  &#9744; No &#9744;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> <FONT STYLE="font-size: 10pt">Note: If
&ldquo;no&rdquo; to Section 3(d), the Commission&rsquo;s staff has indicated that you should be identified as an underwriter in the Registration
Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -1in"><B>4. Beneficial Ownership of Securities
of the Company Owned by the Selling Stockholder.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><I>Except as set forth below in this
Item 4, the undersigned is not the beneficial or registered owner of any securities of the Company other than the securities issuable
pursuant to the Purchase Agreement.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">Type and Amount of other securities beneficially owned by the Selling Stockholder:</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 1in">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -1in"><B>5. Relationships with the Company:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><I>Except as set forth below, neither
the undersigned nor any of its affiliates, officers, directors or principal equity holders (owners of 5% of more of the equity securities
of the undersigned) has held any position or office or has had any other material relationship with the Company (or its predecessors or
affiliates) during the past three years.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in">State any exceptions here:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The undersigned agrees to
promptly notify the Company of any material inaccuracies or changes in the information provided herein that may occur subsequent to the
date hereof at any time while the Registration Statement remains effective; provided, that the undersigned shall not be required to notify
the Company of any changes to the number of securities held or owned by the undersigned or its affiliates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">By
signing below, the undersigned consents to the disclosure of the information contained herein in its answers to Items 1 through 5 and
the inclusion of such information in the Registration Statement and the related prospectus </FONT>and any amendments or supplements thereto<FONT STYLE="font-size: 10pt">.
The undersigned understands that such information will be relied upon by the Company in connection with the preparation or amendment of
the Registration Statement and the related prospectus and any amendments or supplements thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF the undersigned,
by authority duly given, has caused this Notice and Questionnaire to be executed and delivered either in person or by its duly authorized
agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-size: 10pt">Date:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-size: 10pt">Beneficial Owner:</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 10%">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 4%">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 5%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 31%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>PLEASE FAX A COPY (OR EMAIL A .PDF COPY) OF
THE COMPLETED AND EXECUTED NOTICE AND QUESTIONNAIRE TO:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">4</P>

<P STYLE="margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>8
<FILENAME>ea179675ex10-3_peraso.htm
<DESCRIPTION>AMENDMENT NO. 1 TO PERASO INC. COMMON STOCK PURCHASE WARRANT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 10.3</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>AMENDMENT NO. 1<BR>
TO THE<BR>
PERASO INC.<BR>
COMMON STOCK PURCHASE WARRANT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">MAY 31, 2023</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Amendment No. 1 to the
common stock purchase warrant (this &ldquo;<B><I>Amendment</I></B>&rdquo;) issued by Peraso Inc., a Delaware corporation (the &ldquo;<B><I>Company</I></B>,&rdquo;),
dated as of November 30,&nbsp;2022, to purchase 3,675,000 shares of the Company&rsquo;s common stock, par value $0.001 (&ldquo;<B><I>Common
Stock</I></B>&rdquo;), at an exercise price of $1.36 per share (the &ldquo;<B><I>Warrant</I></B>&rdquo;), is made and entered into by
and between the Company and Armistice Capital Master Fund Ltd. (the &ldquo;<B><I>Investor</I></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>, the Investor
is, and as of the effective date of this Amendment will be, the holder of the Warrant;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>, the Company
and an affiliate of the Investor (the &ldquo;<B><I>Affiliate</I></B>&rdquo;) entered into a securities purchase agreement, dated as of
May 31, 2023 (the &ldquo;<B><I>2023 Purchase Agreement</I></B>&rdquo;), pursuant to which the Affiliate has agreed to purchase and the
Company has agreed to issue and sell to the Affiliate shares of Common Stock at a price of $0.70 per share and the Company will also issue
to the Affiliate warrants to purchase additional shares of Common Stock (together, the &ldquo;<B><I>2023 Warrants</I></B>&rdquo;); and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>, in connection
with the entry into the 2023 Purchase Agreement, the Company agreed to amend the terms of the Warrant to (i) reduce the exercise price
from $1.36 per share to $1.00 per share (the &ldquo;<B><I>Exercise Price Adjustment</I></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>NOW</B>, <B>THEREFORE</B>,
in consideration of the foregoing and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged,
the parties hereto agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">1.</TD><TD STYLE="text-align: justify"><B><U>Definitions</U>.</B> Capitalized terms used and not defined in this Amendment have the respective
meanings ascribed to them in the Warrant.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">2.</TD><TD STYLE="text-align: justify"><B><U>Amendments to the Warrant</U>.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">a.</TD><TD STYLE="text-align: justify"><B><I>Exercise Price Adjustment.</I></B> Clause &ldquo;(b)&rdquo; of Section 2 of the Warrant is hereby
deleted in its entirety and replaced with the following:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><U>Exercise Price</U>. The exercise
price per share of Common Stock under this Warrant shall be $1.00, subject to adjustment hereunder (the &ldquo;<U>Exercise Price</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">3.</TD><TD STYLE="text-align: justify"><B><U>Effective Date</U>. </B>This Amendment, and the Adjustments, are effective as of the Closing Date
(as defined in the 2023 Purchase Agreement).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">4.</TD><TD STYLE="text-align: justify"><B><U>Miscellaneous</U>.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">a.</TD><TD STYLE="text-align: justify"><B><I>Governing Law</I>.</B> This Amendment shall be governed by, and construed in accordance with, the
laws of the State of New York applicable to contracts executed in and to be performed in that state, without reference to conflict of
laws principles thereof.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">b.</TD><TD STYLE="text-align: justify"><B><I>Counterparts</I>.</B> This Amendment may be executed and delivered (including by facsimile or other
electronic transmission) in any number of counterparts, and by the different parties hereto in separate counterparts, each of which when
executed (including by the affixing of signatures electronically) and delivered shall be deemed to be an original but all of which taken
together shall constitute one and the same agreement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">c.</TD><TD STYLE="text-align: justify"><B><I>Continuation of the Warrant</I>.</B> Except as expressly modified by this Amendment, the Warrant
shall continue to be and remain in full force and effect in accordance with its terms. Any future reference to the Warrant shall be deemed
to be a reference to the Warrant as modified by this Amendment.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>(signature pages follow)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>


<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the Company
has caused this Amendment to be executed by its authorized signatory on the date first set forth hereinabove.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 301.5pt; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD COLSPAN="3">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>PERASO INC.</B></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD COLSPAN="2">
</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right"></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">/s/ James Sullivan</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 60%">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 4%">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Name:</FONT>&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 31%"> <FONT STYLE="font-family: Times New Roman, Times, Serif">James Sullivan</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Title: </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">CFO</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 301.5pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>[Signature page to the 2022 Warrant Amendment]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 301.5pt; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the Investor
consents to this Amendment and has caused this acknowledgment and consent to this Amendment to be executed by its authorized signatory
on the date first set forth hereinabove.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 238.5pt; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD COLSPAN="2">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>ARMISTICE
    CAPITAL MASTER FUND LTD.</B></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; text-align: right">&nbsp;</TD>
    <TD STYLE="width: 4%; text-align: right">&nbsp;</TD>
    <TD STYLE="width: 36%">
</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right"></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">/s/ Steven Boyd</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Name: Steven Boyd</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>[Signature page to the 2022 Warrant Amendment]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">3</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>9
<FILENAME>ea179675ex99-1_peraso.htm
<DESCRIPTION>PRESS RELEASE BY PERASO INC. DATED MAY 31, 2023
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 99.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B><IMG SRC="ex99-1_001.jpg" ALT=""></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Peraso Announces $4.0 Million Registered Direct
Offering Priced At-The-Market Under Nasdaq Rules</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>SAN JOSE, CA &ndash; May 31, 2023 </B>&ndash;
Peraso Inc. (NASDAQ: PRSO) (&ldquo;Peraso&rdquo; or the &ldquo;Company&rdquo;) today announced that it has entered into a securities purchase
agreement with an institutional investor (the &ldquo;Investor&rdquo;) in connection with a registered direct offering, which was priced
at-the-market under Nasdaq rules, of an aggregate of 5,714,286 shares of its common stock (or pre-funded warrants in lieu thereof) at
an offering price of $0.70 per share (or $0.69 per pre-funded warrant). The pre-funded warrants will be immediately exercisable at a nominal
exercise price of $0.01 per share and may be exercised at any time until all of the pre-funded warrants are exercised in full. Additionally,
in a concurrent private placement, the Company will issue to the Investor unregistered common stock purchase warrants (the &ldquo;Private
Placement Warrants&rdquo;) to purchase up to 5,714,286 shares of common stock. The Private Placement Warrants have an exercise price of
$0.70 per share and are exercisable for a period of five years beginning from the date of issuance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Coinciding with the registered direct offering
and newly issued Private Placement Warrants, the Company also entered into an agreement to reprice 3,675,000 pre-existing common stock
purchase warrants, which are held by the Investor, from the prior exercise price of $1.36 to a new exercise price of $1.00 per share upon
the closing of the offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Benchmark Company, LLC is acting as the sole
placement agent for the offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The gross proceeds from the registered direct
offering and concurrent private placement are expected to be $4.0 million before deducting placement agent fees and other estimated offering
expenses. Peraso intends to use the net proceeds from this offering for the Company&rsquo;s operations, including the development of its
5G products, and working capital and general corporate purposes. The registered direct offering and concurrent private placement are expected
to close on or about June 2, 2023, subject to the satisfaction of customary closing conditions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The common stock and pre-funded warrants described
above (but not the Private Placement Warrants or the shares of common stock underlying the Private Placement Warrants) are being offered
pursuant to a &ldquo;shelf&rdquo; registration statement (File No. 333-258386) that was filed with the U.S. Securities and Exchange Commission
(&ldquo;SEC&rdquo;) on August 2, 2021 and declared effective on August 9, 2021. Such shares of common stock and pre-funded warrants may
be offered only by means of a prospectus, including a prospectus supplement, forming a part of the effective registration statement. A
final prospectus supplement and the accompanying prospectus relating to the offering of the shares of common stock and pre-funded warrants
will be filed with the SEC. Electronic copies of the prospectus supplement and the accompanying prospectus relating to the offering of
common stock may be obtained, when available, on the SEC&rsquo;s website at www.sec.gov or by contacting The Benchmark Company, LLC, via
email at <I>prospectus@benchmarkcompany.com</I> or at 150 East 58th Street, 17th Floor, New York, New York 10155, United States.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Private Placement Warrants and the shares
of common stock underlying the Private Placement Warrants are being offered in a private placement under Section 4(a)(2) of the Securities
Act of 1933, as amended (the &ldquo;Act&rdquo;), and Regulation D, promulgated thereunder, and have not been registered under the Act,
or applicable state securities laws. Accordingly, the Private Placement Warrants and the underlying shares of common stock may not be
offered or sold in the United States except pursuant to an effective registration statement or an applicable exemption from the registration
requirements of the Act and such applicable state securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This press release does not constitute an offer
to sell or the solicitation of an offer to buy, nor are there any sales of these securities in any jurisdiction in which such offer, solicitation
or sale would be unlawful prior to registration or qualification under the securities laws of such jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Safe Harbor/Forward-Looking Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This press release contains &quot;forward-looking
statements&quot; within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the proposed
offering, the anticipated closing of the offering, the anticipated proceeds from the offering, and the intended use of proceeds from the
offering. The offering is subject to market and other conditions and there can be no assurance as to whether or when the offering may
be completed or as to the actual size or terms of the offering. These forward-looking statements are subject to risks and uncertainties
that may cause actual results to differ materially, including market conditions, risks associated with the cash requirements of Peraso&rsquo;s
business and other risks detailed from time to time in the Company&rsquo;s filings with the Securities and Exchange Commission, and represent
views only as of the date they are made and should not be relied upon as representing views as of any subsequent date. The Company does
not assume any obligation to update any forward-looking statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>About Peraso Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Peraso Inc. (NASDAQ: PRSO) is a pioneer in high
performance 60 GHz unlicensed and 5G mmWave wireless technology, offering chipsets, modules, software and IP. Peraso supports a variety
of applications, including fixed wireless access, immersive video and factory automation. In addition, Peraso's solutions for data and
telecom networks focus on Accelerating Data Intelligence and Multi-Access Edge Computing, providing end-to-end solutions from the edge
to the centralized core and into the cloud. For additional information, please visit www.perasoinc.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Peraso and the Peraso logo are registered trademarks
of Peraso Inc. in the U.S. and/or other countries. </I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>CONTACT:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">James Sullivan, CFO</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Peraso Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">+1 (408) 418-7500</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">jsullivan@perasoinc.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>ex5-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex5-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  C &X# 2(  A$! Q$!_\0
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MF","-KB\G;9;6L?WYG]!Z =2QX I-9UF+288P(FN+RX;9;6L9^>9OZ =2QX
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C:I9P6GBL:C;*8KJXM#',Z,1Y@5AMW#."1DX.,X.*** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>ex99-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  O .\# 2(  A$! Q$!_\0
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M_K%.ES<SIS^'FM9WM=7^FOA=_P ';7PAUOQ%96'Q=_9"\=^!/#EU<0P7&O\
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M"-A9[70=)L=9O7MY5PZ&\U/3KE!Q):JQP/*_#G_!>OQXM]&?%7[/O@^\TQG
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M1O$_A[5(C!J.A^(-,L]8TF^AR#Y=WI^H0W%K.H8!E$D3;7 =<, 1^/G[1?\
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M5J.JV(CENK&66V:&^EWP-&[!&)4?"W_!>O\ Y1=?M"?]A'X3?^K:\%U] _\
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M..(\JQV1YE0QU/"Y30IO$X.I-JCBJ6/Q%>,5*5.E*-2'[JJFD[>ZU*ZLO@O
M#A?.N'^#<[ROB;)L5EE;&Y]BZOU+,:5-/$8*OE6$PLY.G&MB(SHU?W]&2E)<
MRYXN-G=_Y97[0OP=\6?LN?M$_$WX.:Z]Q:>)?A+\0-4T.&_C+P2W,&G7PNO#
M^OV;[8V6'5](DTW7-/F15S;WMO*AP0:_T6O^"=7[3<'[7'['WP:^,DMW'<^)
M[[PY#X;\?HLC/)!X^\* :)XF:;S#YJG4;NU76H/,"M)::G;3*/+D0G\F_P#@
MKA_P1G^)W[:GQ\\-?';X ZQ\/O#^KZEX.M/#?Q+M/&6JZCHXU'4_#TTD7A_7
M+$Z9H.JBZN)M%GBTF_:X>*18M(T_R]ZE@GT1_P $=/V%/VK?V!]*^+GPZ^-/
MB#X<:_\ #/QI=:-XN\+1>#_$.M:KJ&B^-[6,Z1KA>TU'0M*MXM/US0XM*,\L
M4CR+=:';#RR+B1U^LX_XDX:XUX R7'O-LOI\5Y9'#8BKELISAC)RK1A@LVPT
M(_5^1JI4I4LQHP5;E<;VM)6/@?"?@SC/PT\6.(\JAD&;5N!,ZEC<)0SF%.G4
MR^G##U)YED&,J5/K:J)TJ5?$9/B9O#<T9N/,G%\Q]W?M]_M1:9^Q]^RI\5/C
M7<3VZ^(-+T=M!\ 6,Y'_ !-/B!XC#Z;X7M4CVR--':7<C:Q?JL<GEZ7I=_.Z
M^7$Y'^;O=7FN>,?$&HZG=-?:YXA\0ZG?:I?3;9+O4-2U*_N)[Z^NI1&K237%
MQ-)-<SN%)9VDD(Y-?W#?\%>_V#?VN?V]M1^%W@[X1^(OAMX?^$7@"WU#Q!?V
M7BSQ%K.FZEKOC[5#)8_VA-::=H.IP/9:+H2"STLRRB5)=6UIL!)T \E_X)1_
M\$;_ !S^Q[\8_%'QH_:%U'X>^*M<L?#$GAWX;:;X7N[[7;73;O6Y-OB'7[\Z
MMHNFQPWD6FPKI.FB&.658M2U.1I$!C5O1\,N*.#_  ^X'S/-Z^9X#'<3YBWB
MY9+1KSCCIT\//ZMEN6N?U64*-W.OCL5/VDXTE44FISA&!XGC;P+XB>+GB=DG
M#^%R7-<KX(R>,<!#B7$X:G/*Z=7%4OKF=9S&E]?A4Q%E3PN5X&'LJ<J[HR@I
M4J=2<S^/VV\,^/(46*+0O$T<:[L1KIVHJBY))POE8&3R<=S[U;F\,^,!$US?
MZ%KXBMHR\L]SI]Z(X(4&YV>22(+'&H#,Q)  !)K_ %!/^$>T#_H!Z/\ ^"RR
M_P#C%9VL^!_!_B#2-5T'6/#.B7VDZWIM[I&J64VF6GE7FG:C;26EY:R;8@WE
MSV\TD;;2& 8E2#@UZE+Z3,8SCS<&I1YES2CG=YJ+:4W%/+(IR4>9Q3DE*22D
MTFVO!K_0FG4A/D\2&Y\DO9QGPS:FYJ,W",VL[DXP<^2,I1A*48.4HQ<HJ,OX
M)?\ @E!^U>_[*'[7'@;7-9U!K/X<_$2:'X;?$=7D9;6WT7Q#=6\6FZ[<*&5
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9OEF%J3P^0Y#ETZF'RR3A7K3H?4\#@H?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>12
<FILENAME>prso-20230531.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.18b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 8qI5s7xRiXgen8uOYHxcWa+MWcP9zp5y+ZlBvGd8HekaHy4iXbl70i4hNr42MUYI -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:srt-types="http://fasb.org/srt-types/2023" xmlns:PRSO="http://perasoinc.com/20230531" elementFormDefault="qualified" targetNamespace="http://perasoinc.com/20230531">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://perasoinc.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="prso-20230531_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="prso-20230531_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" />
    <import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd" />
    <import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd" />
    <import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd" />
    <import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>13
<FILENAME>prso-20230531_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.18b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>14
<FILENAME>prso-20230531_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.18b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://perasoinc.com/role/Cover" xlink:href="prso-20230531.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://perasoinc.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139647561517456">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>May 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May 31,  2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-32929<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Peraso Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000890394<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">77-0291941<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">2309 Bering Dr.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">San Jose<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">95131<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">408<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">418-7500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.001 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">PRSO<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>ea179675-8k_peraso_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="prso-20230531.xsd" xlink:type="simple"/>
    <context id="From2023-05-31to2023-05-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000890394</identifier>
        </entity>
        <period>
            <startDate>2023-05-31</startDate>
            <endDate>2023-05-31</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2023-05-31to2023-05-31">0000890394</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2023-05-31to2023-05-31">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="From2023-05-31to2023-05-31">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2023-05-31to2023-05-31">2023-05-31</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2023-05-31to2023-05-31">Peraso Inc.</dei:EntityRegistrantName>
    <dei:EntityFileNumber contextRef="From2023-05-31to2023-05-31">000-32929</dei:EntityFileNumber>
    <dei:EntityIncorporationStateCountryCode contextRef="From2023-05-31to2023-05-31">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="From2023-05-31to2023-05-31">77-0291941</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2023-05-31to2023-05-31">2309 Bering Dr.</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="From2023-05-31to2023-05-31">San Jose</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2023-05-31to2023-05-31">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2023-05-31to2023-05-31">95131</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2023-05-31to2023-05-31">408</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2023-05-31to2023-05-31">418-7500</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="From2023-05-31to2023-05-31">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2023-05-31to2023-05-31">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2023-05-31to2023-05-31">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2023-05-31to2023-05-31">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="From2023-05-31to2023-05-31">Common Stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2023-05-31to2023-05-31">PRSO</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2023-05-31to2023-05-31">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="From2023-05-31to2023-05-31">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>17
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M> \^>Q\ETWLJ.?]74_P$4$L#!!0    ( &5%PE:7BKL<P    !,"   +
M7W)E;',O+G)E;'.=DKENPS ,0'_%T)XP!] AB#-E\18$^0%6H@_8$@6*19V_
MK]JE<9 +&7D]/!+<'FE [3BDMHNI&/T04FE:U;@!2+8ECVG.D4*NU"P>-8?2
M0$3;8T.P6BP^0"X99K>]9!:G<Z17B%S7G:4]VR]/06^ KSI,<4)I2$LS#O#-
MTG\R]_,,-47E2B.56QIXT^7^=N!)T:$B6!::1<G3HAVE?QW']I#3Z:]C(K1Z
M6^CY<6A4"H[<8R6,<6*T_C6"R0_L?@!02P,$%     @ 947"5JK$(A8S 0
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M6N=6RKV'5[+E&''\GN4/4$L#!!0    ( &5%PE8D'INBK0   /@!   :
M>&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'.UD3T.@S ,A:\2Y0 U4*E#!4Q=
M6"LN$ 7S(Q(2Q:X*MR^% 9 Z=&&RGBU_[\E.GV@4=VZ@MO,D1FL&RF3+[.\
MI%NTBB[.XS!/:A>LXEF&!KS2O6H0DBBZ0=@S9)[NF:*<//Y#='7=:7PX_;(X
M\ \PO%WHJ45D*4H5&N1,PFBV-L%2XLM,EJ*H,AF**I9P6B#BR2!M:59]L$].
MM.=Y%S?W1:[-XPFNWPQP>'3^ 5!+ P04    " !E1<)699!YDAD!  #/ P
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M<' N>&UL4$L! A0#%     @ 947"5N-QJ?#N    *P(  !$
M ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ 947"5IE<G",0
M!@  G"<  !,              ( !S $  'AL+W1H96UE+W1H96UE,2YX;6Q0
M2P$"% ,4    " !E1<)66INF^3L$  !M$   &               @($-"
M>&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ 947"5I^@&_"Q
M @  X@P   T              ( !?@P  'AL+W-T>6QE<RYX;6Q02P$"% ,4
M    " !E1<)6EXJ[',     3 @  "P              @ %:#P  7W)E;',O
M+G)E;'-02P$"% ,4    " !E1<)6JL0B%C,!   B @  #P
M@ %#$   >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ 947"5B0>FZ*M
M^ $  !H              ( !HQ$  'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR
M96QS4$L! A0#%     @ 947"5F60>9(9 0  SP,  !,              ( !
MB!(  %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&      D "0 ^ @  TA,

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="ea179675-8k_peraso.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://perasoinc.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="ea179675-8k_peraso.htm">ea179675-8k_peraso.htm</File>
    <File>ea179675ex10-1_peraso.htm</File>
    <File>ea179675ex10-2_peraso.htm</File>
    <File>ea179675ex10-3_peraso.htm</File>
    <File>ea179675ex4-1_peraso.htm</File>
    <File>ea179675ex4-2_peraso.htm</File>
    <File>ea179675ex4-3_peraso.htm</File>
    <File>ea179675ex5-1_peraso.htm</File>
    <File>ea179675ex99-1_peraso.htm</File>
    <File>prso-20230531.xsd</File>
    <File>prso-20230531_lab.xml</File>
    <File>prso-20230531_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>22
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "ea179675-8k_peraso.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 22
   },
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "ea179675-8k_peraso.htm"
     ]
    },
    "labelLink": {
     "local": [
      "prso-20230531_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "prso-20230531_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "prso-20230531.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    }
   },
   "elementCount": 59,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2023": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 22,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "PRSO",
   "nsuri": "http://perasoinc.com/20230531",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "ea179675-8k_peraso.htm",
      "contextRef": "From2023-05-31to2023-05-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://perasoinc.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "ea179675-8k_peraso.htm",
      "contextRef": "From2023-05-31to2023-05-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://perasoinc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r10": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r11": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r12": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r13": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r14": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r15": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r16": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r19": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r7": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r8": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r9": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>23
<FILENAME>0001213900-23-045405-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001213900-23-045405-xbrl.zip
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M.[G44-J=D</SC=04JYDU12NE72*6W(DV4LO%>4'R<1^4,0]D"Q2P.P%I3@"
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M @3?/1QTA_O''X8KB,1GYRSMHEZ''>F%KGE=9I[ALQO#CCC[9ZU:J]69AR<
M1\NJ1Y9PP[V1O8S0?X =TZZ.D@52%"Q("4:MDW#K9-3@JT@)IB8$X^>B=_8K
M[<,E&"*+\EB:DK4MM[C:]:QSZQZ?6,?#X<,Y*)N<1F$VGY?.@PFE8& 9GQ;E
MHHGQV(GA7_.0'1]W[Z@]^6DLSP6S'#D6VNJ<]:?,I'P(]+H&A<"IABB3JQ !
M@\T'0Q\''C*0]K?A"'/+8P\3&$; +#X0CBS6E3':6GO^,$'B"$$SMO=QO5O/
M*%Q;:Z]C3DJZ"XU^I9$S1-YQA&(A,QBZ$-A_O;I""W[E+L%!&I],H_.!C#LO
M+]/U%'JZ5S1;5TZ6SZI#8^ W;JS&A\N'GP2[CS^[!+![N[)/(2-Y-,CA+TT/
MF/W.95:1S2D6"R-@16Z#(PFLZ+CD5D8!IV8P+^4N&=U<(\C5E.?M<:MH,GN*
MLU/M"-*A TN")SZ_$0'T P8W'!,#SH9)5[Q@8[PVR#)\*Y!)2ROATU+"9G;(
M:,V(G=HD#U<?3NXQ@:R6$N8V_7N<"D^<^L[U,!*GQK_[H;]'$(UYN$>8GT'[
M3Q$&G6!8N0 RC^9QN<0A2^Y5O9&S69MD?,X?ED]BU]O5UPK, >!SX[K2Y\!5
M *5'4">GW,R9$<'XTBF3F[KB_?QQM>8" ?J\OWL4\C'L,_A*!UASC[4:+C.8
M3M&Q?;10!);)%0M[0Y]3V++ZB"4WWUB'G#DL>4ZOS!(GO]@:BEVLKVK4GBD%
M2]_JS]:+!7(BR'8CC"6,K?/(!TD-"B1&6&JD^<=Z4*U$&%XL)\((=0#L@7!N
M>!""3LD;Q=>=R^GHL0Q28 <%.0QNVUCK2/4SX!AQ^ H-L4D\&&I-6$PBUFH)
MGY/-.* :YC*"9PP!\J$ZR=DH-]JU<JU6DYYV &9E DQY04N\0&AO2I<]N,ME
MSV(_]O/C!3,C!%@=/G1#K$4B'2HQZX')PZE\'T;=JLT&K;++!$; L'+ERJ S
MX<2UK3F<P&B\,HC("K@U?#09 FP4SQ9Y^+59;FVVRHWM384'7*L$NUB0;E)J
M^V#,0SGF7VK,V;I@#VS!(QPA.Y;RN&#E*1CC(D R8X!LJNP PU;STQ0+X);P
M"?=-$5#(&LT8+!J42,],)/&5QFL<$YL?'%T>P/AFITSHE 843;6X;[&0[IRD
M 3E]#JX8PBK&8V[ASMO3U(IPZC$P=7\VNT6T EL>@H1@:(6!/4;L(/$X#XV<
M8M8?]F00V?;J7*/O*O80K9(URQD$)%"L=E"S=98&10#"!O$=>?!;O,]S*)V-
MN)P!6$96(/[[G"H"%8OVJ4ZP6-#\FY1WZ E ,Y,JNH,1MP>QB4^F-!7DDRS&
MLXU8I-BK@#M]ZE99L]FL--K;S>U-X#TI-V_).3=M Z>=C2L!8.] (R*I4/%^
MD!3]B+/83D\<IDR)Q(/N3!XZ;"\:PJZP#BF@>JKE17(!/;T W?F)D.(1*AQP
MCP&'/FX/R(D;5"T>F*"TWG)2BY'X(KF-^@N)8TY<W^:2FQ9A&6DKJ=P=R@ .
MZ=\%U"O!4,-E939Y;1F%T"YOU?,5 LO1!QGXTLR 4);O!28098*MT]!F&$P)
MURQBI)W07RQ>B=V)^<&A2"WB""U%,%@.E"PH%O FA!E#A\2E<PHAHZ-I2P@(
M/O&$3RD761Y\PRMX^P(T< 1>)VSX<1EP=FJ&,S\1#EF^3<FM<9&7U&:81C"R
M>:"WNUCH&X&@6O5R2AD"]J8978=$QE$=.RXL0ZRGA>L"L8IVA RL!(8]4P,9
MN#5]HCXE#L=8B< IF!8 :@#/=P,/IHP"' @6=F,(&U?YA'8UPPM(^/+L!J(O
MS;7%@M[P(.I_1),<E9Z%PQ'ZA602>9V*.Z#])1N;R6L 86C =.#9 @2JSY%]
MN&H0_V@:G@@!SL^TM_B+ZP\-1WVG_F(,F^"#N,-PF&'*=J0L ],7?6DH(2":
M3I_0;N7X=1C6-<!; ^(%7(Y1(/D<_(4 'NJ:'A)G$AO:1##T ('FD]@E44;7
M3)WA+[/1!0C[L3,[\^N+X4C9:K-S$_&HX%WAG"3IBP73=@-I3M%#[=(Q<@@\
M&?X$HG)-X$0F]]OHNU'(7D?@'S2TAYR@OQE<>FQ B$51TB#M:B7F(%T)Q,91
MF R!RRD*:G)N$=QTNF0BQE+Q_+/%@.)L7*K (G?'4:'16 ?./%,9/ )2M"*3
MPJRQ"0$()Q'%%?Y];AL$28P#!,X)^%,A5TPQ$'8LY:6'^?1+GE"Q$(@)H_N-
M #V#4&6R])8FATB*=B7(-<6F[:2$.89B:V3 7AN26LEW1L+$<Y@P-.PKD%1
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MOB_(O 'JZ*-E[01 $93_!;/.&Z&>,XTD+N1P@"2@,0I=D/H"BPK)5CCQR\R
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M$;\V,A:H)*. ];5H285 8@&BI K61=X(>8T;Q5+ ^\QD;/!28O>&$^<W:Y1
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M+8#=HQ*;,L*$2DTF[@3\+!*QF<7+KJ*42DDV6?Y-O0!@UU>U+Q(@T\!+,JC
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M:N"R<IF$K,MULTYR.',W:4&'(SA](45YL^$N1R4>M>BJ+.?TT4V2KY-ICI+
MO"*6NS!+LQ5?]60.5R&9;<8C>/OM=0:G!N4''MLI[.SL?5'>YNG\*IV'![)[
MQJ($)X6'80&\N[RM?Q@B]K3,YW^8XG"'BQH6O/PA6J]6:36#=_<I)^V]N%LM
M^&+3.CZ_/#MY=3H>G7UU4_M**?;B].79:U ZW[R^V"WU\G#_, (-Z 6*"A;F
MJ +MP]$IX"JS?%<QPZ)?I4J:U^DM7NL^)H(,!(0#LO]562N'#Y_!(?EFHX;'
M@U\GH! 0STJ3 CX&(=+5+51>PMP'6<+_SMTR*OX,%0XD'&CL=5D$^FY]C;1O
MTQ(XJ<A1V$]0IJ^)YH$"LO_TBTC4KX.@2()/0L;'^X=[OW\9\^&KH.1BD>49
MJ/$!,9%Z:#=LY, "21-@ G/0%&>@-4; ,&!$_:NYKLKUU368B2E^0]I@ALQ[
MF<ZSI,IPPJC%5&5>TT]K_3-'A7<CG[&B/"N72WBA/# >W6; 3!*91XP*AMO&
MFI25=<VJD5@YH.:OX0,>['P-.M"3@Z>#]LE^]*G)_UGV>'@[7UZ\>O76[&7$
M6WE<P?,ORP_1Q>PZ6RS&(W@J(M*6< # 4H_R<L;^AB8Z_/;PV^B_HXL&N#_L
M^F])?0U7J4'ROSB)C@X.#K[9V?ORO$RJ.0K(%W3ZR\ +H1<'S]E4'YSK@RW#
M:7=)N*Y!)ZGKZ$6R&> Z\V0C)@TP'N#5Z'6"SV 2<)$38AC\-?U1B.F"K ,T
MR0S,IVE2O*^1*UPBP;-F@\3'-?VSK-X3VTC6S7599?]&]U85B4L N=%XE">W
M*"ZJ= EV5S3+02>:/XM^?/GF]:72:PJVT15PO6+^:%;F9?4#3J%)P=Q[]].J
M*F_ YIKCVF+4UZ[+6[2_^6]4MF8Y<$6X=F*5=>9-LFP\0CM]FH(.!SH8";#I
MEFE'?;..YNL4/Q3BUPV0"R[X=;E,A>JQ^^XZS8&IPK8]6N7)S'T_'LD#15D\
M@EU#IR!,-%VN\G*3ZF-\KG!*N'V\-W6VS&"A\"'PWIJG"]PYF[$;JF1^C!-%
MER*Y4#;1ZGI3 V& $F @P)X26\+GQR.8./Z [Y-8S/B3*S"5JP+55/B9T <V
MO"[AQZ0!T,]2="A699'-H@5L&WQ(%@C.<U,W*0B3/>_!Q$VZA?>XA^H)OLUO
MU'BT_81=I84Z7'!MJ[2@,4%6X5;-X*+ %B!1"A9G<[P*>,!^VEFV< (' 6@_
MP$YG_*WR4.>I(D]8DJ?.=<<>174?.A>;=6JJZG>T?[CKU 8>W*OZ(>TNJV3.
MCQ@>BTJVD/H2[T;"I'Q1SM;L3R4-?(K1B?0#J%JD4L!FS-,\@VO*K I_G:Q6
M.5QT=%*MDHKTL88#"N35@NN>Y]9KO4*_%2Y&W=+6EUK5_U75I.Z44R #<PQ\
M<)7PVR[64S0$V"U\O 3&W7B?L1'*,DQMQR'7J,R_?<;T?*%#CSUBZ,B(#15J
M&*3F* KPE 0&F>_NH0/^F=5UVW3S1^Y=D>&!N<"X0A!(0UJ??H"]+JYHKV28
MG:8DG.2+IIR]'^*8_$B-C[14SQBO'#F)T^BO!_L'!X?1"@4AGFOV*7LI#KI*
M3:JKB0" <5<*/R#I9;Y:PH7#:YPL0)D *4G^9APBTSO F_@U7 )X]__SZ%'T
M,DOS^0_1V^0J?08O^-<Z+68IS.-9](;X1?T#3D2%QJ-'DA#PXXNS?X21]T=-
MN8+?':U<[/[1M&Q TO\0?8.?34D3<I\]!S7K?72X_Q0649=Y-@?ML1O+7S5V
MVC_^'=[:,X$I4/S]HVD*2@9,?45+L9/ZIF=..-&/?:6AU]^18$R.3[")7]^U
MBDY!MX8[@E*M:U#C!1F.B8ENBU(G$Q>(W)?;<IW/(U2BFYP]5==E+KX)BB/"
MS4K(79BBIHZ#-;#(R,[,Q-IC=I"4ZR;*0=UNQ*+@H.$4C'<0FZ"^HMRM^:>4
M6Q*#2LI/WK( \Q951AX4"NJBTP<=,W8>()%!##89RFUB _!#$/2@%-<HR\<C
M^IOO. EW.)&Q&_TV Y5-%E\/K)[B4S? A^R2OP)N\<5.))VH$U!9ZC3OX?6_
M9LWL&F/!%UD^32OXWU7T7\D2K+'_+M:K5;3-T_/D\;?1KZ#EH8OO^";=CZ.C
MI_#DR[S$75-K!O[U3UCNP='1SF[#BZQ60_4"J#U?P_D=D+M]C[;Y@]>&X3X!
M$T'O7,Z"$[?J@<PI#=VE<$RJ?]:.3R&7P@0CSE5*R"VDW N]*$EHS%01J2?1
M]S\<'$3)_G(_VG.6.YGRR.HXJ81%:K3,Y@4RSO&H]TE\*6RK>4D,@S_>-KCD
M5-EY94MRF#<I' 43:T.?!WP8,8N,HW4!)PJL$L]1F6?/)%T,)0@:(U6>(6=%
MKBTVUUMT[!"]CJ]<^@"90-LHJMEF2H/6>L \<M3Z_H>C[[>ON4.FHN2#ER>-
MNOON1[G_#$UV]NJ=NA2O+2X!)F#=*#^C/:"+MI>P'4V!Z22/SE/RRIS;=+$+
MERX&-CM;QW,T#I /^@PSV1=OY,&=GTXB\HC*:UU:I9C?:I$;JQMS$ZS/AR)!
MAT^>4( *[AH8)L//J$K%Z3(N68Q<>/#9>*1\G'VRZ&Z%#_(L <.!92T98,S7
MX173/)O!4YCNP)1P?EL3IL(7XQW2E]^4.:AA/-^B +NA7#PBFEHO*NA_>[-)
MBUM@'&X#6P7#%2AFZJ3:. ED_#Z1>JIY"Q-5QN#1(0HK/P5U00.',K(C"FE[
M>_.)=14-#3>T$]TLOB#OD*D69.(=3MP\6ME['T5/VH&6SD6GU4ML#20SL> 7
MF 99$$.[A=<V*<[O7VNX?6CQPIE=P9V0$"J^*\EEX3#9 E>_3.9TZH-1[R"<
M)1;]SI.+[0Q]*X?%IT"6C%S02_:8@F'2T&D%NQ&4/]#4,=UKEJX:4MI;:]Q=
MIDB)=.SA;'/%/Y-P4.]NPH'SXL'=') RY@+;I_%.''[_^ DE 23 D.>8EJB>
M_HKT;/RK<BFXZ#4NE^O\BNP=GXV[P\1'+A&=U<@\9FE0!1#Y#<CD>Z0X"O::
MF0[\%3A(UBM1Q<0!0,^S8Z%F;[<$7UB\8"!LW3AFF3@FYV3_>#3W F6["L%*
MP<#$X-U#GAS*F);8):>EU.N\81<^&\A534Z,H;!]2TYMU,%:R<JC50[2"ZP^
M8*AS^"CE!%UB!9)@%R.W3V [?^=(I;R  JPR-=B,Y92GPE]V\P[(C.D,(K^C
MV"BY@%$B$4F#X?WJ0/@!R\_JZYZ)\@=I=8-^ \R;Q\O#K"WP)J,*8IQA/>?"
M.X7HC%3B1ZI-&-?<>DIRGT?NOL;^*/%7%)+IT=Y9%0/ISJS6J6*-#U5Q[A$2
M@I@":9OM$HB_.V^8697Q<D4M)]=X1#G85=<[-G! 98'(K>R5L)9-3PYFJ*ZU
M/>\HB31G !0+89!@Q.%%'AZ6B@J*&>H!_%BQQA-$'O_6&U#[Q4B8>=CM\ HT
M*#C82I7QB#YH[;1\UAUYSR1[]&PA7[$:-.RFYB&7TZQ@%C^1:0'?2T44D,25
MMV!*JKXF)K6T[IRS0)E"3@,<9Q:>F62%Q.?STKUT\ZRF?#>X2YAS,< Y8B3*
MMAU$#JDGPU6(J7:*6^D>599M"T> ;FI'D#TO(\W7E=H%\'8J(:0BF!7(E#*L
M:-D_/$)NC]=.\^G@VFV<B1[HX.1'KE6K98<U[ 0,"RR'TX7!/N"(/5[O_L(A
M4DO-=C?J AN8=W2?:;=O"G%II+63:ZR[E45.Y@=62VF&(1S%2OD;KJK9&(U<
M'YJ(DIUAW+<!$V'!'G].@^3R-^_Y1QT%4T!P[;"BF8\1X.>W!5\V^'=2URE3
M)(FFFB15;^ !)!T<2<?/W+?M6AS4[6EM0H$6JW99XIA@DQ9P<AK*86DGCV=P
M9>N&-PA>00DS(+7 BN+1D<MP#"*%N9J;@H,Q;>Q;,[YJN'ISW($;@$:3D;.K
MTJP.$COPRBK)R$Z=):NLP7P;WA8T##%\L(&WE,QVEFC=.H+@JVCR5(A81/;V
MD[<KG=S[<"(_?HDFT\6C[YCV<!E7*5:U"9V"WX4Q4G$-=#G,L,Y@2Z=F>8+)
M0J#D[*RR^O+D[?& A0"[DL)0<,"J:@TO>%OA\9N)Q4]VPK??6COA*R#B]FCS
M46^T^5GT#PS2P]>?*^Y\?ZKTU>K8^1ST3(="RY8,2H!GT>5F!>L\KI)I-GL6
MO89]8R*]+G'I1T'D67^%WSQ$Q?_C%_'GX^.WG\SU<;V[#.VLP)A\.D=!]<GH
M.=UA"7$&7(>  K!B]FV%.A;&H\Y)-;4Y&W^&P*O=I>^K] IMJO-T6=X A3^9
M"Q14]KW9#I,U2XN^[($DRN&;&#/D*A B*ZJ\=J7WFTAM3#"SBQE8Z9@AGTI&
M#RH]BZRJT1A;K.LDI]0?B@D@:@,_HEX-$_'8W4T #?S1NU74![^B&T()O9T'
MXP"9I1.*GFXD<8"CYGU>*E<^[_P'ZC$@CY"X(6,R!;GPEAT:Y,%E%"#2C*.D
M:1+,,1$HEIW=S%\Q>0##SL=S]#6EXQ&'LS^5#-AA&>M(^Y8\.Y].<2EVEZ9O
ML>!AEJW8;_!K\B%;KI>?2K(>[B4[3%G,"T"?NX'9>8M>9\L)$/,DKS'S_=L#
MBYD4)7-\C4OUJ%)B)@JR<HL1&.N*CN6O>8:N-G*1\0?6/\TL'<4N[*I4Q 6N
M9>_"\_$!<EN6,Y#[DJEV_[! 4!W%#G?,[?<X2@YWR.4&L(SJ4"XBPD7+K%@3
ML0YVMUJJ![9!T\"I$![HCR8(A28<]!I5630%_/0Z6\6PZ6M4W;)"'^%RB'41
M?)+4=3G+Y/<$TA3=P)S66)A!&=[P3)XETRQ'C7#F(@O\J#M^')?SE9'DUD87
M,^@?,_(]P[''>=?.ZUXN)EY#%">KN$??PQIW=^]#Y:WG$& %Z'.@ZS6\[+V/
MBKYZ=1)'AT\/HM,$U/*GWS77<+OADV\',ZP/G^XNI$</T%M?^F\7&=#\,."A
MC@FZV'&0PQ66#T;".34]#F,B,[B6<Y_2)R)V/#K:=_$FU/<YW-&'4^?XJPT=
MVR1?'ZY)/ZPP@'9[S763%%.E. "BJL71H!TP'KUX, 2VGJ+QB%/FNB4\2-$M
M\7G:+4IEL.DMK1.G>[W#!"^C\Z1)HK=E]<DP>4B+37=8BZW*69K.^ZOA48K/
M!#@B3[(E:K 9*184]KR28&2%>J&,8J -XJB_7DS3D_.><=!:27(S'N@;M&\8
M7P.NN@*>B0]/D!FF7#6*2 G .N<2&$^!X15?11CN"^THYX"?^1SP\>AEDN6@
MUWT*'\43$$D[[*/80MWH;;)9MDLX_QR9H]VE<U52_L-ZJ/9MD17,*.0Q3+.0
MO$+.Z.Q+Y7P@9QU=K%>K?,@-38J*>\ IK_[75'VRH0H$U%09]>SH"9[5?D1C
MK8WC[7%I1;[F)L3L&(]\48[6O;3A7P/]>7>WM%6O<4\;YG,8+E%HMXQ'8KBT
M9]QOMHA QU>03JRI=)Q51:PT<8F73F$F3QM.>H%1J+VG$ZI+JKFDQPVQ+<[Q
M_"LU;[9G\SQ^2-R1Q)W'#XD[7P\W^D_8PFWV\17<S2]+["K"\,[F$QG"W^TL
M/?N5Q:'"Y+L:5) D-/H-:C[1ZW(_>OSX\:.CI]\]_NX;\>3Q "A:Z5)TL.7:
M7D?3QV&X:876;=XEOQ]V&S>'$[C&H[[<#,.P>G[3S=)@'T8RU7KN(%<C6992
M8V SZ,,=VJJ>G'REZLF7VL1.Q1Z(G)ZKJR!*0[=UF::-5G\$W5I:^/)WG '!
MA ;5&0;CCCA<@.W '_P]W%YPO<-;*D@%QU0!E>2?+@%DAQV\6JC5(\T<%H0M
M7>Y@8@05)5T#W^.DTW "LZ E@83>#CNR F:%WAEJ]@,KI+'@OS%5VU"=BB0L
M8'$U _BZ[D8.Y,^5N78G">>":GX8;0"=R/E&I.K25_M0-AS)[V#6NWTXGAP-
M'@[XZN%P[.KAN#@] 9FW A'XZ1CQ#I=D^)LQA$5A=/Z.GO^@([2(>#]0#X_E
M\?@!R^./4[WMR@G"!5MQ!ZC?BGAUNJ[\4'I\\0Y^7P>M@>%&%TD_ZB-R7M=%
M 1\DC"<U=7I*](\.#G!K3*_(BU_>F!XU >K-7EAV'32$D!KL\8C;)"##9_2*
M:5E5# C6?Q(F^U^0K%_#AG;QX/LB-8P<V.ZFB5N47,&E0%Z$/H0U7Y8I0MEG
M'.[LP8AW@1V#;$)*S2J=,3HV]?YD.>U>IXCTXU&!>E%O*]X>5 _J\PDD4!7P
M.F7,12%!S_IC/;!P2D,<]GF9YXD4IV#?RB"%[28!)9" ?A$D8'<Y!!"4@AM-
M]#(K$HJ4/63T_X<(.QZ]+IM64O^?HN\.Y\XXC/*A7DP.RF3301NQ_C@@)8XF
MB,=D5R03]HYJEBNEAU6V]0=PV+QV8HQARZD6SG:8PV2SH2F@2Y85&@%-G[<+
M)MC5N[/;:[!V>RM.@P9:#+8#NY&MDMS!]/Z:5.]32A=Q?8P:_FKGJ<JD&;@X
M<E0]-NN2GJXM>E@=$K^EK$=Y5DN9" RN4')"_  M#!@:\,@:.=H/^"EPR']>
MG()DAQ7/D +XY.NDGB?_BDX84D<F'WSU<UY.MWYS06VTP@<4HEFP]F1E<?3F
M\N1_GI.W"/_U?Z4$A:"89FE=8[FKP.$X2H%*5<+2O@9NO#W!X\E#@H<D>#QY
M2/#XHGRHVX*KUR70[>;L6U?=(Y:*CW0*X=% HMH5BH6R?5"[E@<-!T.YF9?_
MMVDM-'=-PTKI'\]_N<9A'XWF^. 5NM2NAD/%:HB%BACM(-YA1%^MAH15Q'+7
M&C$AN()V\RAIR;M,&$,MF<\KP:([/#P\B$[@-YAXC16)\*MU=8.=<,"@Q JW
M>#SZ-2WF99-$OZ1TS.+HU]?1TZ>'1P?N>#@)L7TF.[O)_TBJC&SN<Y3]A@E\
M*HMSIZL)_O%;"^Y*G$$+T5]0X8I55YZA.PXI2 X^B7(Q$$M'_V-,/X5#1B,H
MK7\@@.6LIP8\(Q9:>!UP/!(ED%J<A"IH+*H@HBD*T/TM72\TB&[2"D6?0U_M
MO,KA_I(NN2?9^D6*+JQ&.B_BN_#K"6AT8>L2L0^V*K+A2E2;!0.RHE@6D^YY
M7I9+ZE_T:O_M?K0W)5]9L%ILDT(A2>P1,AX--PF!P_WDAX.C:#7TQ(00I*5O
M+="?M-7(*:N=QC&6SBT*PSP^+8EQS:WY)'5@-B/B<L^A&8]DWOWT;ED/[5>@
M>V_!:ZA=S4:P"H0'H*'=MLE9>)L5[Z,W:!XRG<8CTO9-#^ KX#[_3K2F3.K0
MB='SPM&;#;)_L2X\+@*_!;_E24V8_,N28(Y0M8VFV=R@')"S.Z0_)B 19$/I
M)JT=*GCS,6,>P6"Y;@V.G&A$BR2KQ&235HF$ .M>$1*F;K$!!@9(5REQ&<(/
M3K*:0"#(A&+MYJHLY_@BD*>]&4D&:C@K'/Y33U$';4J KD[!LX'>#DW0KH,6
MFXJS.OT 4ZXY8" ='K4<@'S;82'(SLJ(CRQ1[]18#&>*[JX+/8RF#P0VAU-K
MVYF;]XW.3['YS!]=(>NG907FZ7H%' CY1[\!'J[];II_Y+2V6O8?.=F__'1\
M?GEV\NIT/#H[>R#;_<GV]MWYR2_'Z'=[_2*Z.'YUNEM7^6C_, H;N>]';PK.
MN[5]IV+?(0)%9JTMB12&B4Q1W_G;QQ@8XCUNY8SY%HK>1< NA%8AXT:Z:02!
M4A%HVH-<6Y '<0Y\F)R5(+OSN,-I*@1^0JPHF@Y%7D$%(T0>E #T<VI&+L^#
M#?PT_O;P27STW3<H9PT#ZTH*\[O(_VH@OV.A*#\:G&XA0<'S?WT2'QP<T/_#
MZ7CWDZ)'X7;%N'W7Y2VNQ?V-U@K_H;#XV&E!:D@3DS?B%*": $L(!K_,J3O"
M#(A*0 .^[X'_W5Y37A%J />R'8A_^X9CM6]1+9C]:/QR1YDDNJK*]2K2(2,_
MXLJ]4.PX[4/1$VKW[YI(QUY&RY_QB2MO">@^_3 S&/S/W1/1FUM!?8I>&9"%
MLG(IC'[QF'WIFQ;.KDOJ#Y.A\IZNZ;S*O'&!<E!ZAF"WO#TK?8 T,JPY<XB0
MCZ-Q2S1NOXL-<32]GG(QW7$:CUKG:9J2<BZ*86M>8>N!?8))$FE_!ZW"F"ZH
MGD_VO__^;V@UQ5(O,Q[1B@5V/[B,K8J:./H>?^PJH4U[$W>'.G:.U:2#; >*
M+5YEE+G*::FN%X!MFM32SH7961ZX'YTFO<>\)S.C$V@-,D!@4]#T% ^K\YUV
M]\-1DQK.F<0-.)BR+R^$44;_@#U9UPJ>X/8C;9K<U%-9)HG^B8QJE:EM:,K[
MK=_RNX4/]^2<X2^EN0(6<1F.F#@]+K2Q;)9:6.$,?$TYM*WJ:;VQ-2-X6/I?
M-^FR56=BAM<?$.%:I5O1NQ6:FS4<X7J1!(<3:U *I_CWRC;_GII>A \>[3^.
M@Y,C?4L8&)#?KEV=X4W'+R]>O3J)Q-,@S5"YW3-)PCJ0=#S6<HW@V;D(N?WH
M==G@UAH[<@,"$_XA[56\> :UJ +IEBV"_N!BWKL8/'Y(;,Q+Y$$9;'<+I9CS
M=X3)5]QEA9.1!-7&O2JXK<"C?#,7(>%XM-=X/B2(41?^7+^E_C+&^)C$G7L$
M2H +7:H$0KU Y,J*D9#BL&PP; CB A7$/EHO:)7T(TA@N_06WZ/W(ABX]=N]
MKC$ZM/2>XN">M7,>1[(&'1E.U8R.CL]FVU-PH5:O&=?O5*,V7>[DW4UX!O 2
M!YF.\,>Z<!>'7CL%WC@/]"H9,]Q13_ZM9'X6=90A5%9$>PW8F*1AND514RSF
M(W0D[OG^\'CR&YP80/<6" $]0[I$UU=KL6VM;D.>T37IT_(6ZPJY@U]H< -Q
M '1BS=X7Y2W!D LS%DW8$09X%T7L#66PI5Z3-6M,C427&TP(IN8\?\H*>XX
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MLTBD+DV;W;@/\*=+4F066AA]!7,FC'VI:9<"':WHMM-(A"L(>C]"%1!(L0O
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MT8&'!*2Z+KPY-OHH+?C8T:7B9#Q2>1+MR1U$(LN4L7+$(Z ,^(.I[96#16%
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MG0MCM^KHKD4W057,_9I8+FX>PG%2X$7S_8W!$[N<>^*?^ \@UG*=7VG;&DY
MU]P^TN/&(TVMZMS.2"^G;MXS5H%(7OK43B",3"O2M7C51E/>3?93*:V-Y/4F
MGM-]N^VILB4H]2SR*-E;6$2??4=N*Y<VR@N)=2&>9C ?MNZ<&D'@C<B4X@Z
M8\L"K$M-$9SYD%<G<D<&-Y+V/F;A@]DG0J68<)M C8D0Q"&>Q7ZA0MYB*U2
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MB8&V&16.FE_@15YO@H>E8W3K$II.%>IV0\59*-ZC0BKBJVZ/]M:A-A'ZNTY
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M7WMHTZT-05N=J:=)3K[X^CH%\V"O[.G";?I[^U6B+##KQ*D7Z5799$)$[1S
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M<I0!OSP '6<)=W0D2S#G]KH/R5H8'2H;VP5677T($S&(E6"+R2K@)4@Y[GF
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MNF_*'J+R+;CU-S"UN2D@8R=7$5V5)9AGSIKSMH'BI.&_ Q :L67#3AGR)I.
MBD7EW*LB]J7H,=FGTB$BYIQ+F*="AFVPAM]Y/[2\A8Q$/K?.<Q/64(@3E#K<
M+I<:9?YCC1(BZAGE@]B* HE&;[N(S'@+7*B=57(2&6*["TN6W-#MY6;TI%2N
M<6^B:2<?^<Y*CJW+\_Y+.B]"TG\+XE#04<9O&VJRV_8MZMDV[4>3U(')))X
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MPB4.S:WGZ\VCLR)ZB^NS9I;OS0:&.C;U(IOV>,+T\AL[=%\[)=L(J*6>!;K
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M^7\?^Y,CI$EWQ0M3:VR&8$YV4NCA:E TB0+U?6%.)OT9]Y,.^1E=)1 8 PJ
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MH2A\6B(.)>\/D1_^7QOY"3KY;S0//[S;>_\G8/1^^.WHP\XO_Q]02P,$%
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MS[DZ8Z\%::,/'=_ I*+%R2^H2+^.LJX0D*D6WWC/$>*&<PM!>Q*^OI[\61?
MK)G8974QT;HTQ6D_8;M[$0&D>;?"JW(PWC4S)[X>,^>/#F3SZ#1/IKX:DE,G
M&,+@XL:,\,^Q35K%NS0MHK,H%:M 5 -2,T#C6)!LJZL<+<C(W8S6E)4S+1I9
M'K2*\JT5LGSD"_/>8%.W-!<6P07<9:4]",$\G\=7V8#N&Z:GK><D?;QQDK*3
M]/&==)+>9N8Y&P57QSW?<.H):85>5I1M"7P",XY#!S>$G@AT78"PX\286BEI
MCV%.#S7BEZ'1T\D\:-'C&0H5<UR6:2Q=.9U.^I7*M"G8A)V.I5&J]=DH?XWK
M^NGZ@0J@1/\/=1XB9^NI]L\NP0C=L3V9>LZ=5>\18OPA;D-:X9#\H@VK "6P
MQ:+F8!#/U;X(U,K^Z]_V/@7E>8G/28TD*LJLUW-[<%TV[Q8$^[PX.2\Q,9OR
ME+9%1G]G(N1R5_3X>O2;RS3+P5,:GYO* DNUXF1M!$N;M]3S#[E\0^QEH5"H
M2TDE,^[EI#W;VT*'TI5>7?%4;PFCK6K;F[@_$3BD^,RB4E?G.#E5S@DQ MIP
M6A]RXX0[0+$GUT.Q<&#B(6<GQ(J:.07 &EX$Q-RF,L%8K!F3M37)\P6B+ND>
M.VL2JE^%4*Q6R#41M_YHM"K6I>H-FU$TE9FE8.?@!R]!20T./Y]CW;EKQJ(U
M^U+E+@=_9 EENI-@+DUUDLV8M.%#VP13 SV9C#BZ^!?9(;J*N$TCC8I#@5C.
MT^M,?X,AITP\1OY*_>.$7==4WN4%/CU/3LRD4L^<,7DEWC99/^IJ7M13]M!3
M'ZF2P6NMU@S-"H8@!JIXX>-EF="6M%AL&$C 7&";BDM!XM*\C8 _;<Y.S0.C
M/615],5K/J['@(O3,8AY,Z&J4&:[3-Z(&O+'Q<5IP@ZL!;J W4(:(]T--@L&
M_\$,:YQT9-!R/,NOF _I9&;,$H\FZ"+C!.R8O. 4Y\?\4"9"JL&(4X1X(:5\
M@I5Q="4U6"Q=NM[8K[Q#4(J"2KI[Q7&M?5C7#6"%TAO=%F[,X#6<=JF49U=:
M*4ROB342FJ(9VY -6$@:'R/J:&A8A5SW/B9K[ *!-H+CR8USD]4?/R6#W831
MW/%*?2KH/96SO!OT^]<H^&,AMH'S5MM()3M9T9T*G#\U=HS6IAK K&T9JD[6
M^<[U*OJ,HCO)D/JX;$AS-E=#Z I68(@2V(Z-': @F2($DD!\L3NCK#O,J6P)
M QZN,L*F;BX0=JU"Z)*IZPIA!"_M0*C:S&J-5 =>=99[U!,M7A5J]C1>4[]5
MS[R^ZA!4Z-+1%9"5$6AV$!LNBB1^0BHX7CKA+R%(ZX3E>=<:,Q,O]!JWI:ER
MVE\J2H1'<X$@47 ],2+B@CU!H@;"DI=!H738.FIH3V*.:AV#-S*(QCDB6+9G
MX=2R1OJR<$P:C'K<3\Q1:6QFYBP6S+@PIBM]=Z_Q*^HT('3#TQ]G=!NMYM6>
M2V21SLNE]+?5'(FR6JSKN[4'Y1B+EJJD2IE:0-$M*&4=IT1X;AJ7RVWV7Z-Z
MKE-_Z*M>T:+#J-T]2'J0I#0NJ1![=WL2RNTPN>"D^N62ZC@</'E0PUY< :'(
MR(FB^]50$W_8X-=ZD88GFT@#1QJ>W,E(PRVCV0Z][_/UN(<^6'ZT)(5LI:.'
MJV]8Q!DD.@E1%A@<,!J\[6K@L@],NEE;B=MPT%6$H]2T]I[@W(;YE]W.TKG0
MZ4GU9JZ>#DBFA9>368N48,BZK?BOK6JM9S:U9H)U1<(D1B:SD $339;[6GGS
M1DQ.\[A4T.JF)77&F8(@]V$#N$X<AK1;: KV;!-&LVXV%C7\L%;61)WT,UY;
M_'HT,:]^JC.['RD!%3S5F"$R7J)(*1#M7J>:I=Z"'[82-.QNF)/I"%6[X<#7
MKKJ4.XLKQOEZK#2AEB):G@4QVW)H"A*L,I3.$:LV8#?K_5OEI+X;)S.OG8SQ
M="#Z ,=Z/3]Z/XH!.X+@LCH+S15)=U?*,"X!UN=F\2P1N9"?97$#JI9S^6=>
M1XAZ!)3&0KL=6/""0K.NXI#L!3)63O/*A*<LJT#KB)##\C3(35XY3W8[>.W0
MP%F=+9M^WP0-)P/=.X_CBJ%3VK"-VAMY7H"#@+:';L%QS)78RKOO.AC(00F^
MBLIW,W$"=/75>D1X+8F,I\4XOT(:I\7@X&@SEJ\;!%S34, @^E5>SZ$@SU)E
M9%5YFL8<""" D?U3B^"#!.G,&?)%U==N0^-Q&JF7BOW%AE_+\*$&'M3;@Q%R
MSS6J=N0[X K->[[>R(^V@Z &8P8G\04SU@3%+-C#6K18!&<L7Z%RDTR57PKN
M!VVFI+12@,YV63TC=)D:@$DM-]X>(5@[64RPX_IK*221GA9$DEWRO9 "IW7\
MV>Q^:"Y/0?E3.3@E99@F5@&U9<M,U91IM="N0U*"(;FVU?CB8:.DF)@\.?V*
M*#[$07$[0S_UUE[:2V$SC0*J+&IM:2Q]3-H23X8#J@7J^%G-Y>;>@F=G&-#O
M4?$YKAS&BQG!" ADK^182A,*J9!T+W2.]:L1'5"-VK3QP(GC?9%5I>L1< _/
MV:=/I3ZO.*WAP-(3B)DQ4*%I##:SQV.T%/7VND9KI^@%7TNO]J,!NEKOC0I'
M)%UR*#;DR&<5Q6DZL[_VHCZXA,Z6K.R:G"/>.AA;U/0N3N/%"2:8>9$L,X[4
MSUQXY[C$I(:X (0@&F2"/D/I"2WYLY;AH'%14A&%2 /[J$W>;S(&"52QV?!1
M5 UL&)UDGFK2=:IB*Y7+^=Q732D0)W9((\KBLT[JU&<JLSHZ83&J1VDK7Z3N
M*:&H/_ !-%8U,U]RWXLU9AQ<?,(KJ8T<Q5%*^?+L#M4;WL"BPY'R<SP;$3M(
MG&E\S+5EPM@(DG\I],CQ2'JE#15EV9)JYV ?K7N@<>"4N4>;TW6:R)D48%P?
MO+/N XON5O9$Z&YGSD;$,_9+&WR!V';&^'&1?V8Q6<+^8M_GB678%N/,XMK:
M_"D_W]%F.7#-%'UUY(Y[.'AM$A)%.:2MI[VSA463O*PL>Q+K_J85J0VBK4&T
M?;PVHNT!4-\\L_+F1T"RO56 K,TMKDD-UKH;<2F*'C::VC?*M_QDT41&XJ W
MQKJ' [!MYU3Y[@-E<@(G\=A0@WW.8S3AL1M)5%090X4>\]5G7J-U"?O1V4G.
M^:"<#!IW(AF1RPT5C$FR0&ZL'(04,EN C7@<F_(JTWD+N] PYS>=D^3$,7*5
MUKT,HU#P/MD[,3U-RKPN21 ]47).?=G.VB38U=F$"Z$1#PZX]2F&R$"OSE.I
MDI24<-QDLA'8$*XHJ[UQ= '%<(P12X_)&D$AH/'ILY%-OV=&.@_Y7S(6[K(X
M+YKY*ULJ,U"!FIHXX,[C#K@JF(8\,QSL/C /:;_YR(K+?HK1"19-^JE)\I[M
MQW#^C>U_T+K]G% D>TUVFRD=,,C&RS0EEV9+TE.MK9=#68N.(\3*\%(@T[PD
M=7B21LD<-Y:]+:%5:A&/#Z>"XG657J4"+1'()C"LSTLQ%4E<CWSE=FN"/AGR
M_J.KQ(&)OJ-)^:W/(J<W8ONV(BF)PI:5V/\:, [1+53)+^NC\3%LSSKI'0X;
MKA='ARY/$Q>#N 0G*:IO)%R]"FC:/;F ]23(:XMS]2JJ]6NL'9UZ"BT/B4H#
M(LC2W6?-)5]9O@H:@+5Z;C_KHR.O_K*5T*-:D@O50NZ..-9TFN2IS2DVV^ ^
M;*(EM,6XZMS(*^'7"C;=-?D2 XAR,"9^R&L5T/D.W;[FU:I[=ML:M+6KU S3
M1 Y0ORA)ZIC12T2LJ'X?2DEN$@4>G5OC"#%9Q!^Z7%#*<UMYLA8&7NV.:E;K
M6<0UQSNP!9#$5,HD<1B; ^5@?X7?N6:R_EQ2<A74';%%>RMZBS?#D(*"*%@5
M">S=ZIC>&=E1W%'8L#69/S74.?47W[58ZKC#8:H^9M,"YKTF2]E**FDW2>0#
M0C)7Z>0RG9,(-2,S;49YW@OD#>P"24H#LS&R!<>-J]Y W3"@&V+#GR]B/UZK
ML\?(B7,?'2$2I,5=J>V;C+*L*#8 XBHV>8[&$N04@,R5G^F2)%NV8TN:(H4S
MK@=R1\<8!O6\+]B."\W"G'(SVN3C6BLH%W_=O"5[TU.#,F#]'VH;GVQ-1AV@
M\770+AN[-Z@Z@DD@/A[$72%NABT,%<@+B3P#P&(D$6D83))M;.TBKAL8Q7/-
MFJ!7= :\:#LXY#M/9D9ENT1)\V+3[!'V>L)^/^G^Q$PJ-87TY"K3@/RF=39!
MN\-M@9?.K+9FC!JD$ [VL9$AZ8;%*07U[#IGADH[(P:"X.7[*MH2+]VISJZP
M=.R690FME]GVRR:SC3/;?MEDMGU[FKU9\/MV%X[P#7;?Z%X0XK[!5K=4_Q68
MYCE_Y4E6I>=M;IK >FF\6 <JH,[2QMB!L;_;;.H>9X%FYI=U%.!8JSP%H745
M* =!8]88TK*. ,/FF\9VN=+:'@[6,K=!3KP3,UM;L36=MFG2-C3OI^U6[7!P
M<;-6B:<6P]9++%Q;UZ1,PTO8K\'5FJ^@%5S:?@VNP7S%XUG;?D7+K-^4"SQ+
MKM6*TT8<]4DW1\]8\S5H*J\[3;?)4LO%\LTUAW2W F==C+&ZYX3,B0NO>[7Q
M9Q,5]*,VWH3^"N8T*YK7&/"YZS(9E?&UALT8K&$RKFWW!;[9-QQTVWU?88:V
MQ!<EFNE5K/B9@-1.XY@0('D<VT!=X.2 74>%^=B6U.4,H;V5Q96)GUN78UMS
M^H[T7O*(6M8D"->J!N>QE35N I06+/EJ>@C<9V<74A63YEG88GYL\M2M1.J[
MU2-T+4DKD-IREJ:H<@U,# UJJ1^KT9* 7!0X^2JOF443DUA@/54_K*URLP#S
MH/>]DF9R<(IU%5"AP[(.>-# 1W4Y;E2RI^SYV \&B,JFZ]"4C>T22K?@XCDO
M_8$RC#]&177N.^R)2AK/R*2L]T%Y)F06I#^!]CAW<Z!TR9+7L(6/-B=Q3GI;
M?18>Y(2YKLV?R*0H:Y><,"3+41DIL:R/F4T\0Q8BJ#580*'!F&+1*(WR9=*'
M5*H7ER]$J)1:D=;<'C-)5807M65$]B>*R&0#.]<FD(2);0K7:LX$IGB,+BV-
M;NE0)PI&_63YV;*C+>YKH#X55/+R)3M\VA2D0Q5@U.;_32I+X<,!U</ +AN(
M48.',,$N<'PB\T5,/_: +Z38T$<F%7P*51<)0C+F=)\9=I6C$F44Y".EC<B.
M&J<449/14\4,DWIQQEKX"XAG$G?1Y'>0!?SUK',OTX0'2F'O;>0K!DH"H52X
M+IP:!T1[)S,1KI@!DRSP%Q:'MG8]QM)"VUPS/R%,[$,>S#)5@W'ITKPZ.!XB
MS>(<*)"%1O93"E!V7!Q2R3@K%-53%3Q!+8$)K<X,0FJ6N)JW(87&4\=\6SF<
MQO*2K>1<8'<":W"WCKUH/RJ&,'W(2T"$C"F?&JOS+3^@,*,N=TNPWU@T=3\<
M&=TF&.<&_Z2;VS:WC<6%ZO/:RJZ= ]INA, A,U]0ABKB'*8)RW(+: R,)DT^
MQWP4!-(L>:,,Z&^&)W.1L*D$=Z6Q'G-U>F3<EFURAK8M):AV[(H'#-#R)AW3
M$T8<I]2P#'T 7;>T>5^Z=KZ7D)$Q7TA0VSU1V0FMB;9@GLQSKOCG)AF-)?3<
M_?8YCZ3DOW<U8S:#5%9E&5=5ZAPY+;R- QMP8B8- X4M'@I(.(.:9,%S^)^&
M5F7(9::(%M]R$J<"WY%&Y_%T.WB?=\[;I7^PR84!K-KH]4VQY!4:;...I1H4
M9+7:)'.(]"8^U*ZT8*2(6 "5WI!'D[9.#2-\@0H<X!E;24JP]XA+VL?+V;F'
M>3/.<,TD>2:P%4IT@45Y  9024V:?X9W0L#[,).8EM^!,^EQT8X+VJXQ*TG0
M^P)/@^Q7GU5TD%-*&(-'Y# QF&GC2I(S!C8QBPM!L,>;0+C[E8F%.O?!R"19
MCV-V2G2)F)K/V#C/X:+5JNKL!11=W;"_VHLUH_6L E^5[S38BCB94ZE$%YMV
MK4IR&SAN5UNTZ]RH#+8T&E^C&C&W7O4;4?K)JUW7^@7#I ;>4O.)?+\EV%\1
MJ?W[)E++D=J_W\E([2V61=?5$8_]=#8(8+UQG%7C<P3VHUD7\E9$R52/M\8C
MJ>RV"4-D^+1;DU@ZAC'-A MBAP,*X;8^;>.Z1K4T@<@*JQPI7MNIFT[,HFR?
M9W%TD[Q"J1B=TU3% 3T<M @O$PZBR G+ \;%HK #:(Y1):;-+#7HHNQS)WM5
M$O,[1 T*DQ:;K",-241+V)GM**V.L!I (3;RCN&LS["N0* ;#4Y=&I^B#PN=
M^15M!@E];#Q&@XG^WUR1)]16+<D9'KZDT]#S(9X.:BLT,<:R#6T=,V5N\0;@
MPOXEP:TZ:LSE$J9UM'%EQ!8D>X1YM=RL#C'<HL\Q_4ZRL$(;$6:ES0M58F")
M.S^&G5L(/V_3HJQCE?P#$A@TJ=.GTF$:)O8YR\^H"B3$A"S*B? G04[)!5+S
MDIS3A"54%()@BY#\UD*/I!]*:PR'$_7X3@T'+9=*+)E&E8J]QIHN#.:BK0ZO
MH;JY//W2[XI=T\0Y=;HOD]_6W)D*O$9AIPU)+8R_H"W IG1GW[O+S(1_RQV3
M'/B?SL:S_=^:$VGGOLU"0Q7/P^BLQW[U-%JR\ZAO YHSWYMR=RGA>>2N3F"R
M/<A-:5U ?%+B7<!WL:YO&6,R<Q*ECC7E!U8129)<7CZW@],+@*U&U/3+=B;D
M'!S+D5U@7CU%4[0X4H3&U !^[>+@&IO!^(^3.5PVE%SLR)^(3Q*]1<=%M#CI
MBG9[ZW>A$6:0+L.Y*V]T_6"X+?.^IFAX\\S:@^'#P55'PWM%4[\<JL7,@60O
M$BIOBX%WG.<=BW\?.4[+"HQ4KIF-B8QL*?T<-(^ T&V6.)@!X_=W;C8;N&Q(
M?#P=A/!AKW##C<*N\6^ MK4I!S?EX$_6+@?_/2DGH&5'69PORTTQ^-5;JI]0
M3TP,V-(!LS];I!,%Z'\ SE:OC2MT=P&CA#+#3 KCG*<"F%7U:L.!*@0W>74V
MXYC1O0._H:O/%CBIK14SF9S(&!("=EV :L&,/HW.2#IU3$>[CZDO!RW,UL&V
MHC1+#=.DK6)/)M VFB1J^UA*@6F4-!R8HB!\7LQ1L.GB"O-6C2!U:I9HL[ Y
M(#PY3#5'P<XZA3'XN<#74\V=9-7GG3BA[90'Z?3;]-ASZC@WA#+.435OV_+5
MD1:N=&*GUKJ#7IQ'&MSP!$.7[4%X7)3%1*F&]-E9E)SZ06P)OQ9([N?4<0ZH
M@/=N[+;L3JCNUUB7\#X//B;'Q^=C*F_/O/S!\AE:>-3@CM2C+'C#$&2$U-N1
M:FCJ&:3-EC95X3$8\5!Z]P4/MW>VSD;X.!@B517AYT;ZM[7\,-T!],W+3 T^
MWUPIYCT/3)>&+>-,B7RH>>,:FD2+:((_,+8,)\LA+B@R+Y.!H+' _*O?FXE?
M!K7A.T!$F_5^PP%>DD9/!36(<H$Q0F'4"9DA&+D*SVTUSIT8A01R")8#_LQU
MI&@!U*RGIRG%\ GZ1MW-7PA)>=M(45D!N+.)R*J;ET$:5*N>22:,*KW$8LX6
M1E?FP$/QQ6@] AF=Z?.L[4VNTELHG8/%2NO&WPW><WVYL:]!5;1]OU\[+&;F
M("_/Z4I'$VXMT9N<'VIL&E^*D85H:G))8')T=3BPG=IJ^ 'U"NASOP3Z<T)P
M=.4$S*..$NA M]@(/<N9&E80.^0T3[<%<--\..J^QD4&Q*;C\C)'X#Y=!%_C
MER74,G"Y)%EGW9)+1F]-6P\-%?M5!05;$76 M^8<.0=<.4$\M8UOXNFHUGRC
MV=MC.+C!YA[>Z$)$E/,YL1[E4FK)-<*O8*&[HF?CA_$A+=51,[/R3[O'<>'2
MMQ5L+;F&I::AKNCIUAUW@TE=7V!PSTDCI(4_44\U19M'*U3L>H9YR[,&&38D
M4A7?JUP/,&WF^90]Y5Y-#J:1<#D238;!<UU+URFFNF!/JM)UHU1#2U:)&@^S
MQ#.;;F63%UUNMN(=5#D/)]($KS3^0Z-CP1B/'VSO_$21H;RPUY,"E_FRLN!*
M'62_A5:&5"XQZ#0J(C86(/C )AFLKUX?E)0E?4;"P!J;O&VX@PX=P?SL?%33
M:2C=TJN3LL=C/=ER('2U;;24G<Q^[G@".X;9EM8>1Y#Z8Y 9"YR&;*"@4*IL
M/ :P;KP<SH?>!S/M>YW&^F2VQ"4G74+$NMMM0U6!2NMF5<.!KUO*?GCM*Z:8
MF-D"P,M4RMVPU;6H3)<H!PW?V\S/Z7*<@137"ZOYH>ERPGG4$I"@R"M^:_M*
MF.;'WF^;>:L("7N<49M&$@!BB:@Y#@<:D=U,(1>X+[JA/?66F,7I8Y%1FKN!
ME@Z]75;=-ID)M#$ -G$PW:P&Q!R95$<)HW, -_Y"A:&GL:OC% >)%_1 P/5Y
M[&V?'[3A>NY4\A_,O\#TXU12_[UL\)B7B10G-L4%I75PE4)SG95DBNM0F6F\
M?Y0E9C90%O\,#5;#!I#GA_C!27Z&I?G\;ZN ]##W-MX>&-8>UGD[EBZ0\=P2
MLFP;"+N_%Z <V=',\,X  S4 DX&]N)@B1<1=C"5VS8F,C!/#Y5SX3YQTC< T
MW?E\4+* S31;++*ZI/$G%J5@L26EF1<I.>I,56%!S3GWG:DZ7Y&C]^LF1X]S
M]'[=Y.C=,E4\OD9?)1KNILN$@L!DB][#DI[/EYE&P!?\>.0;UBA#?F=A-UE[
ML"I?S>:B+&_7[B-J9."TN2R_-WYTN?.>7>EY\Y+TJ1^:ODVL5.R5J&]9 \QW
M]$EW#4'\Q5/A=D$2OZ#(P3AA-<JE#O@#.)*(>"B*IBA,72N '(A8UY!*@?2]
M"T8AX"&"+9'XH-;,X^(X+D8Z$(5D[8)RNIQ[K1H>)3J5DG0!2\Q')\*I\[2I
MWL /'LJ,W0P-3!!754@1(ET7P>N-2K7CM>3:[5^L2^>.7J[CZPS\'.CZ%KNQ
M<K7>KXZV'"['H+4EW(0!4X)(V,?<MD\.CESRID@WRRT[K<6F.]X:!I((9&$?
MVUW\(0\M.6'&>S>W=3O*R%%A(@9&)@5>)2E2S)-M$IP13#&QO0YKH6DA9154
MJF,A:C!)4S]:MJGRQBA;*W+V9"L9L?6Q1DRL<4K&R$9<[,STMJ_OVW! BS1I
MQ5X$1':A83XVXG"J_-?8$K:W&IM#Z!NFNF-!$T6<KKMQLT^N[6;O?Z%&RY+G
M_ J3^>("95:[T!3C.J9?25[766Z==A/U^]#($C:>STYL\G>5'U.:NBE1'3N;
MCH)JL?4.DKT7>4D(YB<3=""X*".]7@^O PK6 TDB=F$S[ZV.9EWCK!%*16DG
MI!+5F!O!;AM7DW!65JJ=2RWQQL8$V!>$R@#LL9H+YEA$$^JP(BBC*LT15W%_
M'B6IZW)$KA6)T&POIC,)S 2<PXY<,*( J 27W+!2^$%9IO"*4Z!%1JH2M4>C
M_&A]YEP(@,)#C*)Z=I)3<B=AJ=:&24I+,"/'SFB7&MBM46DKU>T>D+.E97UN
M!#3*.(<8:[F!Y5"[W$JXY)U@$<DHN$(>X1C$;Y@CE1$QO(O.7-,^4U-"69X3
M?L2ZH*MB*:401%,)WJ8XH\.V%YE0$1;8W*J]OTA;%0P#VJWEYKJK2N!?UT0'
MKY;S)9?.# =^5B%7//$GODV<<*+OQ/[4@I-:/[%-+I2DE?IK.*'O>SNZKW#6
M[3S8>.O86[?S8..NNV7,Y?,U,1>,>B%^,2?_>P!WR/I#Q]_# )-VLXCM)435
M*:3*ORE $O0MI&N"!&"%TQACC22Q0/E+J>\<2+"<*_66F4@P='APM)6!Z"5%
MFGPD6""F9ENZZ;('2$U8FVRFF\IZ^/;:E81):F>LE$<"$A.*'<I.2UE09/,
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MZ%5;Q<<M:"Y<$6^ JPT.D#<Z9>_VC.X+6=N/RD B+91 E+9=ZF0;HZU8ZG#
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M_3F%]T'2/!E-QMM?] CO;'__E82'/!EV2+_]+F[.=@2?'")I^$S19\/!0;*
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MK>3(N?5,/YKRV!AK#H+*G<%I6\]A[#!V/S'RP $@:F19Z,I<&SQ('/>1STL
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M.DK1JA[Y+B2]RMCFX30N[?ILEF15[>Z+[?OU4>"ZE(#,#BS]V='=HC\(5?)
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M+*(K?CCN+P%C@NG02(<.3+FK1[O$/4AIL+J30I7+&M0ERC,/DZM#M/EN1G1
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M>W/;R)7O_ZK2=\#U)BGR%BS+KYF,[;B*DNBQ=FU)*\GC3*6V;H$$*&$, @P
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M:SA)]ZDF@''HS8@/YR):F5"LAIF!QK@5%*'(TG\N4T;DQ]$<E/_*)!"@JR0
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M]/")=WR*UCDFE7/ *(\?T8B_$"*%0BUPA69]1K87%#"*1Z$W4"]\]Y'=WNH
MECJ<RV'>KK9$]A^!2TT"VWW0H3<!;CS]AM$0C,;3_YT8C=_UA+*1IVE9;TI6
ME$'.B08!C.-L6J8+L=OUP9EYT!0X0E@@/FF+@"#3M \JPS#20P2]*6_5!T8G
M7Z:8B#J<@V#KB"RR2N'$2/T,*B,CC>;>P%FW?5VD:&2L31I=#46>(-MMGB!E
M\#L"B<TWRJ(WD^_.'><G]1G1DIU(9S/; 40*0LREXA1IT;##DI9&I+DG7/2*
M?4G[L*0+_.IY])F#)(CO8)2?^!0<;$ GDEWJSQA!.J4A&PJ%AI#8/F"@*;L3
MZN@S_ ZZ)6T_"&;RY%&= YI&6Q?QX H=\8902TG(&=:5&?AB)VAQ>\MH,";)
MJ&^]-K>@[H_FRRW@OY;T+]:K4P1^#/)Z:O$NJN.1;:MQ2F(0(7YR65PG5U+1
M+@PX%U^#BE<F!M(1=V%\C9UP)!.R_A!G":ZE&_H>[6NTK(WS6=RV;7,&W3Q(
M1>>*C:CN ,4WWE!-'BKC8XOR^.6!%.GJ^+U=[H'$$V6'4Y%L&3Y\#@?4M X3
MW 6>MIS#_V:@Q*7BNP*M<SX!72E!95$/IWLFD>68HR@C[P0=:"=B6/!OPS]&
MF%FCEA&^&VC\,*9DOV*:5)6D^'G%'YR:?Y2# N/.)/R%B^I#)3&>.N=-!9T<
M%.&T0A)/LR0BE(];<4_T6#)%!(%M<-5#6S?&GS0QZK+(00]>'TNX-_Q1&"38
M*[)3>T7Q27WMYP[#8$<VFOZ<-XARK4*]79 0$_P>(ZBXU$C*3DB&- F7 O&.
M][@R41N^%)W".W35?$D2OW]Z?D()\@VWFZVO],X"P.R>-.XF[HF$,_'#?GK2
M96N7/&H')QS'R*I14Z=G?ZQ?VW/2AGJG8>F&?[.;6'P0,G%58HS0XX=LVE_D
MUC@L-BABY8%]!G5QD1#?,/Z\!LE'P#<S=&)4H:DEPYSF)"DK(#^[R3FH'@68
MHX?*4_>H@;#:;IBF?54PH$7+&T*G$..HKLMTLF2?X DG[[EH2DRU)U5UDN0)
M<GPJ455<DX:(GM3*Q"SWS!/!\35<Q>H2-&U[KKS,:BH8-MR1C* W7&J&0%"$
M$\;AT%BZ*%P/3[-T38]'JCG3%A"/H@BU1Q_\J(L4)DZ*#HYDL_=OF+_:C=AB
M%YFFMS#A4LU9Y,*$6#V6IP7TWWQ:/+YN9F.6&'5L.$10="&*@]PZ>9';H'O/
M/;V9\/:T-L@/?W"H'RCQ27\F\):=6XDJ"LC+RG$Z+YW)45VWG)^I_<G:J^8D
MYOO^-B?F8'Q9+CHV= ;QJ#LVONYJZ*.T[)<#3N8TDR]=_A=EQ46Q-+J)_19Z
M;+62B/CW;IO0>@_'GS%Q*8A:95ZI=DW3X1IJB2@&+^II<*MRALY4::+,%(Q^
M.XVR*=93$&6Z)ROX\=,!.O)%GX9)@IX-)M%H6AN%MEQF<HM+4Z&A<LLSL-(I
M/LRTE@OE9"DW2=B*ZFCU%L]WT PI:'D579A<7PKU8%2@?W%![]IL9)-#JCB%
M"BYM94#?)*+1"" JN"YOK"6=9BWR$C%P&B#FVW+3/W].(9N4"\\@*,NIO"IY
MM9(0ZW$NLAH3,8[<=/S*@X(-R"@5<B$\OG5)VV<<L3&N4$0:]#-T/>E2ZUN-
MV3Y.UIB?M519'\!] ":=5E.P8SH"9;IS5(&U4D[5"=AL1JXD@:,MS)N$19_2
MW5 VN(FPVUNW15FRN@DB*4$]PS?[%0HP)5UNW%6-D!1-]0,Z4288]PHUYI6(
M$0K<DX(W!8)$TY5Q@7C4]I @(>(B_<V(C.^/M34,CB[).8%7)X%[3QR( 1C.
MAIL4U@UX7XL]V$J,7\+[=CQ=JY-G![0I.KMV#4<'TVD=J[ZN$5KMGST,F0'3
M=H[3I[)0*&9F4W@'HV#H.9?,[7"SE!GV"98U<<8<79><C2RLT.C0^P9*$#*"
M58#HXE(*@\$>O"^"P<O$#+Z$XS1%XN<%6/D,-/7S="E=9[_US48 L?V=N@T+
M0C KN:A)%'OTZZ.]2U>5ZQ_4?ZUS0-.I)+JTL)%=^'"G=*8#F27%A+$O)6DB
MI%?G])*&; R29O9-;[C=3ZW6%1RRC6\+SCITV. @=5VZ'NN03D&WDH;3;BJ.
MCI_3HE5\Z[6EFI%.%MRH_5:I1K4)Y!15EKNR*_2+2'#ME'Y@X]X:@3=8;FY;
M!TO*9SL__/!G0X6NG=4[UG4TO6#^FJWPG-/K[:W.N&ZSZ(KL@@3=Y2XVL_3G
M!&ZB_("$ 23R\P9F+A7,;M9P]75B/V]F$],9;I4I2TC^:<4P_>!L0C=O^$J;
MT"2]#QD&PR7KLL+K%FRQ+8XD"[9 A5NPA*!PKG:"4>[LDFAFEI#;6YV4-,[%
M2>(D=MI:VM\]#EZ=?3AY7=6O'N&_5+[.P1LJ_&-=:>ESMI?Z*_DZ!A#\O2Z7
M4ETM1<S/G'L34'!!?)HV3*A)4_"E%/8'&3#ZGNM5NP!6JU80T!(AJ$59TM;Z
M,QJ(&:%Z&_L^A\)O-,B2*,$H(H.3QT1,=6;044';,$:8W4UG6FQ9:UUPR;XY
MUC]B-8<#MLN%$ 7LKP3]39B+09>R2DO%J "U0>QG7);8GEZX" 22,6]E)N!F
MN[:LF]8VT7%C6YY*J%05O-VFY=U#:/PFF)!GWS A@@EY]@T3\GMVPWEJNN'L
M2R>BD4$Z5/>N,0Y+VX.44($QFWUGBRRM%5_0U$K=AC7 S+.D98\["@&7G5U0
MWBP'W;@*;Y+'7KB%N#0^$V,]!%5<D2D[OU=4H<SJ"ZCV^II(Z7A3!4I8F)\<
M]+"C=2O ,LW[-)$!B2QR3F*IY2*-576)B^6D#IV E+KUQ=+I4RZ39B6F]9[]
M(6?5H^R9,/6J38Q=D)SD+D:X1]FRE$+)II\6\PE(J\H#QR/D7)H8H-V2\-8A
MUA(.QO +7E[-,8FLZ^U4I/9JR/2HN''!-,,F")0B)ZX>3^VD0^@8\QZ1I]R8
M3 Y9$_1*9J#G&JK;Z"*+E_%P2)&+P'*15["HI,368/:;&]FD PZSD&&'RN:R
M7!FR: )"GU+-_%W4$%;=/3<9NTSS@GQ)7SRS]:J\?6?(7KO.,3>,5EF,#VA:
MK"/*NZ1ZK9055XNFKTZ$A/=:(W.L"11Q5OUB5N^=VO8$BO+QN(YVBX5#S1RI
M=H)1[M%?V"0-N<VXG +9UIH_TO)>.\"#JK/$.7L+'1[I<42"/N&LL&RH/ZV.
M#2,_O/D[3<ROCT :*/$4=EHQ,XB4^99@T__'L^<O_7MY3\0?]U@X1/."P9I
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MC=>.B'SK5XX+1RNC!X;$3H'!7C6%8*Z=>DK@JBD-=&K2^9SXVWFK W>G._#
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M5ZX*>(-A\H:??;8"RGV_NSN:DH=U1E^E*1R_.T?39K'*T$D&:A@I!R:!AI^
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M?&&2%&K@$]755. /3S@RA39-014_1G,VA2\*][K6BV6MDR 9TD,K^CY^R<9
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MBI*;)#3)(V=J2TE?$#!K9B[@.R1TS<+D)%-*"9,/[0KG.]<V'+@,JJ1N48#
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M@<C>"F M,\;_9FOVK\UO%+['4"WV8^, -.<BO%++2A1:)1>0H9E+_C,ZZ7@
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M08#28\ZX:UO*6Z!XFH$N:9[D>_D\W<UVLR+<TCA3XHH-R)QB0B\/@@7 E,Y
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M%9*6,CQ4;/;Z@"ECD CR<6)=X2IO:%A?)=/*W;T";+%U> 6X41@$!#9'YBO
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M;VZZ%I_$9K5)_+7"&1%;_@M02P,$%     @ 947"5I$PC[]6!P  UU<  !4
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M+;YQO]Q;6.V1_P%02P$"% ,4    " !E1<)6\)@S>SD@   GL@  %@
M        @ $     96$Q-SDV-S4M.&M?<&5R87-O+FAT;5!+ 0(4 Q0    (
M &5%PE97,<- TJP  (R( P 9              "  6T@  !E83$W.38W-65X
M,3 M,5]P97)A<V\N:'1M4$L! A0#%     @ 947"5KOWCXB&5@  ER " !D
M             ( !=LT  &5A,3<Y-C<U97@Q,"TR7W!E<F%S;RYH=&U02P$"
M% ,4    " !E1<)6 VS115H*  !E/0  &0              @ $S) $ 96$Q
M-SDV-S5E>#$P+3-?<&5R87-O+FAT;5!+ 0(4 Q0    ( &5%PE:E:.&J]3X
M %I' 0 8              "  <0N 0!E83$W.38W-65X-"TQ7W!E<F%S;RYH
M=&U02P$"% ,4    " !E1<)6ZJ$=X.=$  ",30$ &               @ 'O
M;0$ 96$Q-SDV-S5E>#0M,E]P97)A<V\N:'1M4$L! A0#%     @ 947"5I>.
M 8=8/@  CRX! !@              ( !#+,! &5A,3<Y-C<U97@T+3-?<&5R
M87-O+FAT;5!+ 0(4 Q0    ( &5%PE8#G>^2L L   <U   8
M  "  9KQ 0!E83$W.38W-65X-2TQ7W!E<F%S;RYH=&U02P$"% ,4    " !E
M1<)6EN$O@<,+  #'*@  &0              @ & _0$ 96$Q-SDV-S5E>#DY
M+3%?<&5R87-O+FAT;5!+ 0(4 Q0    ( &5%PE:CJ&R1+ ,  *X+   1
M          "  7H) @!P<G-O+3(P,C,P-3,Q+GAS9%!+ 0(4 Q0    ( &5%
MPE:A3?;=_@H  ("&   5              "  =4, @!P<G-O+3(P,C,P-3,Q
M7VQA8BYX;6Q02P$"% ,4    " !E1<)6D3"/OU8'  #75P  %0
M    @ $&& ( <')S;RTR,#(S,#4S,5]P<F4N>&UL4$L%!@     ,  P /0,
' (\? @    $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
